<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>v448174_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="color: Black"><B>Exhibit 2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>ARRANGEMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUNOVION CNS DEVELOPMENT CANADA ULC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>- and -</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUNOVION PHARMACEUTICALS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>- and -</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase; color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CYNAPSUS THERAPEUTICS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase; color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>August&nbsp;31,
2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">TABLE OF
CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;1 Interpretation</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>2</B></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; width: 8%; text-align: left">1.1</TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: left">Definitions</TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right">2</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">1.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Construction</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">17</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">1.3</TD>
    <TD STYLE="vertical-align: top; text-align: left">Currency</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">1.4</TD>
    <TD STYLE="vertical-align: top; text-align: left">Accounting Matters</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">1.5</TD>
    <TD STYLE="vertical-align: top; text-align: left">Knowledge</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">1.6</TD>
    <TD STYLE="vertical-align: top; text-align: left">Accounting Terms</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">1.7</TD>
    <TD STYLE="vertical-align: top; text-align: left">Subsidiaries</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">1.8</TD>
    <TD STYLE="vertical-align: top; text-align: left">Disclosure Letter</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">1.9</TD>
    <TD STYLE="vertical-align: top; text-align: left">Schedules</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;2 Arrangement</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>19</B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Arrangement</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">2.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Interim Order</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.3</TD>
    <TD STYLE="vertical-align: top; text-align: left">The Meeting</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">20</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">2.4</TD>
    <TD STYLE="vertical-align: top; text-align: left">The Circular</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">21</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.5</TD>
    <TD STYLE="vertical-align: top; text-align: left">Final Order</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">23</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">2.6</TD>
    <TD STYLE="vertical-align: top; text-align: left">Court Proceedings</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">23</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.7</TD>
    <TD STYLE="vertical-align: top; text-align: left">Articles of Arrangement and Effective Date</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">24</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">2.8</TD>
    <TD STYLE="vertical-align: top; text-align: left">Payment of Consideration</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">24</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.9</TD>
    <TD STYLE="vertical-align: top; text-align: left">Announcement and Shareholder Communications</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">24</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">2.10</TD>
    <TD STYLE="vertical-align: top; text-align: left">Withholding Taxes</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">25</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">2.11</TD>
    <TD STYLE="vertical-align: top; text-align: left">List of Securityholders</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">25</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;3 Representations and Warranties of the Parent and Acquiror</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>25</B></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">3.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Representations and Warranties</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">25</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">3.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Survival of Representations and Warranties</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">25</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;4 Representations and Warranties of the Corporation</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>26</B></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">4.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Representations and Warranties</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">26</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">4.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Survival of Representations and Warranties</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">26</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;5 Conduct of Business</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>26</B></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">5.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Conduct of Business by the Corporation</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">26</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;6 Covenants Relating to Acquisition Proposals</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>31</B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">6.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Non-Solicitation</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">31</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">6.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Notification of Acquisition Proposals</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">33</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">6.3</TD>
    <TD STYLE="vertical-align: top; text-align: left">Responding to Acquisition Proposals and Superior Proposals</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">33</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;7 Covenants Relating to Regulatory Approvals</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="text-transform: uppercase"><B>37</B></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">7.1</TD>
    <TD STYLE="vertical-align: top; text-align: left">Regulatory Filings and Approvals</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">37</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">7.2</TD>
    <TD STYLE="vertical-align: top; text-align: left">Cooperation Regarding Regulatory Filings and Approvals</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">38</TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"> (<!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence -->)</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;8 Other Covenants</B></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="text-transform: uppercase"><B>38</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 8%; text-align: left">8.1</TD>
    <TD STYLE="width: 82%; text-align: left">Further Assurances</TD>
    <TD STYLE="width: 10%; text-align: right; vertical-align: bottom">38</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8.2</TD>
    <TD STYLE="text-align: left">338 Election</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">8.3</TD>
    <TD STYLE="text-align: left">Access</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">41</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8.4</TD>
    <TD STYLE="text-align: left">Pre-Acquisition Reorganization</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">42</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">8.5</TD>
    <TD STYLE="text-align: left">De-listing and Deregistration</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">44</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8.6</TD>
    <TD STYLE="text-align: left">Shareholder Litigation</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">44</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">8.7</TD>
    <TD STYLE="text-align: left">Directors and Officers Insurance and Indemnification</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">44</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8.8</TD>
    <TD STYLE="text-align: left">Employment Matters</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">45</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">8.9</TD>
    <TD STYLE="text-align: left">Covenants of the Parent</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">45</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8.10</TD>
    <TD STYLE="text-align: left">Outstanding Rights</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">46</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;9 Conditions</B></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="text-transform: uppercase"><B>46</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">9.1</TD>
    <TD STYLE="text-align: left">Mutual Conditions</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">46</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">9.2</TD>
    <TD STYLE="text-align: left">Corporation Conditions</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">47</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">9.3</TD>
    <TD STYLE="text-align: left">Acquiror Conditions</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">47</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">9.4</TD>
    <TD STYLE="text-align: left">Notice and Cure</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">49</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">9.5</TD>
    <TD STYLE="text-align: left">Merger of Conditions</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">50</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;10 Termination</B></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="text-transform: uppercase"><B>50</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">10.1</TD>
    <TD STYLE="text-align: left">Term</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">50</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">10.2</TD>
    <TD STYLE="text-align: left">Termination</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">50</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">10.3</TD>
    <TD STYLE="text-align: left">Termination and Payment</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">52</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">10.4</TD>
    <TD STYLE="text-align: left">Effect of Termination</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">53</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">10.5</TD>
    <TD STYLE="text-align: left">Remedies</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">54</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;11 General Provisions</B></FONT></TD>
    <TD STYLE="text-align: right; vertical-align: bottom"><FONT STYLE="text-transform: uppercase"><B>54</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.1</TD>
    <TD STYLE="text-align: left">Amendment</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">54</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.2</TD>
    <TD STYLE="text-align: left">Waiver</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">55</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.3</TD>
    <TD STYLE="text-align: left">Expenses and Expense Reimbursement.</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">55</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.4</TD>
    <TD STYLE="text-align: left">Notices</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">55</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.5</TD>
    <TD STYLE="text-align: left">Process Agent</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">57</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.6</TD>
    <TD STYLE="text-align: left">Severability</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.7</TD>
    <TD STYLE="text-align: left">Entire Agreement</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.8</TD>
    <TD STYLE="text-align: left">Assignment</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.9</TD>
    <TD STYLE="text-align: left">Governing Law</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.10</TD>
    <TD STYLE="text-align: left">Contra Proferentem</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.11</TD>
    <TD STYLE="text-align: left">No Third Party Beneficiaries</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.12</TD>
    <TD STYLE="text-align: left">Time of Essence</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">58</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left">11.13</TD>
    <TD STYLE="text-align: left">No Liability</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">59</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">11.14</TD>
    <TD STYLE="text-align: left">Counterparts</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">59</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"> (<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->)</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">Schedule&nbsp;A
Plan of Arrangement under Section 192 of the <I>Canada Business Corporations Act</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">Schedule&nbsp;B
Representations and Warranties of the Parent and Acquiror</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">Schedule&nbsp;C
Representations and Warranties of the Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">Schedule&nbsp;D
Arrangement Resolution</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"> (<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->)</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>ARRANGEMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>THIS AGREEMENT
</B>made  August 31, 2016, between</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; color: blue"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">SUNOVION CNS DEVELOPMENT
CANADA ULC,<BR> <FONT STYLE="color: Black">an unlimited liability company existing under the laws of British Columbia,
(hereinafter referred to as the &ldquo;<B>Acquiror</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">- and
-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">SUNOVION PHARMACEUTICALS INC.,<BR>
a corporation existing under the laws of Delaware,<BR> (hereinafter referred to as the &ldquo;<B>Parent</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">- and
-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">CYNAPSUS THERAPEUTICS INC.,<BR>
a corporation existing under the laws of Canada,<BR>
(hereinafter referred to as the &ldquo;<B>Corporation</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>WHEREAS
</B>the Acquiror desires to acquire all of the common shares of the Corporation (the &ldquo;<B>Common Shares</B>&rdquo;)<B> </B>pursuant
to an arrangement under section&nbsp;192 of the Act (as hereinafter defined);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>AND
WHEREAS </B>contemporaneously herewith, the Acquiror has entered into voting and support agreements (the &ldquo;<B>Voting and
Support Agreements</B>&rdquo;) with each of the directors and officers of the Corporation and Dexcel Pharma Technologies
Ltd. and Dexxon Holdings Ltd., pursuant to which, among other things, such Securityholders (as hereinafter defined) have
agreed to vote all of the Common Shares and Warrants held by them in favour of the Arrangement Resolution (as hereinafter
defined) on the terms and subject to the conditions set forth in the Voting and Support Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>AND WHEREAS
</B>the board of directors of the Corporation (the &ldquo;<B>Board</B>&rdquo;) has unanimously determined, after receiving financial
and legal advice and following the receipt and review of recommendations from its special committee of directors, that the Arrangement
(as hereinafter defined) is fair, from a financial point of view, to Securityholders and that the Arrangement is in the best interests
of the Corporation and has unanimously approved the entering into of this Agreement and its recommendation that Securityholders
vote for the Arrangement Resolution, all on the terms and subject to the conditions contained herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>AND WHEREAS
</B>the Acquiror is a wholly-owned subsidiary of the Parent, and the Parent has agreed to guarantee all of the obligations of
the Acquiror under this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"><B>NOW THEREFORE
THIS AGREEMENT WITNESSES</B> that, in consideration of the mutual covenants and agreements hereinafter set forth and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties hereby
covenant and agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;1<BR>
Interpretation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Definitions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">In this Agreement,
unless something in the subject matter or context is inconsistent therewith, the following terms shall have the respective meanings
set out below and grammatical variations shall have the corresponding meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Acquiror</B>&rdquo;
has the meaning set out in the preamble to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Acquisition
Proposal</B>&rdquo; means, other than any of the transactions contemplated by this Agreement, any proposal, offer or inquiry (whether
or not in writing) by any person or group of persons other than the Acquiror or any of its Affiliates relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         merger, amalgamation, plan of arrangement, business combination, consolidation, share
                                         exchange, recapitalization, redemption, reorganization or similar transaction, or any
                                         liquidation, dissolution or winding-up, in any case, in respect of the Corporation or
                                         any of its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         take-over-bid, tender offer, exchange offer, treasury issuance or other transaction that,
                                         if consummated, would result in any person or group of persons beneficially owning 20%
                                         or more of any class of voting or equity securities or any other equity interests (including
                                         securities convertible into or exercisable or exchangeable for voting or equity securities)
                                         of the Corporation or any of its subsidiaries (in terms of the number of securities outstanding
                                         of any class of voting or equity securities or other equity interests, in each case calculated
                                         on a non-diluted basis);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         direct or indirect sale, transfer, disposition, alliance or joint venture (or any lease,
                                         long-term supply arrangement, licence or other arrangement having the same economic effect
                                         as a sale), in a single transaction or a series of related transactions, of assets of
                                         the Corporation representing 20% or more of the consolidated assets of the Corporation;
                                         or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         other similar transaction or series of transactions involving the Corporation or any
                                         of its subsidiaries.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Act</B>&rdquo;
means the <I>Canada Business Corporations Act</I>, as amended, including the regulations promulgated thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>Adagio&rdquo;</B> means Adagio Pharmaceuticals Ltd.,
a former subsidiary of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>Adagio Purchase Agreement</B>&rdquo; means the share
purchase agreement dated December&nbsp;22, 2011, among the Corporation, Adagio, and the shareholders of Adagio, as further amended
by an agreement dated January&nbsp;28, 2015, as further amended by an agreement dated August 31, 2016, providing for the acquisition
of all of the common shares of Adagio by the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Affiliate</B>&rdquo;
has the meaning given to it in the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Agreement</B>&rdquo;
means this arrangement agreement entered into by the Corporation, the Acquiror and the Parent, together with the Schedules attached
hereto and the Disclosure Letter, as the same may be amended, supplemented or otherwise modified from time to time in accordance
with the terms hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Approval
Requirement</B>&rdquo; has the meaning ascribed thereto in Section 20(c) of Schedule&nbsp;C hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Arrangement</B>&rdquo;
means the arrangement under the provisions of section&nbsp;192 of the Act, on the terms and subject to the conditions set out
herein and in the Plan of Arrangement, subject to any amendments or variations thereto made in accordance with this Agreement
or the Plan of Arrangement or made at the direction of the Court in the Final Order with the prior written consent of the parties,
each acting reasonably;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Arrangement
Resolution</B>&rdquo; means the special resolution of Securityholders approving the Arrangement to be considered at the Meeting,
substantially in the form attached as Schedule&nbsp;D to this Agreement and any amendments or variations thereto made in accordance
with the provisions of this Agreement or the Plan of Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Articles
of Arrangement</B>&rdquo; means the articles of arrangement of the Corporation in respect of the Arrangement to be filed with
the Director after the Final Order is made, which shall include the Plan of Arrangement and otherwise be in a form and content
satisfactory to the parties, each acting reasonably;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Authorization</B>&rdquo;
means, with respect to any person, any order, permit, approval, registration, right, grant, consent, waiver, licence or similar
authorization of any Governmental Authority having jurisdiction over the person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Board</B>&rdquo;
has the meaning set out in the recitals to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Board
Recommendation</B>&rdquo; has the meaning set out in Section&nbsp;2.4(b);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>BofA
Fairness Opinion</B>&rdquo; means the oral opinion (to be confirmed by delivery of a written opinion) of Merrill Lynch, Pierce,
Fenner &amp; Smith Incorporated rendered to the Board to the effect that, as of the date of the written opinion and based upon
and subject to the various assumptions and limitations to be set forth in the written opinion, the Consideration to be received
under the Arrangement by the Shareholders is fair, from a financial point of view, to the Shareholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Business
Day</B>&rdquo; means a day, other than a Saturday or a Sunday, on which the principal commercial banks located in Toronto, Ontario
and New York, New York are open for the conduct of non-automated business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Change
of Control Payments</B>&rdquo; has the meaning set out in Section 25 of Schedule&nbsp;C to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Circular</B>&rdquo;
means the notice of the Meeting and accompanying management information circular of the Corporation, including all schedules,
appendices and exhibits thereto, and all information incorporated by reference therein, to be prepared and sent to the Securityholders
in connection with the Meeting, as amended, supplemented or otherwise modified from time to time in accordance with the terms
of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Claim</B>&rdquo;
means any demand, complaint, investigation, action, cause of action, suit, damage, liability (actual or contingent) or obligation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;C<B>ommercialization</B>&rdquo;
means any activities, including pre-launch activities, directed to preparation for sale of, offering for sale of, or sale of a
Product, including activities related to marketing, advertising, promoting, detailing, manufacturing (including the API included
in the Product), distributing, importing, exporting such Product;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Common
Share</B>&rdquo; means a common share of the Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Company
Assets</B>&rdquo; means all of the assets, properties, permits, rights or other privileges (whether contractual or otherwise)
of the Corporation and its subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Company
IP</B>&rdquo; means all Intellectual Property Rights that are owned, licensed or controlled by the Corporation or any of its subsidiaries
(including without limitation those set forth in the Disclosure Letter);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Company
Licensed Registered IP</B>&rdquo; means all Registered Company IP that is licensed by the Corporation or any of its subsidiaries
and set forth in Section&nbsp;34(a)(aii) of the Disclosure Letter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Company
Owned IP</B>&rdquo; means all Intellectual Property Rights that are owned by the Corporation or the any of its subsidiaries (including
without limitation those set forth in the Disclosure Letter);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Company
Owned Registered IP</B>&rdquo; means all Registered Company IP that is owned by the Corporation or any of its subsidiaries and
set forth in Section&nbsp;34(a)(ai) of the Disclosure Letter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Competition
Act</B>&rdquo; means the <I>Competition Act</I>, R.S.C. 1985, c.&nbsp;C-34, and includes the regulations thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Confidentiality
Agreement</B>&rdquo; means the mutual confidentiality disclosure agreement effective October&nbsp;29, 2015 between the Acquiror
and the Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Consideration</B>&rdquo;
means $40.50 in cash per Common Share or, in the case of a Right, the excess of $40.50 over the exercise price of such Right;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Contemplated
Transactions</B>&rdquo; has the meaning set out in Section 2&nbsp;of Schedule&nbsp;B to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Contract</B>&rdquo;
means any agreement, commitment, engagement, contract, franchise, licence, lease, obligation, undertaking or joint venture (written
or oral) to which the Corporation or any of its subsidiaries is a party or by which it or any of its subsidiaries is bound or
affected or to which any of their respective properties or assets is subject;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Corporation</B>&rdquo;
has the meaning set out in the preamble to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Corporation
Associate</B>&rdquo; means each current or former officer or other employee, or individual or entity who is an independent contractor,
consultant or director, of or to the Corporation, excluding for clarification only ARx LLC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Corporation
Sub</B>&rdquo; means an unlimited liability company to be formed pursuant to the <I>Business Corporations Act</I> (British Columbia)
as a direct, wholly-owned subsidiary of the Corporation for the purposes of effectuating the Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Corporation&rsquo;s
Constating Documents</B>&rdquo; means the articles of amalgamation and by-laws of the Corporation and all amendments to such articles
or by-laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Court</B>&rdquo;
means the Ontario Superior Court of Justice (Commercial List) or any appellate court, as the case may be;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Depositary</B>&rdquo;
means any trust company, bank or financial institution agreed to in writing by the Acquiror and the Corporation to act as depository
for the Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Development</B>&rdquo;
means the conduct of all research, formulating, preclinical and other testing, nonclinical activities, clinical trials, and other
studies, and all other activities (including test method development, stability testing, toxicology studies, process development,
statistical analysis and report writing, packaging, labeling and regulatory affairs, product approval, and registration activities)
required by a Governmental Authority in connection with the Product;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Director</B>&rdquo;
means the director appointed pursuant to Section&nbsp;260 under the Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Disclosing
Party</B>&rdquo; has the meaning ascribed thereto in Section&nbsp;7.2(c);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Disclosure
Letter</B>&rdquo; means the disclosure letter dated the date of this Agreement delivered by the Corporation to the Acquiror contemporaneously
with the execution and delivery of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Dissent
Rights</B>&rdquo; means the rights of dissent granted in favour of Securityholders in respect of the Arrangement as described
in the Plan of Arrangement and the Interim Order;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>EDGAR</B>&rdquo;
means the U.S. Securities and Exchange Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Effective
Date</B>&rdquo; means the date shown on the Certificate of Arrangement giving effect to the Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Effective
Time</B>&rdquo; has the meaning set out in the Plan of Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Employee
Plans</B>&rdquo; has the meaning ascribed thereto in Section 24(a) of Schedule&nbsp;C hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Encumbrance</B>&rdquo;
means any lien (statutory or otherwise), pledge, hypothecation, charge, restriction or adverse right or Claim, mortgage, encroachments,
option, right of first refusal or first offer, occupancy right, covenant, assignment, security interest, adverse interest, defect
of title, statutory or deemed trust, other third party interest or encumbrance of any kind, in each case, whether contingent or
absolute, except in each case for any Permitted Encumbrance;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Environmental
Laws</B>&rdquo; means all Canadian or foreign federal, provincial, state, municipal or local Laws of any Governmental Authority,
including common law, and all other statutory requirements relating to safety, noise control, pollution or the protection of the
environmental or health matters, including legislation governing the generation, production, installation, use, handling, manufacturing,
processing, labeling, importing, transportation, recycling, treatment, storage and release or threatened release of any pollutant,
contaminant, waste of any nature, hazardous substance, deleterious substance, hazardous material, toxic substance, dangerous substance
or dangerous good as defined, judicially interpreted or identified in any Laws and under Canada&rsquo;s Workplace Hazardous Materials
Information System (WHMIS), including civil responsibility for acts or omissions with respect to the environment, and all Authorizations
issued pursuant to such Laws, agreements or other statutory requirements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Environmental
Liabilities</B>&rdquo; means, with respect to any person, all liabilities, Losses, investigations, assessments and Legal Proceedings
to the extent based upon, related to or arising under or pursuant to any: (a)&nbsp;Environmental Law; (b)&nbsp;agreement with
or administrative order issued by any Governmental Authority or other person which relates to the environment; (c)&nbsp;condition
in the environment; (d)&nbsp;actual presence or alleged release or threatened release of any material, contaminant, substance,
pollutant or waste as those terms are defined or identified under any Environmental Laws; (e)&nbsp;actual or alleged exposure
of any person to any substance, material, contaminant, pollutant or waste as those terms are defined or identified under Environmental
Laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Exchanges</B>&rdquo;
means the Toronto Stock Exchange and The Nasdaq Global Market, as applicable, and &ldquo;<B>Exchange</B>&rdquo; means any one
of them;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Fairness
Opinions</B>&rdquo; means the BofA Fairness Opinion and the Stifel Fairness Opinion;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>FDA</B>&rdquo;
means the United States Food and Drug Administration or any successor thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>FDCA</B>&rdquo;
means the Federal Food, Drug, and Cosmetic Act of 1938, as amended;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Final
Order</B>&rdquo; means the final order of the Court in a form and content satisfactory to the parties, each acting reasonably,
approving the Arrangement, as such order may be amended by the Court (with the consent of the parties, each acting reasonably)
at any time prior to the Arrangement becoming effective or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed
or as amended (provided that any such amendment is in a form and content satisfactory to the parties, each acting reasonably)
on appeal;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Governmental
Authority</B>&rdquo; means any:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">nation,
                                         state, commonwealth, province, territory, county, municipality, district or other jurisdiction
                                         of any nature;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">
                                         international, multinational, national, federal, state, provincial, local, regional,
                                         municipal or other government;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">governmental
                                         or quasi-governmental authority of any nature including any governmental division, department,
                                         agency, board, body, commission, instrumentality, official, ministry, center, organization,
                                         unit, body or entity and any regulatory authority, court, arbitrator or other tribunal
                                         or any political subdivision thereof, or any central bank (or similar monetary or regulatory
                                         authority) thereof, any expropriation or taxing authority, any ministry or department
                                         or agency of any of the foregoing, including authorities and agencies having regulatory
                                         powers in their respective health care systems such as the FDA and Health Canada;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">stock
                                         exchange, including the Exchanges;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">entity
                                         exercising executive, legislative, judicial, regulatory or administrative functions of
                                         or pertaining to government;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">corporation
                                         or other entity owned or controlled, through stock or capital ownership or otherwise,
                                         by any of such entities or other bodies pursuant to the foregoing; or </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">subdivision or authority of any of the above;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>HSR
Act</B>&rdquo; means the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>HSR
Approval</B>&rdquo; means the expiration or early termination of any waiting period, and any extension thereof, applicable to
the completion of the transactions contemplated hereby under the HSR Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>IFRS</B>&rdquo;
means the International Financial Reporting Standards and the official pronouncements issued by the International Accounting Standards
Board;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Intellectual
Property Rights</B>&rdquo; means all past, present and future rights in any type of intellectual property which may exist or be
created under the Laws of any jurisdiction in the world, including without limitation: patents, industrial designs, copyrights,
trademarks, trade names, domain names, social media accounts, inventions, trade secrets, confidential information, know-how, moral
and economic rights of authors and inventors, any and all applications and registrations, including without limitation the right
to claim priority, obtain extensions of term and listing in the Orange Book, the Canadian Patent Register, or any equivalent thereof,
for any of the foregoing, all goodwill associated with any of the foregoing, and any and all past, present and future causes of
action and rights to sue or seek other remedies and receive damages arising from or relating to the foregoing, including without
limitation past damages;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Interim
Order</B>&rdquo; means the interim order of the Court, in a form and content satisfactory to the parties, each acting reasonably,
as the same may be amended by the Court (with the consent of the parties, each acting reasonably), containing declarations and
directions with respect to the Arrangement and providing for, among other things, the holding of the Meeting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Investment
Canada Act</B>&rdquo; means the <I>Investment Canada Act</I>, R.S.C. 1985, c.&nbsp;28 (1<SUP>st</SUP> Supp), and includes regulations
thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>IP Contracts</B>&rdquo; means any Contract that is
a Contract under which the Corporation or any of its subsidiaries: (a)&nbsp;was or is assigned, granted, obtained, or obtains
or agrees to be assigned, granted or to obtain any license, ownership or any other rights or interests with respect to, any Intellectual
Property Rights, including without limitation any and all Intellectual Property Rights relating in any way to the Product (other
than standard form Contracts granting rights to use readily available shrink wrap or click wrap software having a replacement
cost and annual license fee of less than $100,000 in the aggregate for all such related Contracts, other non-exclusive rights
with respect to non-material Intellectual Property Rights entered into in the Ordinary Course and proprietary information and
inventions agreements entered into with employees of the Corporation or a subsidiary in the Ordinary Course, other than agreements
with named inventors on any patents included in the Company IP); (b)&nbsp;is restricted in its right to use or register any Intellectual
Property Rights; (c)&nbsp;grants rights to or permits or agrees to grant rights to or to permit any other person to use, enforce
or register, or grants any other rights or interests with respect to, any Intellectual Property Rights owned by or non-exclusively
or exclusively licensed to the Corporation or any of its subsidiaries, including license agreements, collaboration agreements,
research and/or development agreements, non-assertion or co-existence agreements, grants of royalty or revenue interest, research
and development or commercialization financing arrangements, or covenants not to sue, other than Contracts for sales of the Corporation&rsquo;s
product and associated non-exclusive licenses entered into in the Ordinary Course; or (d)&nbsp;that would, as a result of the
Arrangement and the transactions contemplated thereby, require the Acquiror to license or assign rights in its or its Affiliates&rsquo;
Intellectual Property Rights to any other person, or prohibit the Acquiror from using any of its or its Affiliates&rsquo; Intellectual
Property Rights due to the Acquiror or its Affiliates constituting an Affiliate of the Corporation;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Laws</B>&rdquo;
means , with respect to any person, any and all applicable laws (statutory, civil, common or otherwise) including supranational,
national, provincial, state, municipal and local civil laws, treaties, statutes, judgments, decrees, injunctions, writs, certificates
and orders, by-laws, rules, regulations, ordinances, policies, notices, directions or other requirements of any Governmental Authority
that is binding upon or applicable to such person or its business, undertaking, property or securities, and to the extent that
they have the force of law, policies, guidelines, notices and protocols of any Governmental Authority, as amended unless expressly
specified otherwise, including, but not limited to, the Securities Laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Legal
Proceeding</B>&rdquo; means any action, suit, charge, complaint, litigation, arbitration, proceeding (including any civil, criminal,
administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination, oppositions, interferences, re-examinations,
post-grant proceeding, or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court
or other Governmental Authority or any arbitrator or arbitration panel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Licensed
Field</B>&rdquo; means apomorphine, alone or in combination with any antiemetic, for the treatment of humans in the indications
of: (a)&nbsp;the acute, intermittent treatment of hypomobility, &ldquo;off&rdquo; episodes associated with Parkinson&rsquo;s disease
in patients that have motor fluctuations; (b)&nbsp;restless leg syndrome; and (c)&nbsp;erectile dysfunction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Loss</B>&rdquo;
means any loss (including loss of profits and punitive damages), cost, liability, Tax liability, damage, fine, penalty, settlement,
judgment, award or expense, including where applicable costs and expenses (including attorneys&rsquo; fees and expenses of investigation
and defence);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>Market Value</B>&rdquo; market value of a class of
securities for a period is calculated by multiplying the number of securities of the class outstanding, as of the close of business
on the last Business Day of the period, by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the arithmetic average of the closing prices of the securities of that class on the Published Market
on which that class was principally traded for each of the trading days during the period, if the Published Market provides a closing
price for the securities; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the arithmetic average of the simple averages of the highest and lowest prices of the securities
of that class on the Published Market on which that class was principally traded for each of the trading days for which the securities
traded during the period, if the Published Market does not provide a closing price, but provides only the highest and lowest prices
of securities traded on a particular day;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Match
Period</B>&rdquo; has the meaning set out in Section&nbsp;6.3(b)(iv);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means any change, event, occurrence, effect, state of facts or circumstances that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">is, or would reasonably be
expected to be, individually or in the aggregate material and adverse to the business, financial condition, operations or results
of operations, assets, properties, condition (financial or otherwise) or liabilities (contingent or otherwise) of the Corporation
and its subsidiaries, taken as a whole, other than any such change, event, occurrence, effect, state of facts or circumstances:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to the Canadian or U.S. economy, political conditions or securities markets in general;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">affecting
                                         the industry in which the Corporation operates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">arising
                                         directly or indirectly from any act of terrorism, war, national or international calamity
                                         or any other similar event;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to a change in the market trading price or volume of the Common Shares (it being understood
                                         that the causes underlying such change in market price or trading volume may be taken
                                         into account in determining whether a Material Adverse Effect has occurred);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to or arising from or out of the execution, announcement or performance of this Agreement
                                         and the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to any action taken (or omitted to be taken) by the Corporation at the request, or with
                                         the approval, of the Acquiror;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         Legal Proceeding against the Corporation by Securityholders challenging or seeking to
                                         restrain or prohibit the consummation of the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">arising
                                         from or out of the results of any of the Corporation&rsquo;s clinical trials relating
                                         to the Product;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to any determination by, or delay of a determination by, the FDA, the European Medicines
                                         Agency or any other Governmental Authority, or any panel or advisory body empowered or
                                         appointed thereby, or any indication that any such entity, panel or body will make any
                                         determination or delay in making any determination, with respect to the approvability,
                                         labeling, contents of package insert, prescribing information, risk management profile,
                                         pre-approval inspection matters or requirements relating to the results of any pre-clinical
                                         or clinical testing sponsored by the Corporation and relating to the Product;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">arising
                                         from or out of the launch of any drug products that compete with the Product;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(xi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         recommendations or statements published or proposed by any professional medical organization,
                                         Governmental Authority or panel or advisory body empowered or appointed thereby, relating
                                         to the Products or to any product or product candidates of any competitor to the extent
                                         that such recommendation or statement compares such product or product candidate to the
                                         Product; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(xii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">relating
                                         to any generally applicable change or proposed change in applicable IFRS or Laws, including
                                         the rules, regulations and administrative policies of the FDA or the European Medicines
                                         Agency or interpretations of any of the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="color: Black">provided,
however, that the effect referred to in clauses&nbsp;(i), (ii), (iii) and (xii) above does not have a materially disproportionate
effect on the Corporation and its subsidiaries, taken as a whole, compared to other companies operating in the industry or jurisdictions
in which the Corporation and its subsidiaries operate; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">would,
                                         or would reasonably be expected to, prevent or materially delay the ability of the Corporation
                                         to consummate the transactions contemplated by this Agreement by the Outside Date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Material
Contract</B>&rdquo; means any Contract: (a)&nbsp;that if terminated or modified or if it ceased to be in effect,
would reasonably be expected to have a Material Adverse Effect; (b)&nbsp;relating to the formation, creation or operation of
any corporation, partnership, limited liability company, joint venture or similar agreement in which the Corporation and/or
its subsidiaries have an interest; (c)&nbsp;relating directly or indirectly to the guarantee of any liabilities or
obligations or to indebtedness (currently outstanding or which may become outstanding) for borrowed money;
(d)&nbsp;restricting the incurrence of indebtedness by the Corporation or any of its subsidiaries or (including by requiring
the granting of an equal and rateable Encumbrance) the incurrence of any Encumbrances on any properties or assets of the
Corporation or any of its subsidiaries, or restricting the payment of dividends by the Corporation or by any of its
subsidiaries; (e)&nbsp;under which the Corporation or any of its subsidiaries is obligated to make or expects to receive
payments (including royalties) on an annual basis in excess of $250,000 or in excess of $250,000 over the remaining term;
(f)&nbsp;under which the Corporation or any of its subsidiaries is obligated to make or expects to receive payments
(including royalties or milestone payments) in excess of $250,000, (g)&nbsp;that creates an exclusive dealing arrangement,
right of first offer or refusal or &ldquo;most favoured nation&rdquo; obligation; (h)&nbsp;that is a collective agreement or
other agreement with a union; (i)&nbsp;providing for employment, severance or change in control payments; (j)&nbsp;between
the Corporation or any of its subsidiaries and any director or executive officer of the Corporation or any of its
subsidiaries; (k)&nbsp;containing a put, call or similar right pursuant to which the Corporation or any subsidiary would be
required to purchase or sell, as applicable, any equity interests of any person; (l)&nbsp;providing for the purchase, sale or
exchange of, or option to purchase, sell or exchange, any property where the purchase or sale price of such property exceeds
$250,000; (m)&nbsp;providing for the lease of any real property; (n)&nbsp;involving the settlement of any Legal Proceeding
or threatened Legal Proceeding that exceeds $250,000; (o)&nbsp;that limits or restricts in any material respect
(1)&nbsp;the ability of the Corporation or any subsidiary to engage in any line of business or carry on business in any
geographic area, or (2)&nbsp;the scope of persons to whom the Corporation or any of its subsidiaries may sell products or
deliver services; (p)&nbsp;that requires the consent of any other party to the Contract to a change in control of or
assignment by the Corporation or any of its subsidiaries of such Contract; (q)&nbsp;that is an IP Contract; (r)&nbsp;that relates to research, pre- clinical, clinical or other development, manufacturing or supply (including of any
components, and any quality and other ancillary agreements), testing, distribution, marketing, promotion or other
commercialization of any pharmaceutical product or medical device (including pharmaceutical products or medical devices under
development) of or licensed to the Corporation or any of its subsidiaries; or (s)&nbsp;that is otherwise material to the
Corporation and its subsidiaries, taken as a whole;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Meeting</B>&rdquo;
means the special meeting of Securityholders to be called and held for the purpose of considering the Arrangement Resolution and
any adjournments or postponements thereof in accordance with the terms of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>MI&nbsp;61-101</B>&rdquo;
means Multilateral Instrument&nbsp;61-101 &ndash; <I>Protection of Minority Shareholders in Special Transactions</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Misrepresentation</B>&rdquo;
means an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is
necessary to make the statements contained therein not misleading in light of the circumstances in which they are made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>NASDAQ
Rules</B>&rdquo;<B> </B>means the NASDAQ Marketplace Rules as promulgated by The Nasdaq Global Market, as amended;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>NI&nbsp;54-101</B>&rdquo;
means National Instrument&nbsp;54-101 &ndash; <I>Communications with Beneficial Owners of Securities of a Reporting Issuer</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>officer</B>&rdquo;
has the meaning ascribed thereto in the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Option
Plan</B>&rdquo; means the stock option plan of the Corporation as amended and restated on May&nbsp;10, 2016;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Optionholder</B>&rdquo;
means a holder of Options;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Options</B>&rdquo;
means the outstanding options to purchase Common Shares issued pursuant to the Option Plan or any predecessor plan, as set forth
in the Disclosure Letter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Ordinary
Course</B>&rdquo; means, with respect to an action taken by any person, any action that is taken in the ordinary course of the
normal day to day operations of the business of such person consistent with past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Outside
Date</B>&rdquo; means December&nbsp;31, 2016 or such later date as may be agreed to in writing by the parties, provided that
if the Effective Date has not occurred by December&nbsp;31, 2016 as a result of the failure to obtain any of the approvals
set out in Section&nbsp;9.1(e), and provided that the parties have a reasonable expectation to receive such approval, either
party may elect, by notice in writing delivered to the other party prior to December&nbsp;31, 2016 to extend the Outside Date
by a specified period of not more than two (2) months, provided that, notwithstanding the foregoing, neither party shall be
permitted to extend the Outside Date if the failure to obtain the approvals set out in Section&nbsp;9.1(e) is primarily the
result of such party&rsquo;s failure to comply with its covenants herein or if such person is not using commercially
reasonable efforts to obtain such approvals;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Parent</B>&rdquo;
has the meaning set out in the preamble to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>party</B>&rdquo;
means a party to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Permitted
Encumbrance</B>&rdquo; means, in respect of the Corporation or any of its subsidiaries, any one or more of the following (a)&nbsp;easements,
servitudes, restrictions, restrictive covenants, party wall agreements, rights of way, licenses, permits and other similar rights
in land or real property, including rights of way and servitudes for highways and other roads, railways, sewers, drains, gas and
oil pipelines, gas and water mains, electric light, power, telephone, telegraph or cable television conduits, poles, wires and
cables that do not materially adversely affect the use of the Company Assets or otherwise materially impair business operations
at the affected properties; (b)&nbsp;Encumbrances imposed by Law and incurred in the Ordinary Course for obligations not yet due
or delinquent; (c)&nbsp;zoning and building by-laws and ordinances and regulations made by public authorities that do not materially
adversely affect the use of the Company Assets or otherwise materially impair business operations at the affected properties;
(d)&nbsp;Encumbrances incurred, created and granted in the Ordinary Course to a public utility or private supplier of services,
municipality or Governmental Authority in connection with operations conducted with respect to any Company Assets that do not
materially adversely affect the use of the Company Assets or otherwise materially impair business operations at the affected properties;
(e)&nbsp;the reservations, limitations, provisos and conditions in any original grant from the applicable Governmental Authority
of any of the lands forming part of any Company Assets, or interests in them and statutory exceptions to title that do not materially
adversely affect the use of the Company Assets or otherwise materially impair business operations at the affected properties;
(f)&nbsp;Encumbrances for Taxes for which appropriate provisions have been made in accordance with IFRS and either which (i)&nbsp;are
not due or delinquent, or (ii)&nbsp;are being contested in good faith by appropriate proceedings; (g)&nbsp;inchoate or statutory
Encumbrances of contractors, subcontractors, mechanics, workers, suppliers, materialmen, carriers and others in respect of the
construction, maintenance, repair or operation of any Company Assets, provided that such Encumbrances are related to obligations
not due or delinquent, are not registered against title to any Company Assets and in respect of which adequate holdbacks are being
maintained as required by Law; (h)&nbsp;the right reserved to or vested in any Governmental Authority by any statutory provision
or by the terms of any lease, licence, franchise, grant or permit forming part of any Company Assets, to terminate any such lease,
licence, franchise, grant or permit, or to require annual or other payments as a condition of their continuance; or (i)&nbsp;such
other non-financial rights, imperfections or irregularities of title, encroachments and encumbrances or Encumbrances as do not
materially affect the use of the real properties subject thereto or affected thereby or otherwise materially impair business operations
at such real properties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>person</B>&rdquo;
means an individual, general partnership, limited partnership, corporation, company, limited liability company, unincorporated
association, unincorporated syndicate, unincorporated organization, trust, estate, trustee, executor, administrator or other legal
representative, government (including Governmental Authority) or other entity, whether or not having legal status;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Plan
of Arrangement</B>&rdquo; means the plan of arrangement substantially in the form attached as Schedule&nbsp;A and any amendment
or variation thereto from time to time made in accordance with this Agreement or upon the direction of the Court in the Final
Order with the prior written consent of the parties, each acting reasonably;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Pre-Acquisition
Reorganization</B>&rdquo; has the meaning ascribed thereto in Section&nbsp;8.4(a);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Product</B>&rdquo;
means sublingual apomorphine strip or film, APL-130277 and its associated packaging (and shall include any new or previously used
name under which it is branded or tested);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Proxy
Cut-off</B>&rdquo; has the meaning given to it in Section&nbsp;2.4(c);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Public
Disclosure Record</B>&rdquo; means all documents filed or furnished by or on behalf of the Corporation on SEDAR or EDGAR since
January&nbsp;1, 2014 and June&nbsp;12, 2015, respectively;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Published
Market</B>&rdquo; means a recognized national Canadian or United States stock exchange;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Receiving
Party</B>&rdquo; has the meaning ascribed thereto in Section&nbsp;7.2(c);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Registered
Company IP</B>&rdquo; means all Registered IP that is Company IP;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Registered
IP</B>&rdquo; means all pending applications, issuances and registrations with any Governmental Authority for any Intellectual
Property Rights, including without limitation all patents and patent applications (including industrial designs), inventor certificates,
registered copyrights, registered mask works, and registered trademarks, service marks and trade dress, registered domain names,
social media accounts and registered business names;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>related
party</B>&rdquo; has the meaning given to such term in MI&nbsp;61-101;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Representative</B>&rdquo;
means, in respect of a person, its subsidiaries and its Affiliates and its and their directors, officers, employees, shareholders,
agents and representatives (including any financial, legal, accounting or other advisors);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Rights</B>&rdquo;
means the Options and the Warrants;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Securities
Act</B>&rdquo; means the <I>Securities Act</I> (Ontario), as amended from time to time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Securities
Authority</B>&rdquo;<B> </B>means the Ontario Securities Commission and the applicable securities commissions or securities regulatory
authority of a province or territory of Canada and, in case of the Corporation, also includes the United States Securities and
Exchange Commission;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Securities
Laws</B>&rdquo; means the Securities Act and any other applicable Canadian provincial and territorial securities laws, rules and
regulations and published policies thereunder, and the U.S. Securities Laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Securityholders</B>&rdquo;
means, collectively, Shareholders and Warrantholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo; <B>SEDAR</B>&rdquo;
means the System for Electronic Document Analysis and Retrieval;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Shareholders</B>&rdquo;
means holders of the Common Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Special
Committee</B>&rdquo; means the committee of independent directors of the Board comprised of Rochelle Stenzler, Ronald Hosking
and Tamar Howson;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Stifel
Fairness Opinion</B>&rdquo; means the oral opinion (to be confirmed by delivery of a written opinion) of Stifel, Nicolaus &amp;&nbsp;Company,
Incorporated rendered to the Special Committee to the effect that, as of the date of the written opinion and based upon and subject
to the various assumptions and limitations to be set forth in the written opinion, the Consideration to be received under the
Arrangement by the Shareholders is fair, from a financial point of view, to the Shareholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>subsidiary</B>&rdquo;
means, with respect to a person, any entity, whether incorporated or unincorporated, (a)&nbsp;of which such person or any
other subsidiary of such person is a general partner; or (b)&nbsp;at least a majority of the securities or other interests of
which having by their terms ordinary voting power to elect a majority of the board of directors or other persons performing
similar functions with respect to such corporation or other organization is directly or indirectly owned or controlled by
such person and/or by any one or more of its subsidiaries; and shall include any body corporate, partnership, joint venture
or other entity over which it exercises direction or control. For purposes of this definition, &ldquo;control&rdquo; when
used with respect to any person means the power to direct the management and policies of such person, directly or indirectly,
whether through the ownership of voting securities, by contract or otherwise. For greater certainty, Cynapsus Therapeutics
(USA) Inc. and, once formed, the Corporation Sub shall each be considered a subsidiary of the Corporation for the purposes of
this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Superior
Proposal</B>&rdquo; means any unsolicited <I>bona fide</I> written Acquisition Proposal made subsequent to the date hereof from
a person who is an arm&rsquo;s length third party:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">to purchase
                                         or otherwise acquire, directly or indirectly, not less than all of the Common Shares
                                         not owned by the person making such Acquisition Proposal or its Affiliates or all or
                                         substantially all of the assets of the Corporation on a consolidated basis;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         did not result from a breach of Article&nbsp;6 of this Agreement or result from a material
                                         breach of any agreement between the person making such Acquisition Proposal and the Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         the upfront consideration payable on closing of such transaction shall consist of only
                                         (i) cash, (ii) securities of a class of such person listed on a Published Market, or
                                         (iii) a combination of (i) and (ii), and that has an aggregate value, calculated as of
                                         the date of receipt of the Acquisition Proposal, of at least $625,000,000, and for purposes
                                         of determining value, the value of any such securities shall be determined based on the
                                         Market Value during the 20 consecutive trading days immediately preceding the date of
                                         receipt of the Acquisition Proposal;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         is not subject, either by the terms of such Acquisition Proposal or by virtue of any
                                         Law, to any requirement that the approval of the shareholders of the person making the
                                         Acquisition Proposal be obtained;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         is not subject to any financing condition and in respect of which it has been demonstrated
                                         to the satisfaction of the Board, acting in good faith (after receipt of advice from
                                         its financial advisors and its outside legal counsel) that any required financing or
                                         other consideration to complete such Acquisition Proposal will be available at closing
                                         of such transaction;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         is not subject to any due diligence condition; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         the Board and any relevant committee thereof has determined, acting in good faith (after
                                         receipt of advice from its financial advisors and its outside legal counsel):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">is reasonably
                                         capable of consummation without undue delay taking into account all legal, financial,
                                         regulatory and other aspects of such Acquisition Proposal and the person making such
                                         Acquisition Proposal; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">would,
                                         if consummated in accordance with its provisions (but not assuming away any risk of non-
                                         consummation), result in a transaction more favourable to the Shareholders from a financial
                                         point of view than the Arrangement (including any adjustment to the terms and conditions
                                         of the Arrangement proposed by the Acquiror pursuant to this Agreement);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Superior
Proposal Notice</B>&rdquo; has the meaning set out in Section&nbsp;6.3(b)(iv);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Tax</B>&rdquo;
or &ldquo;<B>Taxes</B>&rdquo; means (a)&nbsp;any and all taxes, duties, fees, excises, premiums, assessments, imposts, levies
and other charges or assessments of any kind whatsoever imposed by any Governmental Authority, whether computed on a separate,
consolidated, unitary, combined or other basis, including those levied on, or measured by, or described with respect to, income,
gross receipts, profits, gains, windfalls, capital, capital stock, production, recapture, transfer, land transfer, license, gift,
occupation, wealth, environment, net worth, indebtedness, surplus, sales, goods and services, harmonized sales, use, value-added,
excise, special assessment, stamp, withholding, business, franchising, real or personal property, health, employee health, payroll,
workers&rsquo; compensation, employment or unemployment, severance, social services, social security, education, utility, surtaxes,
customs, import or export, and including all license and registration fees and all employment insurance, health insurance and
government pension plan premiums or contributions; (b)&nbsp;all interest, penalties, fines, additions to tax or other additional
amounts imposed by any Governmental Authority on or in respect of amounts of the type described in clause&nbsp;(a) above or this
clause&nbsp;(b); (c)&nbsp;any liability for the payment of any amounts of the type described in clauses&nbsp;(a) or (b) as a result
of being a member of an affiliated, consolidated, combined or unitary group for any period; and (d)&nbsp;any liability for the
payment of any amounts of the type described in clauses&nbsp;(a) or (b) as a result of any express or implied obligation to indemnify
any other person or as a result of being a transferee or successor in interest to any party;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Tax
Act</B>&rdquo; means the <I>Income Tax Act</I> (Canada) and the regulations promulgated thereunder, as amended;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Tax
Returns</B>&rdquo; means any and all returns, reports, declarations, elections, notices, forms, designations, filings, statements
and other similar documents (including estimated tax returns and reports, withholding tax returns and reports, and information
returns and reports) filed or required under Laws to be filed with any Governmental Authority in respect of Taxes, including any
amendments or supplements thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Termination
Payment</B>&rdquo; has the meaning set out in Section&nbsp;10.3;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Termination
Payment Event</B>&rdquo; has the meaning set out in Section&nbsp;10.3;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>United
States</B>&rdquo; or &ldquo;<B>U.S.</B>&rdquo; means the United States of America, its territories and possessions, any State
of the United States and the District of Columbia;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>U.S.
Exchange Act</B>&rdquo; means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>U.S.
Securities Act</B>&rdquo; means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>U.S.
Securities Laws</B>&rdquo; means the NASDAQ Rules and the U.S. Securities Act, the U.S. Exchange Act and all other applicable
U.S. federal and state securities laws, rules and regulations and published policies thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Voting
and Support Agreements</B>&rdquo; has the meaning set out in the recitals to this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Warrantholder</B>&rdquo;
means a holder of Warrants; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&ldquo;<B>Warrants</B>&rdquo;
means the common share purchase warrants of the Corporation set out in the Disclosure Letter.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Construction</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">In this Agreement,
unless otherwise expressly stated or the context otherwise requires:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">references
                                         to &ldquo;herein&rdquo;, &ldquo;hereby&rdquo;, &ldquo;hereunder&rdquo;, &ldquo;hereof&rdquo;
                                         and similar expressions are references to this Agreement and not to any particular Section
                                         of or Schedule to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">references
                                         to a &ldquo;Section&rdquo; or a &ldquo;Schedule&rdquo; are references to a Section of
                                         or Schedule to this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">words
                                         importing the singular shall include the plural and vice versa, and words importing gender
                                         shall include the masculine, feminine and neuter genders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         use of headings is for convenience of reference only and shall not affect the construction
                                         or interpretation hereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">if the
                                         date on which any action is required to be taken hereunder by any of the parties is not
                                         a Business Day, such action shall be required to be taken on the next succeeding day
                                         that is a Business Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">a period
                                         of Business Days is to be computed as beginning on the day following the event that began
                                         the period and ending at 4:30&nbsp;p.m. (Eastern Daylight Time) on the last day of the
                                         period if the period is a Business Day or at 4:30&nbsp;p.m. on the next Business Day
                                         if the last day of the period does not fall on a Business Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">references
                                         to any legislation or to any provision of any legislation shall include any modification
                                         or re-enactment thereof, any legislation provision substituted therefor and all regulations,
                                         rules and interpretations issued thereunder or pursuant thereto;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">references
                                         to any agreement or document shall be to such agreement or document (together with the
                                         schedules and exhibits attached thereto), as it may have been or may hereafter be amended,
                                         modified, supplemented, waived or restated from time to time; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">wherever
                                         the term &ldquo;includes&rdquo; or &ldquo;including&rdquo; is used, it shall be deemed
                                         to mean &ldquo;includes, without limitation&rdquo; or &ldquo;including, without limitation&rdquo;,
                                         respectively.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Currency</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Unless otherwise
indicated, all dollar amounts referred to in this Agreement are expressed in United States dollars. All references to &ldquo;C$&rdquo;
are to Canadian dollars.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Accounting
                                         Matters</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Unless otherwise
stated, all accounting terms used in this Agreement shall have the meanings attributable thereto under IFRS and all determinations
of an accounting nature required to be made shall be made in accordance with IFRS consistently applied.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Knowledge</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">References
to the &ldquo;knowledge of the Corporation&rdquo; mean the actual knowledge of any of Anthony Giovinazzo, Andrew Williams, Dr.&nbsp;Albert
Agro and Dr.&nbsp;Thierry Bilbault, after reasonable inquiry, in their capacities as officers or employees of the Corporation
and not in their personal capacities.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Accounting
                                         Terms</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">All accounting
terms are to be interpreted in accordance with IFRS and all determinations of an accounting nature in respect of the Corporation
required to be made shall be made in a manner consistent with IFRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Subsidiaries</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">To the extent
any covenants or agreements relate, directly or indirectly, to a subsidiary of the Corporation, each such provision shall be construed
as a covenant by the Corporation to cause (to the fullest extent to which it is legally capable) such subsidiary to perform the
required action.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Disclosure
                                         Letter</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Any reference
to a matter being disclosed or set out in the Disclosure Letter shall mean disclosure in such section of the Disclosure Letter
that corresponds to the relevant Section of this Agreement and disclosure in any section of the Disclosure Letter shall not be
disclosure for the purposes of any other section of the Disclosure Letter except that disclosure in a Section of the Disclosure
Letter that is referred to in another section of the Disclosure Letter shall be disclosure for the purposes of the section of
the Disclosure Letter in which such reference is made.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">1.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Schedules</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Schedules
to this Agreement, as listed below, are an integral part of this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="color: Black"><B>Schedule</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 83%; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="color: Black"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Schedule&nbsp;A</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Plan of Arrangement<BR>
    under Section 192 of the<BR>
    <I>Canada Business Corporations Act</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Schedule&nbsp;B</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Representations and Warranties of the Parent and Acquiror</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Schedule&nbsp;C</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Representations and Warranties of the Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Schedule&nbsp;D</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black">Arrangement Resolution</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;2<BR>
Arrangement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Arrangement</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Corporation
and the Acquiror agree that the Arrangement will be implemented in accordance with and subject to the terms and conditions of
this Agreement and the Plan of Arrangement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Interim
                                         Order</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">As soon as
reasonably practicable following the date hereof, but in any event not later than September 13, 2016, the Corporation shall apply
to the Court in a manner acceptable to the Acquiror, acting reasonably, pursuant to section&nbsp;192 of the Act and, in cooperation
with the Acquiror, prepare, file and diligently pursue an application for the Interim Order providing, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">for
                                         the calling and holding of the Meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">for
                                         the class of persons to whom notice is to be provided in respect of the Arrangement and
                                         the Meeting and for the manner in which such notice is to be provided;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         the requisite approval for the Arrangement Resolution shall be:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">at least
                                         66<SUP>2</SUP>/<SUB>3</SUB>% of the votes cast on the Arrangement Resolution by the Securityholders
                                         present in person or represented by proxy at the Meeting voting as a single class and,
                                         in the case of Warrantholders, on an &ldquo;as exercised&rdquo; basis; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">to
                                         the extent required, a majority of the votes attached to Common Shares, voting as a separate
                                         class, held by Shareholders present in person or represented by proxy at the Meeting,
                                         excluding for this purpose votes attached to such Common Shares and Warrants held by
                                         persons described in items&nbsp;(a) through (d) of section&nbsp;8.1(2) of MI&nbsp;61-101;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that,
                                         subject to the foregoing and in all other respects, the terms and conditions of the Corporation&rsquo;s
                                         Constating Documents, including quorum requirements, shall apply in respect of the Meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">for
                                         the grant of Dissent Rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">for
                                         the notice requirements with respect to the presentation of the application to the Court
                                         for the Final Order;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         the Meeting may be adjourned or postponed from time to time by the Corporation with the
                                         consent of the Acquiror subject to the terms of this Agreement without the need for additional
                                         approval of the Court;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">for
                                         confirmation of the record date of the Meeting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">that
                                         the record date for the Securityholders entitled to notice of and to vote at the Meeting
                                         will not change in respect of any adjournment(s) or postponement(s) of the Meeting, unless
                                         required by applicable securities Laws.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The Meeting</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall convene and conduct the Meeting in accordance with the Interim Order,
                                         the Corporation&rsquo;s Constating Documents and Law as soon as reasonably practicable,
                                         but in any event not later than October 17, 2016, for the purpose of considering the
                                         Arrangement Resolution and for any other proper purpose as may be set out in the Circular
                                         and agreed to by the Acquiror, acting reasonably, and not adjourn, postpone or cancel
                                         (or propose the adjournment, postponement or cancellation of) the Meeting without the
                                         prior written consent of the Acquiror, except (i) for an adjournment or postponement
                                         for a maximum of four (4) Business Days for any <I>bona fide </I>reason entirely beyond
                                         the control of the Corporation, provided that such reason is not related to any other
                                         Acquisition Proposal, (ii) as otherwise required or permitted under this Agreement, (iii)
                                         as required by applicable Laws or (iv) for quorum purposes;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall use commercially reasonable efforts to abridge the timing contemplated
                                         by NI&nbsp;54-101 to the extent practicable and permissible;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Subject
                                         to Article&nbsp;6, the Corporation shall use its commercially reasonable efforts to solicit
                                         proxies for the approval of the Arrangement Resolution and against any resolution submitted
                                         by any person that is inconsistent with the Arrangement Resolution and the completion
                                         of any of the transactions contemplated by this Agreement, including, if so required
                                         by, and at the cost of, the Acquiror, using the services of a proxy solicitation agent;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall consult with the Acquiror in fixing the date of the Meeting and the
                                         record date of the Meeting, give notice to the Acquiror of the Meeting and allow the
                                         Acquiror and its Representatives to attend the Meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall promptly advise the Acquiror of any communication (written or oral)
                                         from or claims brought by (or threatened to be brought by) any person in opposition to
                                         the Arrangement and/or purported exercise or withdrawal of Dissent Rights by Shareholders;
                                         and not settle or compromise, or agree to settle or compromise, any such claims without
                                         the prior written consent of the Acquiror which consent shall not be unreasonably withheld
                                         or delayed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall not change the record date for the Securityholders entitled to vote
                                         at the Meeting in connection with any adjournment or postponement of the Meeting unless
                                         required by Law or approved by the Acquiror; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall instruct the Corporation&rsquo;s transfer agent and any proxy solicitation
                                         agent to report to the Acquiror and its designated representatives concurrently with
                                         their reports to the Corporation and its representatives, and to promptly advise the
                                         Acquiror, at such times as the Acquiror may reasonably request and at least on a daily
                                         basis on each of the last 10 Business Days prior to the date of the Meeting, as to the
                                         aggregate tally of the proxies received by the Corporation in respect of the Arrangement
                                         Resolution and any other matters to be considered at the Meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The Circular</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">As soon
                                         as reasonably practicable after the date hereof, the Corporation shall prepare and complete,
                                         in consultation with the Acquiror, the Circular, together with any other documents required
                                         by the Interim Order or applicable Laws in connection with the Meeting, in accordance
                                         with applicable Laws, which Circular shall, subject to Article&nbsp;6, reflect the unanimous
                                         approval by the Board of this Agreement and the recommendation that Securityholders vote
                                         for the Arrangement Resolution and include a written copy of each of the Fairness Opinions,
                                         and the Corporation shall, promptly after obtaining the Interim Order, cause the Circular
                                         and such other documents to be filed and sent to each Securityholder and other person
                                         as required by the Interim Order and Law, in each case so as to permit the Meeting to
                                         be held by the date specified in Section&nbsp;2.3(a).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall ensure that the Circular complies in all material respects with the
                                         Interim Order and Law, does not contain any Misrepresentation (except that the Corporation
                                         shall not be responsible for any information relating to the Acquiror or its Affiliates).
                                         Without limiting the generality of the foregoing, the Circular must include a statement
                                         that the Board and the Special Committee, as applicable, has received the Fairness Opinions,
                                         and has unanimously, after receiving legal and financial advice and the recommendation
                                         of the Special Committee, determined that the Arrangement Resolution is in the best interests
                                         of the Corporation and is fair to the Securityholders and recommends that the Shareholders
                                         and Warrantholders (voting together as a single class on an &ldquo;as exercised&rdquo;
                                         basis) vote in favour of the Arrangement Resolution (the &ldquo;<B>Board Recommendation</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall specify in the Circular the time that is 48 hours, excluding Saturdays
                                         and holidays, before the Meeting (or any permitted adjournment(s) or postponement(s)
                                         thereof) (the &ldquo;<B>Proxy Cut-off</B>&rdquo;) before which time proxies to be used
                                         at the Meeting must be deposited with the Corporation or its transfer agent, and shall
                                         not waive the Proxy Cut-off, in whole or in part, without the prior written consent of
                                         the Acquiror, such consent not to be unreasonably withheld or delayed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Prior
                                         to the printing of the Circular and during the course of its preparation, the Corporation
                                         shall provide the Acquiror and its counsel with a reasonable opportunity to review and
                                         comment on it and other related documents, and reasonable consideration shall be given
                                         to any comments made by them, provided that all information relating solely to Acquiror
                                         or its Affiliates included in the Circular shall be in form and content satisfactory
                                         to Acquiror, acting reasonably. The Acquiror shall provide to the Corporation for inclusion
                                         in the Circular or other related documents such information regarding the Acquiror and
                                         its Affiliates as is required by applicable Laws or reasonably requested by the Corporation
                                         to be included in the Circular. The Acquiror represents, warrants and covenants that
                                         any information it provides to the Corporation for inclusion in the Circular will be
                                         accurate and complete in all material respects as of the relevant date of such information
                                         and will not contain any Misrepresentation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation and the Acquiror shall each promptly notify the other party if at any time
                                         before the Meeting it becomes aware (in the case of the Corporation only with respect
                                         to the Corporation and in the case of the Acquiror only with respect to the Acquiror
                                         and its Affiliates) that the Circular contains a Misrepresentation, or that otherwise
                                         requires an amendment or supplement to the Circular, and the parties shall co-operate
                                         in the preparation of any amendment or supplement to the Circular, as required or appropriate,
                                         and the Corporation shall promptly mail, file or otherwise publicly disseminate any amendment
                                         or supplement to the Circular to the Securityholders as required by the Court or applicable
                                         Laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Final Order</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">If
the Arrangement Resolution has been approved by the Securityholders at the Meeting in accordance with the Interim Order,
subject to the terms of this Agreement, the Corporation shall as soon as reasonably practicable thereafter, take all steps
necessary or desirable to submit the Arrangement to the Court and diligently pursue an application for the Final Order
pursuant to section&nbsp;192 of the Act, but in any event not later than two (2) Business Days after the Arrangement
Resolution is passed at the Meeting or within such other time period as may be agreed upon by the parties, each acting
reasonably.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Court Proceedings</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Subject to
the terms of this Agreement, the Acquiror shall cooperate with and assist the Corporation in seeking the Interim Order and the
Final Order, including by providing to the Corporation, on a timely basis, any information required to be supplied by the Acquiror
in connection therewith. The Corporation shall provide the Acquiror and its counsel with reasonable opportunity to review and
comment upon drafts of all material to be filed with the Court in connection with the Arrangement, and will give reasonable consideration
to all such comments. The Corporation shall provide to the Acquiror and its counsel, on a timely basis, copies of any notice of
appearance, evidence or other documents served on the Corporation or its counsel in respect of the application for the Interim
Order or the Final Order or any appeal therefrom and of any notice (written or oral) received by the Corporation indicating any
intention to oppose the granting of the Interim Order or the Final Order or to appeal the Interim Order or the Final Order. The
Corporation shall ensure that all material filed with the Court in connection with the Arrangement is consistent in all material
respects with the terms of this Agreement and the Plan of Arrangement. The Corporation shall not file any material with the Court
in connection with the Arrangement or serve any such material, or agree to modify or amend any material so filed or served, except
as contemplated by this Agreement or with the Acquiror&rsquo;s prior written consent, acting reasonably, provided the Acquiror
is not required to agree or consent to any increase in, or variation of the form of, the Consideration or other modification or
amendment to such filed or served materials that expands or increases the Acquiror&rsquo;s obligations, or diminishes or limits
the Acquiror&rsquo;s rights, set forth in any such filed or served materials or under this Agreement. The Corporation shall oppose
any proposal from any person that the Final Order contain any provision materially inconsistent with this Agreement, and if required
by the terms of the Final Order or by Law to return to Court with respect to the Final Order do so only after notice to, and in
consultation and cooperation with, the Acquiror. The Corporation shall not object to legal counsel to the Acquiror making submissions
on the application for the Interim Order and the application for the Final Order as such counsel considers appropriate, provided
that the Corporation is advised of the nature of any submissions not less than two Business Days prior to the hearing and such
submissions are consistent in all material respects with this Agreement and the Plan of Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Articles
                                         of Arrangement and Effective Date</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The
parties agree that the Arrangement shall be implemented in accordance with the terms and conditions of this Agreement and
the Plan of Arrangement. The Articles of Arrangement shall implement the Plan of Arrangement. As soon as reasonably
practicable and in any event no later than the third (3<SUP>rd</SUP>) Business Day after the satisfaction or waiver (subject
to applicable Laws) of the conditions set forth in Article&nbsp;9 (excluding conditions that, by their terms, cannot be
satisfied until the Effective Date, but subject to the satisfaction or waiver (subject to applicable Law) of those conditions
as of the Effective Date), and unless another date is agreed to in writing by the parties, the Corporation shall file the
Articles of Arrangement with the Director pursuant to section&nbsp;192 of the Act to give effect to the Arrangement and
implement the Plan of Arrangement provided that the Articles of Arrangement shall not be sent to the Director, for
endorsement and filing by the Director, except as contemplated hereby or with the Acquiror&rsquo;s prior written consent such
consent not to be unreasonably withheld or delayed. The Arrangement shall become effective at the Effective Time and will
have all of the effects provided by applicable Law, and the steps to be carried out pursuant to the Arrangement shall become
effective at the Effective Time in the order and at the times set forth in the Plan of Arrangement. The closing of the
Arrangement will take place at the offices of Borden Ladner Gervais LLP, Toronto, Ontario, or such other place as agreed upon
by the parties.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Payment
                                         of Consideration</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Acquiror
shall, subject to the satisfaction or waiver of the conditions set out in Sections&nbsp;9.1 and 9.3, following receipt of the
Final Order and prior to the filing by the Corporation of the Articles of Arrangement with the Director, deliver or cause to be
delivered sufficient cash to the Depositary to pay in full the aggregate Consideration payable to Securityholders (other than
Securityholders exercising Dissent Rights and who have not withdrawn their notice of objection) pursuant to the Plan of Arrangement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Announcement
                                         and Shareholder Communications</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Acquiror
and the Corporation shall jointly publicly announce the transactions contemplated hereby promptly following the execution of this
Agreement, the text and timing of such announcement to be approved in writing by the parties in advance, acting reasonably. The
parties shall cooperate in the preparation of presentations, if any, to the Securityholders regarding the Arrangement. Neither
party shall (a)&nbsp;issue any press release or otherwise make public announcements with respect to this Agreement or the Plan
of Arrangement without the prior written consent of the other party (which consent shall not be unreasonably withheld or delayed),
except as permitted by Article&nbsp;6, or (b)&nbsp;subject to Article&nbsp;7, make any filing with any Governmental Authority
with respect thereto without the prior written consent of the other party; provided, however, that the foregoing shall be subject
to each party&rsquo;s overriding obligation to make any disclosure or filing required under applicable Laws or stock exchange
rules, and the party making such disclosure shall use commercially reasonable efforts to give prior oral or written notice to
the other party and reasonable opportunity to review or comment on the disclosure or filing, and if such prior notice is not possible,
to give such notice immediately following the making of such disclosure or filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Withholding
                                         Taxes</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Acquiror,
the Corporation and the Depositary shall be entitled to deduct and withhold from any consideration or other payments payable or
otherwise deliverable to any person hereunder or under the Plan of Arrangement such amounts as the Acquiror, the Corporation or
the Depositary are entitled, required or reasonably believe to be required to deduct and withhold therefrom under any provision
of any applicable Laws or the interpretation or administration thereof in respect of Taxes and remit such deducted and withheld
amounts to the appropriate Governmental Authority. To the extent that such amounts are so properly deducted, withheld and remitted
on a timely basis to the relevant Governmental Authority, such amounts shall be treated for all purposes under this Agreement
or the Plan of Arrangement as having been paid to the person to whom such amounts would otherwise have been paid.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">2.11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">List of
                                         Securityholders</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">At the reasonable
request of the Acquiror from time to time, at the cost of the Corporation, the Corporation shall promptly provide the Acquiror
with a list (in both written and electronic form) of (i)&nbsp;the registered Shareholders, together with their addresses and respective
holdings of Common Shares, (ii)&nbsp;the names, addresses and holdings of all persons having rights issued by the Corporation
to acquire Common Shares (including Warrantholders and Optionholders), and (iii)&nbsp;participants and book-based nominee registrants
such as CDS &amp; Co., CEDE &amp; Co. and DTC, and non-objecting beneficial owners of Common Shares, together with their addresses
and respective holdings of Common Shares. The Corporation shall from time to time require that its registrar and transfer agent
furnish the Acquiror with such additional information, including updated or additional lists of Shareholders, and lists of securities
positions and other assistance as the Acquiror may reasonably request in order to be able to communicate with respect to the Arrangement
with the Shareholders and with such other persons as are entitled to vote on the Arrangement Resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;3<BR>
Representations and Warranties of the Parent and Acquiror</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">3.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Representations
                                         and Warranties</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Acquiror
and the Parent each jointly makes to the Corporation the representations and warranties set out in Schedule&nbsp;B to this Agreement
and acknowledges that the Corporation is relying upon these representations and warranties in connection with the entering into
of this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">3.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Survival
                                         of Representations and Warranties</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The representations
and warranties of the Acquiror and the Parent contained in this Agreement shall survive the execution and delivery of this Agreement
and shall expire and be terminated and extinguished upon the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;4<BR>
Representations and Warranties of the Corporation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Representations
                                         and Warranties</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Subject to
anything disclosed in (i)&nbsp;the applicable section or subsection of the Disclosure Letter (it being agreed that the disclosure
of any fact or item in any section or subsection of the Disclosure Letter shall only be deemed to be an exception to (or, as applicable,
disclosure for the purposes of) the representations and warranties of the Corporation that are contained in the corresponding
section of this Agreement), the Corporation hereby makes to the Acquiror the representations and warranties set out in Schedule&nbsp;C
to this Agreement, and acknowledges that the Acquiror is relying upon these representations and warranties in connection with
the entering into of this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Survival
                                         of Representations and Warranties</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The representations
and warranties of the Corporation contained in this Agreement shall survive the execution and delivery of this Agreement and shall
expire and be terminated and extinguished at the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;5<BR>
Conduct of Business</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">5.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Conduct
                                         of Business by the Corporation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Corporation
agrees that during the period from the date of this Agreement until the earlier of the Effective Time and the time that this Agreement
is terminated in accordance with its terms, unless the Acquiror shall otherwise consent in writing or as otherwise expressly contemplated
or permitted by this Agreement, the Plan of Arrangement or the Disclosure Letter, or as required by Law or any Governmental Authority,
the Corporation shall, and shall cause each of its subsidiaries to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">conduct
                                         its business in the Ordinary Course and use commercially reasonable efforts to preserve
                                         intact its present business organization and assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to maintain and preserve intact the current business
                                         organization, assets, properties and business of the Corporation and its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to keep available the services of the present employees
                                         and agents of the Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to maintain and preserve good relations with, and the
                                         goodwill of relationships with key suppliers, distributors, employees, inventors, vendors,
                                         contract research organizations, customers and others having material business relationships
                                         with it and its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         split, combine, consolidate or reclassify any outstanding shares of the Corporation or
                                         its subsidiaries nor undertake any other capital reorganization, nor declare, set aside
                                         or pay any dividends on or make any other distributions (whether in cash, stock or property
                                         or any combination thereof), nor reduce capital in respect of outstanding shares of the
                                         Corporation or its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         amend its articles or by-laws, constating documents, including the Corporation&rsquo;s
                                         Constating Documents, or the terms of its outstanding securities, or, in the case of
                                         any subsidiary which is not a corporation, its similar organizational documents;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         issue, grant, deliver, sell, pledge, award or otherwise encumber, or authorize the issuance,
                                         grant, delivery, sale, pledge or other encumbrance of any shares of capital stock, securities,
                                         options, warrants or similar rights exercisable or exchangeable for or convertible into
                                         such capital stock, of the Corporation or any of its subsidiaries, other than the issuance
                                         of Common Shares upon the exercise of currently outstanding Rights in accordance with
                                         their terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         redeem or purchase or otherwise acquire or offer to redeem, purchase or otherwise acquire
                                         any outstanding securities of the Corporation or its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         reorganize, amalgamate, combine or merge with any other person or adopt or enter into
                                         a plan of liquidation or dissolution or resolutions providing for the liquidation or
                                         dissolution of the Corporation or any of its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, enter into or modify any employment,
                                         consultant, severance, collective bargaining or similar plans, agreements, policies or
                                         arrangements (including any Employee Plans) with, or establish, grant or increase in
                                         any material respect any bonuses, salary increases, remuneration, stock options, pension
                                         or supplemental pension or other benefits (including any Employee Plans), profit sharing,
                                         retirement allowances, deferred compensation, incentive compensation, severance or termination
                                         pay or any other form of compensation to, or make any loan to, any of its employees,
                                         consultants, directors or officers, other than (i) as required by Law, or (ii) as required
                                         pursuant to the terms of any employment, pension, supplemental pension, termination or
                                         compensation plans, agreements, arrangements or policies (including any Employee Plans)
                                         existing as of the date hereof, or take or propose any action to effect any of the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         acquire or commit to acquire (by amalgamation, arrangement, merger, consolidation, acquisition
                                         of stock or assets or otherwise), directly or indirectly, in one transaction or in a
                                         series of related transactions, assets, securities, properties, interests or businesses
                                         having a value in excess of $100,000 in the aggregate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, sell, pledge, lease, dispose of, surrender,
                                         mortgage, license, option, encumber or otherwise dispose of, or commit to sell, pledge,
                                         lease, dispose of, surrender, mortgage, license, option, encumber or otherwise dispose
                                         of, or transfer any assets or group of related assets (through one or more related or
                                         unrelated transactions), or any interest in any assets or group of related assets, including
                                         any interest in any of the Company Owned IP or instruct the owner of any of the Company
                                         Licensed Registered IP to sell, pledge, lease, dispose of, surrender, mortgage, license,
                                         option, encumber or otherwise dispose of, or commit to sell, pledge, lease, dispose of,
                                         surrender, mortgage, license, option, encumber or otherwise dispose of, or transfer any
                                         of the Company Licensed Registered IP, other than in the Ordinary Course or immaterial
                                         assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         incur or commit to any capital expenditures having a value in excess of $250,000 in the
                                         aggregate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(n)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         make any loan or advance to, or any capital contribution or investment in, or assume,
                                         guarantee or otherwise become liable with respect to the liabilities or obligations of,
                                         any person;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(o)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         prepay any indebtedness (whether on account of borrowed money, deferred purchase price
                                         of property or otherwise) before its scheduled maturity;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(p)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         increase, create, incur, assume or otherwise become liable, in one transaction or in
                                         a series of related transactions, with respect to any indebtedness for borrowed money
                                         or guarantees thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(q)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         make any bonus or profit sharing distribution or similar payment of kind except as required
                                         pursuant to the terms of any Contract or profit sharing plan existing on the date hereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(r)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         enter into any interest rate, currency, equity or commodity swaps, hedges, derivatives,
                                         forward sales contracts or similar financial instruments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(s)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         pay, discharge or satisfy any material Claims, liabilities or obligations other than
                                         the payment, discharge or satisfaction, in the Ordinary Course of liabilities reflected
                                         or reserved against in the Corporation&rsquo;s annual audited financial statements for
                                         the year ended December&nbsp;31, 2015, incurred in the Ordinary Course subsequent to
                                         December&nbsp;31, 2015 and reflected in the Corporation&rsquo;s reviewed financial statements
                                         for the six month period ended June 30, 2016 or costs related to the Arrangement or incurred
                                         in the Ordinary Course, in each case after June 30, 2016;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(t)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         waive, release, compromise, terminate or relinquish any material contractual right, material
                                         right under any licence or permit or other material legal rights or Claims, other than
                                         in the Ordinary Course;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(u)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         amend or modify or terminate or waive any right under any Material Contract or enter
                                         into any contract or agreement that would be a Material Contract if in effect on the
                                         date hereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">duly
                                         and on a timely basis file all Tax Returns required to be filed by it, which shall be
                                         correct and complete in all material respects, on or after the date hereof pursuant to
                                         applicable Laws in a manner consistent with past practice;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(w)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">timely
                                         pay, withhold, collect and remit to the appropriate Governmental Entity in a timely fashion
                                         all amounts required to be so paid, withheld, collected or remitted;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         (i)&nbsp;make, rescind or change any election relating to Taxes, annual Tax accounting
                                         period or method of Tax accounting in any material respect, (ii)&nbsp;enter into (or
                                         offer to enter into) any agreement (including any waiver) with any Governmental Authority
                                         relating to Taxes, (iii)&nbsp;without the prior written consent of the Acquiror, settle
                                         (or offer to settle) any material Tax claim, audit, proceeding or re-assessment, or (iv)&nbsp;amend
                                         any Tax Return or change from most recent practice any manner of reporting income or
                                         claiming deductions for Tax purposes;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(y)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">except
                                         as required by Law and in a manner consistent with past practice, not make any material
                                         Tax election, information schedule, return or designation, settle or compromise any material
                                         Tax claim, assessment, reassessment or liability, file any amended Tax Return, enter
                                         into any material agreement with a Governmental Authority with respect to Taxes, surrender
                                         any right to claim a material Tax abatement, reduction, deduction, exemption, credit
                                         or refund, consent to the extension or waiver of the limitation period applicable to
                                         any material Tax matter or materially amend or change any of its methods or reporting
                                         income, deductions or accounting for income Tax purposes except as may be required by
                                         Law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(z)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">keep
                                         the Acquiror informed, on a current basis, of any events, discussions, notices or changes
                                         with respect to any Tax (other than communications in the Ordinary Course which could
                                         not reasonably be expected to be material to the Corporation), criminal or regulatory
                                         investigation or action involving the Corporation and any of its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(aa)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         make any changes to the Corporation&rsquo;s existing accounting policies other than as
                                         required by applicable Laws, a Governmental Authority or IFRS;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(bb)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         amend, modify, terminate, cancel or let lapse any material insurance (or re-insurance)
                                         policy of the Corporation or any subsidiary in effect on the date of this Agreement,
                                         unless simultaneously with such termination, cancellation or lapse, replacement policies
                                         underwritten by insurance and re-insurance companies of nationally recognized standing
                                         providing coverage equal to or greater than the coverage under the terminated, cancelled
                                         or lapsed policies for substantially similar premiums are in full force and effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(cc)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         engage in any transaction with any related parties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(dd)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">subject
                                         to Section 5.1(ee), not, without consent or permission of the Acquiror, which consent
                                         or permission not to be unreasonably withheld, delayed, or conditioned, commence or cancel,
                                         waive, release, assign, settle or compromise any Claims or any rights relating to or
                                         any interest in any litigation, proceeding, Claim, action, assessment or investigation
                                         involving the Corporation or any of its material assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ee)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         settle, compromise, concede or acquiesce to any threat, assertion, demand or claim against
                                         the Corporation regarding Company IP or the Product;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ff)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, abandon or materially reduce the scope
                                         of any pending or Registered IP;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(gg)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, (i)&nbsp;in respect of any Company Assets
                                         other than Company IP, waive, release, surrender, let lapse, grant or transfer any material
                                         right or value or amend, modify or change, or agree to amend, modify or change, in any
                                         material respect any existing material Authorization, right to use, contract or other
                                         material document or, (ii)&nbsp;in respect of Company IP, waive, release, surrender,
                                         let lapse, grant or transfer any material right or value in the Company IP or instruct
                                         the owner of Company Licensed Registered IP to waive, release, surrender, let lapse,
                                         grant or transfer any material right or value in any Company Licensed Registered IP;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(hh)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         abandon or fail to diligently pursue any application for any material Authorizations,
                                         licenses, leases, or registrations or take any action, or fail to take any action, that
                                         could lead to the termination of any material Authorizations, licenses, leases or registrations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, except in the Ordinary Course, (i)&nbsp;grant
                                         or acquire, agree to grant to or acquire from any person, abandon or permit to lapse
                                         any rights to any material Intellectual Property Rights or disclose or agree to disclose
                                         to any person, other than Representatives of the Acquiror, any material trade secrets,
                                         or (ii)&nbsp;fail to take any action necessary or material action advisable to protect
                                         or maintain the Intellectual Property Rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(jj)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         enter into or amend any Contract with any broker, finder or investment banker, including
                                         any amendment of any of the Contracts listed in Section 17 of the Disclosure Letter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(kk)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not,
                                         without consent or permission of the Acquiror, which consent or permission not to be
                                         unreasonably withheld, delayed, or conditioned, grant or commit to grant an exclusive
                                         licence or otherwise transfer any Intellectual Property Rights or exclusive rights in or in
                                         respect thereto, other than in the Ordinary Course or to a wholly-owned subsidiary of
                                         the Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ll)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         take any action or fail to take any action that is intended to, or would reasonably be
                                         expected to, individually or in the aggregate, prevent, materially delay or materially
                                         impede the ability of the Corporation to consummate the Arrangement or the other transactions
                                         contemplated by this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(mm)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         take any action that would cause any representation or warranty of the Corporation set
                                         out in Schedule&nbsp;C to be untrue or incorrect in any respect such that the condition
                                         at Section&nbsp;9.3(a) would not be satisfied;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(nn)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         announce an intention, enter into any agreement, or otherwise authorize, agree, resolve
                                         or make a commitment, whether or not in writing, to do any of the things prohibited by
                                         any of the foregoing subparagraphs; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(oo)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">except
                                         to the extent required by Law to protect patient safety, not amend the protocol for clinical
                                         trials CTH-300 or CTH-301, modify or take any action that deviates from the current clinical
                                         trial study designs, time lines and protocols for clinical trials CTH-300 and CTH-301
                                         (excluding the amendment for at home titration recommended by the Data and Safety Monitoring
                                         Board), including without limitation, taking any action that would impact the study cycle
                                         time line, patient and study site recruitment and enrollment status, patient standards
                                         of care, study objectives or strategy, protocol complexity, or the statistical analysis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;6<BR>
Covenants Relating to Acquisition Proposals</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">6.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Non-Solicitation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Except
                                         as provided in Section&nbsp;6.3 of this Agreement, the Corporation and its subsidiaries
                                         shall not, directly or indirectly through any Representative of the Corporation, or otherwise,
                                         and shall not permit any such person to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">solicit,
                                         initiate, encourage or otherwise facilitate (including by way of furnishing or providing
                                         copies of, access to, or disclosure of, any confidential information, properties, facilities,
                                         books or records of the Corporation or any subsidiary or entering into any form of agreement,
                                         arrangement or understanding) any inquiry, proposals or offer from any person (other
                                         than the Acquiror and its Affiliates) that relates to, constitutes or would reasonably
                                         be expected to constitute or lead to, an Acquisition Proposal or otherwise cooperate
                                         in any way with, or assist or participate in, facilitate or encourage, any effort or
                                         attempt by any other person to do or seek to do any of the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">enter
                                         into or otherwise engage or participate in any discussions or negotiations with any person
                                         (other than the Acquiror, its Affiliates and their Representatives) regarding, or provide
                                         information to any person with respect to, any inquiry, proposal or offer that relates
                                         to, constitutes or would reasonably be expected to constitute or lead to, an Acquisition
                                         Proposal;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">withdraw,
                                         modify or qualify, or propose publicly or state an intention to withdraw, modify or qualify
                                         the Board Recommendation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">accept,
                                         approve, endorse, recommend or take no position or remain neutral with respect to, or
                                         propose to accept, approve, endorse, recommend or take no position or remain neutral
                                         with respect to any Acquisition Proposal (it being understood that publicly taking no
                                         position or a neutral position with respect to a publicly announced, or otherwise publicly
                                         disclosed, Acquisition Proposal for a period of no more than five (5) Business Days following
                                         such public announcement or public disclosure will not be considered to be in violation
                                         of this Section&nbsp;6.1, provided the Board has rejected such Acquisition Proposal and
                                         affirmed the Board Recommendation before the end of such five (5) Business Day period (or
                                         in the event the Meeting is scheduled to occur within such five (5) Business Day period,
                                         prior to the third (3<SUP>rd</SUP>) Business Day prior to the date of the Meeting)); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">accept,
                                         approve, endorse, recommend or enter into (other than a confidentiality agreement as
                                         contemplated under Section&nbsp;6.3) or publicly propose to accept, approve, endorse,
                                         recommend or enter into any agreement, understanding or arrangement in respect of an
                                         Acquisition Proposal.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall, and shall cause its subsidiaries and its and their respective Representatives
                                         to, immediately cease and terminate, and cause to be terminated, any existing solicitation,
                                         encouragement, discussion, negotiation, or other activities commenced on or prior to
                                         the date of this Agreement with any person (other than the Acquiror, its Affiliates or
                                         any of their Representatives) with respect to any inquiry, proposal or offer that relates
                                         to, constitutes or would reasonably be expected to constitute or lead to, an Acquisition
                                         Proposal, and in connection therewith, the Corporation will:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">immediately
                                         discontinue access to and disclosure of all information, including any data room and
                                         any confidential information, properties, facilities, books and records of the Corporation
                                         or any of its subsidiaries; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">promptly
                                         request and exercise the rights it has to require (A) the return or destruction of all
                                         copies of any confidential information regarding the Corporation or any subsidiary provided
                                         to any person, and (B) the destruction of all material including or incorporating or
                                         otherwise reflecting such confidential information regarding the Corporation or any subsidiary.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation represents and warrants that neither it nor any of its subsidiaries has waived
                                         any confidentiality, standstill or similar agreement and further represents, warrants
                                         and covenants (as applicable) that (a)&nbsp;the Corporation and its subsidiaries shall
                                         use commercially reasonable efforts to enforce each confidentiality, standstill, non-disclosure,
                                         non-solicitation, use, business purpose or similar agreement, restriction or covenant
                                         to which the Corporation or any subsidiary is a party, and (b)&nbsp;neither the Corporation,
                                         nor any subsidiary or any of their respective Representatives have or will, without the
                                         prior written consent of the Acquiror (which may be withheld or delayed in the Acquiror&rsquo;s
                                         sole and absolute discretion), release any person from, or waive, amend, suspend or otherwise
                                         modify such person&rsquo;s obligations respecting the Corporation or any of its subsidiaries,
                                         under any confidentiality, standstill, non-disclosure, non-solicitation, use, business
                                         purpose or similar agreement, restriction or covenant to which the Corporation or any
                                         subsidiary is a party (it being acknowledged by the Acquiror that any automatic termination
                                         or release of any standstill or other restriction of any such agreements as the result
                                         of entering into this Agreement or as otherwise provided in the applicable agreement,
                                         will not constitute a breach of this Section&nbsp;6.1(c), provided that all agreements
                                         containing such a standstill restriction have been disclosed in Section&nbsp;6.1(c) of
                                         the Disclosure Letter and includes a description of all such standstill provisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall ensure that its Representatives are aware of the prohibitions in this
                                         Section&nbsp;6.1.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">6.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Notification
                                         of Acquisition Proposals</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">If the Corporation
or any of its subsidiaries or any of their respective Representatives, receives or otherwise becomes aware of any inquiry, proposal
or offer that constitutes or would reasonably be expected to constitute or lead to an Acquisition Proposal, or any request for
copies of, access to, or disclosure of, confidential information relating to the Corporation or any subsidiary in connection with
an Acquisition Proposal, including but not limited to information, access, or disclosure relating to the properties, facilities,
books or records of the Corporation or any subsidiary, the Corporation shall promptly (and in any event within 24 hours) notify
the Acquiror, at first orally and then as soon as practicable (and in any event within 24 hours) in writing, of such Acquisition
Proposal, inquiry, proposal, offer or request, including a description of its material terms and conditions, and, unless and only
to the extent prohibited by any confidentiality agreement or applicable provisions entered into by the Corporation prior to the
date hereof, shall provide the Acquiror the identity of such person making such Acquisition Proposal, inquiry, proposal, offer
or request and with copies of all material written documents, material or substantive correspondence or other material received
(and, if not in writing or electronic form, a description of the material terms thereof) in respect of, from or on behalf of any
such person. The Corporation shall keep the Acquiror reasonably informed of the status of developments and (to the extent permitted
by Section 6.3) negotiations with respect to any Acquisition Proposal, inquiry, proposal, offer or request following a change
of status as soon as practicable but not less than on a daily basis.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">6.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Responding
                                         to Acquisition Proposals and Superior Proposals</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Notwithstanding
                                         Section&nbsp;6.1(a), if at any time prior to obtaining the approval by the Securityholders
                                         of the Arrangement Resolution, the Corporation receives a written Acquisition Proposal
                                         made after the date hereof (that was not solicited in contravention of 6.1(a)), the Corporation
                                         and its Representatives may:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">contact
                                         the person making such Acquisition Proposal and its Representatives solely to clarify
                                         the terms and conditions of such Acquisition Proposal; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">engage
                                         in discussions and negotiations with the person making such Acquisition Proposal and
                                         its Representatives, and may provide copies of, access to or disclosure of information,
                                         properties, facilities, books or records of the Corporation or its subsidiaries for a
                                         maximum of 10 calendar days after the day on which access or disclosure is first afforded
                                         to the person making the Acquisition Proposal or its Representatives, provided that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Board, after consultation with its financial advisors and its outside legal counsel,
                                         determines in good faith that such Acquisition Proposal constitutes or could reasonably
                                         be expected to constitute or lead to a Superior Proposal;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">such
                                         person was not prohibited from making such Acquisition Proposal pursuant to an existing
                                         confidentiality, standstill, non-disclosure, use, business purpose or similar restriction
                                         with the Corporation or any of its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(C)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation has been, and continues to be, in compliance with its obligations under this
                                         Article&nbsp;6; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(D)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation first enters into a confidentiality and standstill agreement with such person
                                         that contains a standstill provision that restricts such person from acquiring, or publicly
                                         announcing an intention to acquire, any securities or assets of the Corporation (other
                                         than pursuant to a Superior Proposal) for a period of not less than 12 months from the
                                         date of such Agreement (unless such person is already a party to a confidentiality or
                                         standstill agreement with the Corporation) provided that such confidentiality and standstill
                                         agreement may not include any provision calling for an exclusive right to negotiate with
                                         the Corporation or any of its subsidiaries and may not restrict the Corporation from
                                         complying with this Agreement (including this Article&nbsp;6) and provided the Corporation
                                         sends a copy of any such confidentiality and standstill agreement to the Acquiror promptly
                                         upon its execution and thereafter the Acquiror is provided with access to any information
                                         that was provided to such person and not previously provided to the Acquiror prior to
                                         or concurrently with such information being provided to such person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="color: Black">Notwithstanding
the foregoing, the Corporation shall not provide any commercially sensitive non-public information to any person that might be
considering an Acquisition Proposal that was not, or concurrently therewith is not, provided to the Acquiror.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">If the
                                         Corporation receives an Acquisition Proposal prior to the approval of the Arrangement
                                         Resolution by the Securityholders that the Board determines in good faith, after consultation
                                         with its financial advisors and outside counsel, constitutes a Superior Proposal, the
                                         Board may enter into a definitive agreement with respect to such Superior Proposal, if
                                         and only if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         person making the Superior Proposal was not prohibited from making such Superior Proposal
                                         pursuant to an existing confidentiality, standstill, non-disclosure, use, business purpose
                                         or similar restriction with the Corporation or any of its subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation has been, and continues to be, in compliance with its obligations under this
                                         Article&nbsp;6;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation has delivered written notice to the Acquiror of the determination of the
                                         Board that the Acquisition Proposal is a Superior Proposal and of the intention of the
                                         Board to approve or recommend such Superior Proposal and/or of the Corporation to enter
                                         into an agreement with respect to such Superior Proposal, together with a copy of such
                                         agreement (including any financing documents supplied to the Corporation in connection
                                         therewith unless precluded to do so by confidentiality provisions contained therein)
                                         (the &ldquo;<B>Superior Proposal Notice</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">at
                                         least five (5) Business Days have elapsed since the date the Superior Proposal Notice was
                                         received by the Acquiror and the date on which the Acquiror received all of the materials
                                         set forth in Section&nbsp;6.3(b)(iii), which five (5) Business Day period is referred to
                                         as the &ldquo;<B>Match Period</B>&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">during
                                         any Match Period, the Acquiror has had the opportunity (but not the obligation), in accordance
                                         with Section&nbsp;6.3(c), to offer to amend this Agreement and the Arrangement in order
                                         for such Acquisition Proposal to cease to be a Superior Proposal;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">after
                                         the Match Period, the Board has determined in good faith, after consultation with its
                                         outside legal counsel and financial advisors, that such Acquisition Proposal continues
                                         to constitute a Superior Proposal (if applicable, compared to the terms of the Arrangement
                                         as proposed to be amended by the Acquiror under Section&nbsp;6.3(c)); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation terminates this Agreement pursuant to Section&nbsp;10.2(e) and the Corporation
                                         has previously paid or, concurrently with termination, pays the Termination Payment to
                                         the Acquiror.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">During
                                         the Match Period, (i)&nbsp;the Acquiror shall have the opportunity, but not the obligation,
                                         to offer to amend the terms of the Arrangement and this Agreement, (ii)&nbsp;the Board
                                         shall review any such offer by the Acquiror to amend the terms of the Arrangement and
                                         this Agreement in order to determine, in good faith, after consultation with its financial
                                         advisors and outside counsel, whether the Acquiror&rsquo;s offer to amend the Arrangement
                                         and this Agreement, upon its acceptance, would result in the Acquisition Proposal ceasing
                                         to be a Superior Proposal compared to the amendment to the terms of the Arrangement and
                                         this Agreement offered by the Acquiror, and (iii)&nbsp;the Corporation shall negotiate
                                         in good faith with the Acquiror to make such amendments to the terms of this Agreement
                                         and the Arrangement as would enable the Acquiror to proceed with the transactions contemplated
                                         by this Agreement on such amended terms. If the Board determines that the Acquisition
                                         Proposal would cease to be a Superior Proposal, the Corporation shall promptly so advise
                                         the Acquiror and the Corporation and the Acquiror shall enter into an amendment to this
                                         Agreement reflecting the offer by the Acquiror to amend the terms of the Arrangement
                                         and this Agreement, and shall take and cause to be taken all such actions as are necessary
                                         to give effect to the foregoing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">At the
                                         written request of the Acquiror, the Board shall promptly reaffirm the Board Recommendation
                                         by press release after: (i)&nbsp;any Acquisition Proposal (which is determined not to
                                         be a Superior Proposal) is publicly announced, made or disclosed; or (ii)&nbsp;the Board
                                         determines that a proposed amendment to the terms of the Arrangement and this Agreement
                                         would result in a previously announced Acquisition Proposal not being a Superior Proposal.
                                         The Acquiror and its counsel shall be given a reasonable opportunity to review and comment
                                         on the form and content of any such press release, and the Corporation shall reasonably
                                         consider any such comments, recognizing that whether or not such comments are appropriate
                                         will be determined by the Corporation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Nothing
                                         in this Agreement shall prevent the Board from complying with Section&nbsp;2.17 of National
                                         Instrument&nbsp;62-104 &ndash; <I>Take-Over Bids and Issuer Bids</I> and similar provisions
                                         under Securities Laws relating to the provision of a directors&rsquo; circular in respect
                                         of an Acquisition Proposal for the Corporation; provided, however, that, notwithstanding
                                         that the Board shall be permitted to make such disclosure, the Board shall not be permitted
                                         to make a change to the Board Recommendation, other than as permitted by Section&nbsp;6.3(a).
                                         The Acquiror and its counsel shall be given a reasonable opportunity to review and comment
                                         on the form and content of any such disclosure relating to this Agreement and the transactions
                                         contemplated hereby.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">If the
                                         Corporation provides the Acquiror with a Superior Proposal Notice on a date that is less
                                         than five (5) Business Days prior to the Meeting, at the request of the Acquiror, the Corporation
                                         will either proceed with or adjourn the Meeting to a date that is not less than three
                                         (3) Business Days and not more than 10 Business Days after the date the Superior Proposal
                                         Notice is provided to the Acquiror, as such date is requested by the Acquiror.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Each
                                         successive material modification of any Acquisition Proposal shall constitute a new Acquisition
                                         Proposal for purposes of Section&nbsp;6.3(b) and all of the provisions of this Section&nbsp;6.3
                                         shall apply again to such new Acquisition Proposal, provided that the Acquiror shall
                                         be afforded a new five (5) Business Day Match Period from the later of the date on which
                                         the Acquiror received the Superior Proposal Notice and the date on which the Acquiror
                                         received all of the materials set forth in Section&nbsp;6.3(b)(iii) with respect to the
                                         new Superior Proposal from the Corporation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall advise its subsidiaries and their respective Representatives of the
                                         prohibitions set out in this Article&nbsp;6 and any violation of the restrictions set
                                         forth in this Article&nbsp;6 by the Corporation, its subsidiaries or their respective
                                         Representatives is deemed to be a breach of this Article&nbsp;6 by the Corporation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;7<BR>
Covenants Relating to Regulatory Approvals</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">7.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Regulatory
                                         Filings and Approvals</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">As soon
                                         as reasonably practicable after the date hereof until the Effective Time, each party
                                         shall (i)&nbsp;promptly make all necessary filings, applications and submissions with,
                                         give all notices to, Governmental Authorities under all applicable Laws that are required
                                         for the lawful completion of the transactions contemplated by this Agreement and the
                                         Plan of Arrangement, and (ii)&nbsp;take, or to cause to be taken, all actions, and to
                                         do, or to cause to be done, all things reasonably necessary, proper or advisable, to
                                         obtain as promptly as practicable all such Authorizations from Governmental Authorities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Without limiting the generality of Section 7.1(a), the
Acquiror and the Corporation shall use their commercially reasonable efforts to obtain the HSR Approval.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Corporation will pay one-half of one requisite filing fee and the Acquiror shall pay the balance
of all requisite filing fees in relation to any filing or application made in respect of the HSR Approval.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black"></FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">7.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Cooperation
                                         Regarding Regulatory Filings and Approvals</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Subject
to applicable Laws, each party shall provide the other party with reasonable opportunity to review and comment on all filings,
applications and submissions with Governmental Authorities to be made by it and the other party shall use its commercially reasonable
efforts to cooperate with and assist such party in the preparation and making of all such filings, applications and submissions
and the obtaining of all consents, approvals, authorizations or waivers required to be obtained by such party (including participating
and appearing in any proceedings before Governmental Authorities). Acquiror, acting in its reasonable discretion and with appropriate
input from the Corporation, shall be entitled to coordinate any actual or proposed supplemental submissions to (and substantive
meetings or discussions, as contemplated by Section 7.2(b), with) Governmental Authorities in respect of the HSR Approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">In furtherance
                                         of the undertakings in Section 7.2(a), each party shall promptly notify the other party
                                         of any material communication to such party from any Governmental Authority in respect
                                         of the transactions contemplated herein (and provide a copy thereof if such communication
                                         is in writing) and, subject to applicable Laws, provide the other party with reasonable
                                         opportunity to review and comment on any proposed written material communication to any
                                         such Governmental Authority. Each party shall consult with the other party prior to participating
                                         in any substantive meeting or discussion with any Governmental Authority in respect of
                                         the transactions contemplated herein and use commercially reasonable efforts to give
                                         the other party (except in respect of competitively sensitive, privileged or confidential
                                         matters, which may be withheld entirely except where it can be shared with the other
                                         party&rsquo;s external counsel without risk of loss of secrecy, privilege or confidentiality)
                                         the opportunity to attend and participate thereat.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Notwithstanding
                                         any other requirement in this Section&nbsp;7.2 where a Party (a &ldquo;<B>Disclosing
                                         Party</B>&rdquo;) is required under this Section&nbsp;7.2 to provide information to another
                                         party (a &ldquo;<B>Receiving Party</B>&rdquo;) that the Disclosing Party deems to be
                                         competitively sensitive information or otherwise reasonably determines in respect thereof
                                         that disclosure should be restricted, the Disclosing Party may restrict the provision
                                         of such competitively sensitive and other information only to external legal counsel
                                         of the Receiving Party, provided that the Disclosing Party also provides the Receiving
                                         Party a redacted version of such information which does not contain any such competitively
                                         sensitive or other restricted information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;8<BR>
Other Covenants</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Further
                                         Assurances</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall use commercially reasonable efforts to perform, and to cause its subsidiaries
                                         to perform, all obligations required or desirable to be performed by the Corporation
                                         or any of its subsidiaries under this Agreement, cooperate with the Acquiror in connection
                                         therewith, and do all such other commercially reasonable acts and things as may be necessary
                                         or desirable in order to consummate and make effective, as soon as reasonably practicable,
                                         the transactions contemplated by this Agreement and, without limiting the generality
                                         of the foregoing, the Corporation shall and, where appropriate, shall cause each of its
                                         subsidiaries to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to satisfy all conditions precedent in this Agreement
                                         and take all steps set forth in the Interim Order and Final Order applicable to it;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to obtain and maintain all third party or other consents,
                                         waivers, permits, exemptions, orders, approvals, agreements, amendments or confirmations
                                         that are (A)&nbsp;necessary or advisable to be obtained under the Material Contracts
                                         in connection with the Arrangement or (B)&nbsp;required in order to maintain the Material
                                         Contracts and the HSR Approval in full force and effect following completion of the Arrangement, in each case, on terms that are reasonably satisfactory to the Acquiror,
                                         acting reasonably;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to effect all necessary registrations, filings and submissions
                                         of information required by Governmental Authority from the Corporation and its subsidiaries
                                         relating to the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to, on prior written approval of the Acquiror, oppose,
                                         lift or rescind any injunction, restraining or other order, decree, judgment or ruling
                                         seeking to restrain, enjoin or otherwise prohibit or adversely affect the consummation
                                         of the Arrangement and defend, or cause to be defended, any proceedings to which it is
                                         a party or brought against it or its directors or officers challenging the Arrangement
                                         or this Agreement; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         take any action, or refrain from taking any commercially reasonable action, or permitting
                                         any action to be taken or not taken, which is inconsistent with this Agreement or which
                                         would reasonably be expected to materially prevent, delay or impede the consummation
                                         of the Arrangement or the transactions contemplated by this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation shall promptly notify the Acquiror in writing of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         notice or other communication from any person alleging that the consent (or waiver, permit,
                                         exemption, order, approval, agreement, amendment or confirmation) of such person (or
                                         another person) is or will be required in connection with this Agreement or the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         notice or other communication from any supplier, marketing partner or licensor of Intellectual
                                         Property Rights to the effect that such person is terminating, may terminate or is otherwise
                                         materially adversely modifying or may materially adversely modify its relationship with
                                         the Corporation or any of its subsidiaries as a result of this Agreement or the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         notice or other communication from any Governmental Authority in connection with the
                                         Agreement (and contemporaneously provide a copy of any such written notice or communication
                                         to the Acquiror);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         material Claim or Legal Proceeding commenced or, to its knowledge, threatened against,
                                         relating to or involving or otherwise affecting the Corporation, its subsidiaries or
                                         the Corporation Assets; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         communication, including written or oral, from any Governmental Authority in connection
                                         with the Company Owned Registered IP, including, but not limited to office actions, notices,
                                         maintenance fees, and generally relating to the examination of the Company Owned Registered
                                         IP, the status of developments and negotiations, including with Examiners, with respect
                                         to any patent and trademark prosecution relating to Company Owned Registered IP.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror shall use commercially reasonable efforts to perform all obligations required
                                         or desirable to be performed by it under this Agreement, cooperate with the Corporation
                                         in connection therewith, and do all such other commercially reasonable acts and things
                                         as may be necessary or desirable in order to consummate and make effective, as soon as
                                         reasonably practicable, the transactions contemplated by this Agreement and, without
                                         limiting the generality of the foregoing, the Acquiror shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to satisfy all conditions precedent in this Agreement
                                         and take all steps set forth in the Interim Order and Final Order applicable to it;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to effect all necessary registrations, filings and submissions
                                         of information required by Governmental Authorities from it relating to the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">use
                                         commercially reasonable efforts to oppose, lift or rescind any injunction, restraining
                                         or other order, decree, judgment or ruling seeking to restrain, enjoin or otherwise prohibit
                                         or adversely affect the consummation of the Arrangement and defend, or cause to be defended,
                                         any proceedings to which it is a party or brought against it or its directors or officers
                                         challenging the Arrangement or this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">not
                                         take any action, or refrain from taking any commercially reasonable action, or permit
                                         any action to be taken or not taken, which is inconsistent with this Agreement or the
                                         Arrangement or which would reasonably be expected to materially prevent, delay or otherwise
                                         impede the consummation of the Arrangement or the transactions contemplated by this Agreement;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">provide
                                         notice to the Corporation of any notice or other communication from any Governmental
                                         Authority in connection with the Agreement (and contemporaneously provide a copy of any
                                         such written notice or communication to the Corporation).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
parties understand and agree that the commercially reasonable efforts of any party hereto shall not be deemed to include:
(i)&nbsp;entering into any settlement, undertaking, consent decree, consent agreement, consent order, stipulation or agreement
with the Governmental Authority in connection with the transactions contemplated hereby; or (ii)&nbsp;divesting or otherwise holding
separate (including by establishing a trust or otherwise), or taking any other action (or otherwise agreeing to do any of the
foregoing) with respect to the Acquiror or Corporation or any of their respective subsidiaries, Affiliates, businesses, assets
or properties.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">338 Election</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The parties
understand and agree that an election will be made under Section&nbsp;338(g) of the U.S. Internal Revenue Code for the Corporation
and any of its eligible subsidiaries (other than any subsidiary that is treated as a U.S. corporation under U.S. federal Tax laws).
The parties agree to cooperate as reasonably required to effectuate said election.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Access</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Upon reasonable
notice and subject to the Confidentiality Agreement, the Corporation agrees to continue to provide the Acquiror and its Representatives
with reasonable access (without disruption to the conduct of the Corporation&rsquo;s business) during normal business hours to
the books, records, information and files in its possession and control and access to its personnel on an as reasonably requested
basis as well as reasonable access to the properties of the Corporation in order to allow the Acquiror to continue to conduct
such investigations as the Acquiror may reasonably consider necessary or advisable. The Corporation, the Acquiror and the Parent
agree to establish, within three (3) Business Days of the date hereof, a committee comprised of Representatives of their respective
most senior scientific, medical and clinical officers (or in the event any such officer is not available for a particular meeting,
his or her respective designee) which committee will discuss the status of developments of clinical trials CTH-300 and CTH-301,
including relating to study cycle time line, patient and study site recruitment and enrollment status, patient standards of care,
study objectives or strategy and protocol complexity. Such committee will meet either in person, by telephone or other electronic
means on a weekly basis. Nothing in this Agreement shall require the Corporation to disclose to the Acquiror (a) any material
information which has not been publicly disclosed by the Corporation in accordance with the Securities Laws or (b) information
which it is prohibited from disclosing pursuant to a written confidentiality agreement or confidentiality provision of an agreement
with third parties, or information which, in the opinion of the Corporation is commercially or competitively sensitive (except
where it can be shared with the other party&rsquo;s external counsel without risk of loss of secrecy, privilege or confidentiality).
Without limiting the foregoing, the Corporation shall, upon the Acquiror&rsquo;s request, facilitate discussions between the Acquiror
and any third party from whom consent may be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Pre-Acquisition
                                         Reorganization</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Subject
                                         to Section&nbsp;8.4(b), the Corporation agrees that, upon the written request of the
                                         Acquiror, the Corporation shall, and shall cause each of its subsidiaries, to use commercially
                                         reasonable efforts to (i)&nbsp;perform such reorganizations of its corporate structure,
                                         capital structure, business, operations and assets or such other transactions as the
                                         Acquiror may request (each a &ldquo;<B>Pre-Acquisition Reorganization</B>&rdquo;), and
                                         (ii)&nbsp;cooperate with the Acquiror and its advisors to determine the nature of the
                                         Pre-Acquisition Reorganizations (or any transactions or other steps contemplated by the
                                         Acquiror following the Effective Time) that might be undertaken and the manner in which
                                         they would most effectively be undertaken, and (iii)&nbsp;cooperate with the Acquiror
                                         and its advisors to seek to obtain any consents or other pre-conditions to implementing
                                         the transactions or other steps contemplated by the Pre-Acquisition Reorganization (or
                                         any transactions or other steps contemplated by the Acquiror following the Effective
                                         Time).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Corporation will not be obligated to participate in any Pre-Acquisition Reorganization
                                         under 8.4(a) unless the Corporation determines that such Pre-Acquisition Reorganization:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">can
                                         be completed prior to the Effective Date without adversely affecting the Corporation,
                                         any of its subsidiaries or its Securityholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">is
                                         not prejudicial to the Corporation, any of its subsidiaries or its Securityholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">does
                                         not impair, impede, delay or prevent the receipt of any regulatory approvals or the satisfaction
                                         of any conditions set forth in this Agreement or the ability of the Corporation, the
                                         Parent or the Acquiror to consummate, and will not materially delay the consummation
                                         of, the Arrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">does
                                         not require the Corporation to obtain the approval of any Securityholders or, after the
                                         mailing of the Circular, to require any amendment thereto;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">is effected
                                         as close as reasonably practicable prior to the Effective Time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">does
                                         not require the Corporation or its subsidiaries to take any action that could reasonably
                                         be expected to result in Taxes being imposed on, or any adverse Tax or other consequences
                                         to, any Securityholders incrementally greater than the Taxes or other consequences to
                                         such party in connection with the completion of the Arrangement in the absence of action
                                         being taken pursuant to this Section&nbsp;8.4;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">does
                                         not require the Corporation to contravene any applicable Laws or its organizational documents
                                         or result in any breach by the Corporation or any of its subsidiaries of any Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">does
                                         not require the directors, officers, employees or agents of the Corporation or its subsidiaries
                                         to take any action in any capacity other than as a director, officer, employee or agent;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">shall
                                         not become effective unless the Parent and the Acquiror each has irrevocably waived or
                                         confirmed in writing the satisfaction of all conditions in its favour under this Agreement
                                         and shall have confirmed in writing that each of them is prepared to promptly and without
                                         condition (other than compliance with this Section&nbsp;8.4) proceed to effect the Arrangement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror must provide written notice to the Corporation of any proposed Pre- Acquisition
                                         Reorganization at least fifteen (15) Business Days prior to the Effective Date. Upon
                                         receipt of such notice, the Corporation and the Acquiror shall work cooperatively and
                                         use their commercially reasonable efforts to prepare prior to the Effective Time all
                                         documentation necessary and do such other acts and things as are necessary to give effect
                                         to such Pre-Acquisition Reorganization (subject to Section&nbsp;8.4(b)), including any
                                         amendment to this Agreement or the Plan of Arrangement and shall seek to have any such
                                         Pre-Acquisition Reorganization made effective at the times reasonably requested by the
                                         Acquiror.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror agrees that (i)&nbsp;it will be responsible for all costs and expenses associated
                                         with any Pre-Acquisition Reorganization to be carried out at its request and shall indemnify
                                         and save harmless the Corporation and its Affiliates from and against any and all liabilities,
                                         losses, damages, claims, costs, expenses, interest awards, judgements and penalties (after
                                         the Corporation has taken commercially reasonable efforts to mitigate any such liabilities,
                                         losses, damages, claims, costs, expenses, interest awards, judgements and penalties)
                                         suffered or incurred by any of them in connection with or as a result of any such Pre-Acquisition
                                         Reorganization, and (ii)&nbsp;if the Arrangement is not completed as contemplated herein,
                                         it shall indemnify and save harmless the Corporation, its Affiliates and Securityholders
                                         from and against any and all direct and indirect liabilities, losses, Taxes, damages,
                                         claims, costs, expenses, interest awards, judgements and penalties suffered or incurred
                                         by any of them in connection with or as a result of any Pre-Acquisition Reorganization
                                         if after participating in any Pre-Acquisition Reorganization the Arrangement is not completed
                                         other than due to a breach by the Corporation of the terms and conditions of this Agreement,
                                         including any reasonable costs incurred by the Corporation in order to restore the organizational
                                         structure of the Corporation to a substantially identical structure of the Corporation
                                         as at the date hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror acknowledges and agrees that the planning for and implementation of any Pre-Acquisition
                                         Reorganization shall not be considered a breach of any covenant under this Agreement
                                         and shall not be considered in determining whether a representation or warranty of the
                                         Corporation hereunder has been breached, and the Acquiror and the Parent waive any breach
                                         of a representation, warranty or covenant by the Corporation, where such breach is a
                                         result of an action taken by the Corporation or a subsidiary in good faith pursuant to
                                         a request by the Acquiror in accordance with this Section&nbsp;8.4.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">For
                                         the purposes of Section&nbsp;8.4(d) and Section&nbsp;8.4(e), above, section&nbsp;2.3
                                         of the Plan of Arrangement shall be considered to form part of a Pre-Acquisition Reorganization.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">De-listing
                                         and Deregistration</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Subject to
Applicable Laws, the Acquiror and the Corporation shall use their commercially reasonable efforts to cause the Common Shares to
be de-listed from the Exchanges and the deregistration of the Common Shares under the U.S. Exchange Act promptly, with effect
immediately following the acquisition by the Acquiror of the Common Shares pursuant to the Arrangement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Shareholder
                                         Litigation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">In the event
that any shareholder litigation related to this Agreement or the transactions contemplated by this Agreement is brought, or, to
the knowledge of the Corporation, threatened in writing, against the Corporation and/or the members of the Board prior to the
Effective Time, the Corporation shall promptly notify the Acquiror thereof and shall keep the Acquiror reasonably informed with
respect to the status thereof (it being understood that the Corporation shall control the defense and settlement of litigation
against any of its directors or the members of the Corporation and any of its subsidiaries with counsel of its own choosing).
Neither the Corporation, its subsidiaries nor their respective representatives shall compromise, settle, come to an arrangement
regarding or agree to compromise, settle or come to an arrangement regarding any such shareholder litigation or consent to the
same unless the Acquiror shall have consented in writing, acting reasonably.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Directors
                                         and Officers Insurance and Indemnification</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror shall honour all rights to indemnification existing on the date hereof in favour
                                         of the current and former directors and officers of the Corporation and its subsidiaries
                                         pursuant to the Corporation&rsquo;s Constating Documents, the Act or any indemnity agreements
                                         with such persons to the extent that any such indemnity agreements have been disclosed
                                         in Section 8.7(a) of the Disclosure Letter, and acknowledges that such rights, to the
                                         extent that they have been so disclosed, shall survive the completion of the Plan of
                                         Arrangement and shall continue in full force and effect in accordance with their terms
                                         for a period of not less than six years following the Effective Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         Acquiror acknowledges and agrees that, notwithstanding any other provision of this Agreement,
                                         the Corporation shall, prior to the Effective Date, purchase, as an extension to the
                                         Corporation&rsquo;s current insurance policies, pre-paid non-cancellable run-off directors&rsquo;
                                         and officers&rsquo; liability insurance providing such coverage for all present and former
                                         directors and officers of the Corporation and the subsidiary covering Claims in respect
                                         of acts or omissions in their capacity as directors or officers of the Corporation or
                                         the subsidiary occurring prior to the Effective Time made prior to or within a period
                                         of six (6) years after the Effective Time, on terms comparable to those contained in the
                                         Corporation&rsquo;s current insurance policies, provided that the Acquiror will not be
                                         required to pay any amounts in respect of such coverage prior to the Effective Time and
                                         provided further that the cost of such policies shall not exceed 300% of the Corporation&rsquo;s
                                         current annual aggregate premium for policies currently maintained by the Corporation;
                                         it being understood that if the annual premiums payable for such insurance coverage exceed
                                         such amount, the Acquiror shall be obligated to obtain a policy with the greatest coverage
                                         available for a cost equal to such amount.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">The
                                         provisions of this Section&nbsp;8.7 are: (i)&nbsp;intended for the benefit of all present
                                         and former directors and officers of the Corporation and any of its subsidiaries, as
                                         and to the extent applicable in accordance with their terms, and shall be enforceable
                                         by each of such persons and his or her heirs, executors administrators and other legal
                                         representatives (collectively, the &ldquo;<B>Third Party Beneficiaries</B>&rdquo;) and
                                         the Corporation shall hold the rights and benefits of this Section&nbsp;8.7 in trust
                                         for and on behalf of the Third Party Beneficiaries and the Corporation hereby accepts
                                         such trust and agrees to hold the benefit of and enforce performance of such covenants
                                         on behalf of the Third Party Beneficiaries; and (ii)&nbsp;are in addition to, and not
                                         in substitution for, any other rights that the Third Party Beneficiaries may have by
                                         contract or otherwise. Furthermore, this Section&nbsp;8.7 shall survive the termination
                                         of this Agreement as a result of the occurrence of the Effective Date for a period of
                                         six (6) years.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Employment
                                         Matters</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The
Corporation shall use its commercially reasonable efforts to deliver to the Acquiror on the Effective Date resignations and
releases (in a form satisfactory to the Acquiror, acting reasonably) effective on the Effective Date, of the directors and
officers of the Corporation or any of its subsidiaries designated in writing by the Acquiror at least 10 Business Days prior
to the Effective Date, provided that such resignations will be subject to consummation of the Contemplated Transactions,
Section&nbsp;8.7 as well as any right to receive any Consideration, Change of Control Payment as well as any compensation not
yet paid or accrued benefits not yet provided.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Covenants
                                         of the Parent</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The Parent
hereby unconditionally and irrevocably guarantees in favour of the Corporation the due and punctual performance by the Acquiror
of the Acquiror&rsquo;s obligations hereunder. The Parent hereby agrees that the Corporation shall not have to proceed first against
the Acquiror in respect of any such matter before exercising its rights under this guarantee against the Parent and agrees to
be liable for all guaranteed obligations as if it were the principal obligor of such obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black"></FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">8.10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Outstanding
                                         Rights</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">In accordance
with the terms of the Plan of Arrangement, at the Effective Time, each Option which is outstanding and that has not been exercised
prior to the Effective Time, shall be cancelled and the holder thereof shall receive the Consideration therefor, and each Warrant
which is outstanding and that has not been exercised prior to the Effective Time, shall be purchased by the Acquiror and the holder
thereof shall receive the Consideration therefor. The parties to this Agreement acknowledge and agree that (a)&nbsp;none of the
Acquiror, the Corporation, and all persons not dealing at arm&rsquo;s length with the Acquiror will claim any deduction under
the Tax Act with respect to any payment made to a holder of Options described herein or in the Plan of Arrangement and (b)&nbsp;they
will comply with the requirements described in subsection&nbsp;110(1.1) of the Tax Act (including, where applicable, the filing
of the election described therein) as regards payments to holders of Options, it being understood that the holders of Options
shall be entitled to claim any deductions available to such persons pursuant to the Tax Act in respect of the calculation of taxable
income arising thereunder.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;9<BR>
Conditions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">9.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Mutual Conditions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The obligations
of the Corporation and the Acquiror to complete the transactions contemplated herein are subject to fulfillment of the following
conditions on or before the Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Interim Order and the Final Order shall each have been obtained on terms consistent with
                                         this Agreement, and shall not have been set aside or modified in a manner unacceptable
                                         to the parties, acting reasonably, on appeal or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Arrangement Resolution shall have been approved at the Meeting in accordance with the
                                         Interim Order;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">there
                                         shall not be in force any Law and no Governmental Authority shall have issued any order
                                         or decree restraining or prohibiting the completion of the transactions contemplated
                                         herein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">this
                                         Agreement shall not have been terminated in accordance with its terms; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(e)</FONT></TD><TD STYLE="text-align: justify">the
                                         HSR Approval shall have been obtained.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The foregoing
conditions are for the mutual benefit of each of the Corporation and the Acquiror and may only be waived, in whole or in part
by mutual written consent of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">9.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Corporation
                                         Conditions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The obligation
of the Corporation to complete the transactions contemplated herein is subject to the fulfillment of the following conditions
on or before the Effective Date or such other time as specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         representations and warranties contained in Article&nbsp;3 (disregarding all qualifications
                                         set forth therein relating to &ldquo;materiality&rdquo; or other qualifications based
                                         on the word &ldquo;material&rdquo; or similar phrases) shall be true and correct as of
                                         the Effective Time with the same force and effect as if made on and as of such date (except
                                         to the extent such representations and warranties are, by their terms, made as of a specified
                                         date, in which case such representations and warranties shall be so true and correct
                                         as of such specified date), except where the failure of such representations and warranties
                                         to be so true and correct would not have, or would not reasonably be expected individually,
                                         or in the aggregate, to prevent or materially impair or delay completion of the Arrangement,
                                         and the Acquiror and Parent shall have provided to the Corporation the certificate of
                                         two (2) senior officers of the Acquiror certifying such accuracy as of the Effective Time;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Acquiror shall have complied in all material respects with its covenants herein and the
                                         Acquiror and Parent shall have provided to the Corporation the certificate of two (2) senior
                                         officers of the Acquiror certifying that the Acquiror has so complied with its covenants
                                         herein as of the Effective Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The foregoing
conditions precedent are for the benefit of the Corporation and may be waived, in whole or in part, by the Corporation in writing
at any time.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">9.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Acquiror
                                         Conditions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The obligation
of the Acquiror to complete the transactions contemplated herein is subject to the fulfillment of the following conditions on
or before the Effective Date or such other time as specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">(i)&nbsp;the
                                         representations and warranties of the Corporation in Section 1 of Schedule&nbsp;C to
                                         this Agreement (Board Approval), Section 2 of Schedule&nbsp;C to this Agreement (Corporate
                                         Existence and Power), Section 3 of Schedule&nbsp;C to this Agreement (Corporate Authorization),
                                         Section 4 of Schedule&nbsp;C to this Agreement (Authority and No Violation), Section
                                         5 of Schedule&nbsp;C to this Agreement (Consent and Approvals), Section 8 of Schedule&nbsp;C
                                         to this Agreement (Subsidiaries), Section 15 of Schedule&nbsp;C to this Agreement (No
                                         Material Adverse Effect) and Section 17 of Schedule&nbsp;C to this Agreement (No Brokers)
                                         shall, if qualified by materiality or &ldquo;Material Adverse Effect&rdquo; be true and
                                         correct in all respects or, if not so qualified, be true and correct in all material
                                         respects as of the Effective Time with the same force and effect as if made on and as
                                         of such date, (ii)&nbsp;the representation and warranty of the Corporation in Section
                                         7 of Schedule&nbsp;C to this Agreement (Capitalization) shall be true and correct in
                                         all respects as of the date hereof and as of the Effective Time with the same force and
                                         effect as if made on and as of such date, unless the failure of such representation and
                                         warranty to be true and correct would not result in the Acquiror paying additional aggregate
                                         consideration of $250,000 or more to Securityholders as a result of the failure of such
                                         representation and warranty to be so true and correct, provided however, that any increase
                                         in the aggregate Consideration payable as a result of the exercise of Options or Warrants
                                         listed in Section 7(a) of the Disclosure Letter for Common Shares shall not be considered
                                         an increase to the Consideration payable for purposes of this condition, and (iii)&nbsp;each
                                         of the other representations and warranties contained in Article&nbsp;4 (disregarding
                                         all qualifications set forth therein relating to &ldquo;materiality&rdquo;, &ldquo;Material
                                         Adverse Effect&rdquo; or other qualifications based on the word &ldquo;material&rdquo;
                                         or similar phrases) shall be true and correct as of the Effective Time with the same
                                         force and effect as if made on and as of such date (except to the extent such representations
                                         and warranties are, by their terms, made as of a specified date, in which case such representations
                                         and warranties shall be so true and correct as of such specified date), except where
                                         the failure of such representations and warranties in this clause&nbsp;(iii) to be so
                                         true and correct would not have, or would not reasonably be expected to have, individually
                                         or in the aggregate, a Material Adverse Effect and the Corporation shall have provided
                                         to the Acquiror the certificate of two (2) senior officers of the Corporation certifying
                                         such accuracy as of the Effective Time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Corporation shall have complied in all material respects with its covenants herein, and
                                         the Corporation shall have provided to the Acquiror the certificate of two (2) senior officers
                                         of the Corporation certifying that the Corporation has so complied with its covenants
                                         herein as of the Effective Date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">from
                                         the date hereof and up to and including the Effective Date, there shall not have been
                                         or occurred a Material Adverse Effect in respect of the Corporation; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify">t<FONT STYLE="color: Black">here
is no action or proceeding (whether, for greater certainty, by a Governmental Authority or any other person) pending in any jurisdiction
to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">cease
                                         trade, enjoin, prohibit, or impose any material limitations, damages or conditions on,
                                         the Acquiror&rsquo;s ability to acquire, hold, or exercise full rights of ownership over,
                                         any Common Shares, including the right to vote the Common Share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">prohibit,
                                         restrict or impose terms or conditions beyond those terms and conditions which the Acquiror
                                         are required to accept pursuant to Section&nbsp;8.2 of the Arrangement, or the ownership
                                         or operation by the Acquiror of the business or assets of the Acquiror, its Affiliates
                                         and related entities, the Corporation or any of the Corporation&rsquo;s subsidiaries
                                         and related entities, or compel the Acquiror to dispose of or hold separate any of the
                                         business or assets of the Acquiror, its Affiliates and related entities, the Corporation
                                         or any of the Corporation&rsquo;s subsidiaries and related entities as a result of the
                                         Arrangement;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>
                                         </SUP></FONT>or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">prevent
                                         or materially delay the consummation of the Arrangement, or if the Arrangement were to
                                         be consummated, have a Material Adverse Effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The foregoing
conditions precedent are for the benefit of the Acquiror and may be waived, in whole or in part, by the Acquiror in writing at
any time.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">9.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Notice and
                                         Cure</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Each party
will give prompt notice to the other party of the occurrence, or failure to occur, at any time from the date hereof until the
Effective Date, of any event or state of facts of which it is aware which occurrence or failure would, or would be likely to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">cause
                                         any of the representations and warranties of such party contained herein that are qualified
                                         by materiality or Material Adverse Effect to be untrue or inaccurate in any respect or
                                         any of the representations and warranties of such party that are not qualified by materiality
                                         or Material Adverse Effect to be untrue or incorrect in any material respect, in each
                                         case, at any time between the date hereof and the Effective Date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">result
                                         in the failure to comply with or satisfy any covenant or agreement to be complied with
                                         or satisfied by any other party at or prior to the Effective Date; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">result
                                         in the failure to satisfy any of the conditions precedent contained in Sections&nbsp;9.1,
                                         9.2 or 9.3, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">Subject to
the provisions of this Agreement, a party may elect not to complete the transactions contemplated hereby pursuant to
the conditions contained in Sections&nbsp;9.1, 9.2 or 9.3 or exercise any termination right arising therefrom; provided,
however, that (i)&nbsp;forthwith and in any event prior to the filing of the Final Order and Articles of Arrangement for
acceptance by the Director, the party intending to rely thereon has delivered a written notice to the other party specifying
in reasonable detail all breaches of covenants, representations and warranties or other matters which the party delivering
such notice is asserting as the basis for the non-fulfillment of the applicable condition precedent or termination right, as
the case may be and (ii)&nbsp;if any such notice is delivered, and a party is proceeding diligently to cure such matter and
if such matter is capable of being cured prior to the Outside Date, the other party may not terminate this Agreement until
the earlier of (a)&nbsp;the Outside Date, and (b)&nbsp;expiration of a period of 15 Business Days from such notice, if such
matter has not been cured by such date. If such notice has been delivered prior to the date of the Meeting, unless the
parties agree otherwise, the Corporation shall postpone such Meeting until to the earlier of (a)&nbsp;five (5) Business Days
prior to the Outside Date and (b)&nbsp;the expiry of the period. If such notice is delivered prior to the making of the
application for the Final Order or the filing of the Articles of Arrangement with the Director, such application or filing,
as the case may be, shall be postponed until to the earlier of (a)&nbsp;five (5) Business Days prior to the Outside Date and
(b)&nbsp;the expiry of the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">9.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Merger of
                                         Conditions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">The conditions
in Sections&nbsp;9.1, 9.2 or 9.3 shall be conclusively deemed to have been satisfied, waived or released upon the filing of Articles
of Arrangement as contemplated herein and the issuance of a Certificate of Arrangement under the Act in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: Black">Article&nbsp;10<BR>
Termination</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">10.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Term</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">This Agreement
shall be effective from the date hereof until the earlier of the Effective Time and the termination of this Agreement in accordance
with its terms.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">10.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">Termination</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">This Agreement
may be terminated at any time prior to the Effective Date (except in the case of Section&nbsp;10.2(e) which may only be exercised
prior to the approval by the Securityholders of the Arrangement Resolution):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">by mutual
                                         written agreement of the Acquiror and the Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">by the
                                         Acquiror or the Corporation, if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Meeting shall have been held and the Securityholders do not approve the Arrangement Resolution
                                         in the manner required by with the Interim Order, except that the right to terminate
                                         this Agreement under this Section&nbsp;10.2(b)(i) will not be available to any party
                                         whose action or failure to act has been the cause or resulted in the failure to obtain
                                         the approval of the Arrangement Resolution and such action or failure to act constitutes
                                         a breach of this Agreement or failure of such party to perform any of its covenants or
                                         agreements under this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Effective Date has not occurred on or prior to the Outside Date, other than as a result
                                         of the breach by such party of any covenant or obligation under this Agreement or as
                                         a result of any representation or warranty of such party in this Agreement being untrue
                                         or incorrect; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">any
                                         Law is enacted, made, enforced or amended or any Governmental Authority shall have issued
                                         an order, decree or ruling that makes consummation of the Arrangement illegal or otherwise
                                         permanently restraining or enjoining or otherwise prohibiting any of the transactions
                                         contemplated herein (unless such order, decree or ruling has been withdrawn, reversed
                                         or otherwise made inapplicable) which order, decree or ruling is final and non-appealable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">by the
                                         Acquiror or the Corporation, if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">subject
                                         to Section&nbsp;9.4, any representation or warranty of the Corporation (in the case of
                                         a termination by the Acquiror) or the Acquiror or Parent (in the case of a termination
                                         by the Corporation) under this Agreement is untrue or incorrect or shall have become
                                         untrue or incorrect such that the condition contained in Section&nbsp;9.2(a) or 9.3(a),
                                         as applicable, would be incapable of satisfaction, and such breach or failure is incapable
                                         of being cured on or prior to the Outside Date or is not cured in accordance with the
                                         terms of Section&nbsp;9.4; provided that any wilful or intentional breach by one party
                                         shall be deemed to be incurable; or </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">subject
                                         to Section&nbsp;9.4, the other party is in default of a covenant or obligation hereunder
                                         such that the condition contained in Section&nbsp;9.2(b) or 9.3(b), as applicable, would
                                         be incapable of satisfaction, and such breach or failure is incapable of being cured
                                         on or prior to the Outside Date or is not cured in accordance with the terms of Section&nbsp;9.4;
                                         provided that any wilful or intentional breach by one party shall be deemed to be incurable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">by the
                                         Acquiror, if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">the
                                         Meeting has not occurred by the date specified in Section&nbsp;2.3(a) or such later date
                                         as the Acquiror has agreed or requested in writing, and the failure to hold the Meeting
                                         by such date was primarily caused by, or was primarily the result of, the Corporation
                                         (A) intentionally or wilfully failing to fulfil any obligation hereunder, or (B) adjourning,
                                         postponing or cancelling the Meeting other than as permitted under Section&nbsp;2.3(a),
                                         and in any event the right to terminate this Agreement under this Section&nbsp;10.2(d)(i)
                                         shall not be available to the Acquiror if the failure to hold the Meeting by such date
                                         was primarily caused by, or was primarily the result of, the Acquiror failing to fulfil
                                         any obligation hereunder;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: Black">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">(A)&nbsp;the
                                         Board or any committee of the Board fails to unanimously recommend or withdraws, amends,
                                         modifies or qualifies, or publicly proposes or states an intention to withdraw, amend,
                                         modify or qualify, the Board Recommendation, (B)&nbsp;the Board or any committee of the
                                         Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve,
                                         endorse or recommend an Acquisition Proposal other than this Agreement or any amendment
                                         to this Agreement, or takes no position or remains neutral with respect to a publicly
                                         announced, or otherwise publicly disclosed, Acquisition Proposal for more than five (5)
                                         Business Days (or beyond the third (3<SUP>rd</SUP>) Business Day prior to the date of
                                         the Meeting, if sooner)), (C)&nbsp;the Board or any committee of the Board accepts or
                                         enters into (other than a confidentiality agreement permitted by and in accordance with
                                         Section&nbsp;6.3) or publicly proposes to accept or enter into any agreement, understanding
                                         or arrangement in respect of an Acquisition Proposal, (D)&nbsp;the Board or any committee
                                         of the Board fails to publicly recommend or reaffirm the Board Recommendation in accordance
                                         with Section&nbsp;6.3(d) within five (5) Business Days after having been requested in
                                         writing by the Acquiror to do so (or in the event that the Meeting is scheduled to occur
                                         within such five (5) Business Day period, prior to the third (3<SUP>rd</SUP>) Business
                                         Day prior to the date of the Meeting), or (E)&nbsp;the Corporation breaches Article&nbsp;6
                                         in any material respect; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">notwithstanding Section&nbsp;9.4,
                                         a Material Adverse Effect shall have occurred and be continuing with respect to the Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">by the Corporation, if, prior to
                                         the approval by the Securityholders of the Arrangement Resolution, the Board authorizes
                                         the Corporation to enter into a written agreement with respect to a Superior Proposal
                                         (other than a confidentiality agreement as contemplated by Section&nbsp;6.3), and approves
                                         or recommends a Superior Proposal, provided that (i)&nbsp;the Corporation is then in
                                         compliance with Article&nbsp;6, and (ii)&nbsp;no termination by the Corporation under
                                         this Section&nbsp;10.2(e) shall be effective unless and until the Corporation shall have
                                         paid the Acquiror the Termination Payment in accordance with Section&nbsp;10.3; or </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">by the Acquiror by the close of
                                         business on the next Business Day following the Meeting, if Dissent Rights or similar
                                         rights have been exercised with respect to more than 15% of the issued and outstanding
                                         Common Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any termination pursuant to (b) - (f)
shall be effected by written notice from the terminating party to the other party.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">Termination and Payment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Acquiror, in consideration
                                         for the disposition of its rights under this Agreement, shall be entitled to a cash termination
                                         payment in the amount of $24,000,000 (the &ldquo;<B>Termination Payment</B>&rdquo;),
                                         upon the occurrence of any of the following events (each a &ldquo;<B>Termination Payment
                                         Event</B>&rdquo;) which shall be paid by the Corporation within the time specified in
                                         respect of each such Termination Payment Event:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">this Agreement is terminated by the
                                         Acquiror pursuant to Section 10.2(d)(i) (other than where the reason for adjourning or
                                         postponing the Meeting is only as a result of the occurrence of a postal disruption)
                                         or Section 10.2(d)(ii), in which case the Termination Payment shall be paid to the Acquiror
                                         no later than 10:00&nbsp;a.m. (Eastern Daylight Time) on the next Business Day following
                                         the date the Agreement is terminated;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">this Agreement is terminated by
                                         the Corporation pursuant to Section&nbsp;10.2(e) in which case the Termination Payment
                                         shall be paid to the Acquiror in accordance with Section&nbsp;6.3(b)(vii); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">this Agreement is terminated by
                                         the Acquiror pursuant to Section&nbsp;10.2(b)(i) but only if: (A)&nbsp;prior to the time
                                         of the holding of the Meeting, an Acquisition Proposal is publicly announced or otherwise
                                         publicly disclosed, and not publicly withdrawn prior to the date of the Meeting, by any
                                         person (other than the Acquiror or any of its Affiliates) or any person (other than the
                                         Acquiror or any of its Affiliates) shall have publicly announced or otherwise publicly
                                         disclosed an intention to make an Acquisition Proposal; and (B)&nbsp;within 12 months
                                         following the date of such termination (1)&nbsp;an Acquisition Proposal is consummated
                                         or effected, or (2)&nbsp;the Corporation and/or one or more of its subsidiaries enters
                                         into a definitive agreement in respect of an Acquisition Proposal and such Acquisition
                                         Proposal is consummated or effected, whether or not within such 12 month period, in which
                                         case the Termination Payment shall be payable concurrently with the consummation or effectiveness
                                         of such Acquisition Proposal. For purposes of this clause&nbsp;(iii), the term &ldquo;Acquisition
                                         Proposal&rdquo; shall have the meaning assigned to such term in Section&nbsp;1.1, except
                                         that references to &ldquo;20%&rdquo; shall be deemed to be references to &ldquo;50% or
                                         more&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Termination Payment shall be
                                         paid by the Corporation to the Acquiror by wire transfer in immediately available funds
                                         to an account specified by the Acquiror, provided that in no event will the Corporation
                                         be required to pay more than one Termination Payment. For greater certainty, the obligations
                                         of the Corporation under this Section&nbsp;10.3 shall survive the termination of this
                                         Agreement, regardless of the circumstances thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Except as set out in Section&nbsp;10.4(b)
                                         with respect to wilful breach, the Corporation acknowledges that the amount set out in
                                         this Section&nbsp;10.3 in respect of the Termination Payment represents liquidated damages
                                         which are a genuine pre-estimate of the damages, including opportunity costs, which the
                                         Acquiror will suffer or incur as a result of the event giving rise to such damages and
                                         resultant termination of this Agreement, and is not a penalty. The Corporation irrevocably
                                         waives any right it may have to raise as a defence that any such liquidated damages are
                                         excessive or punitive.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.4</TD><TD STYLE="text-align: justify">Effect of Termination</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of termination of this Agreement
pursuant to Section&nbsp;10.2, this Agreement shall be of no further force and effect without liability of any party (or any shareholder,
director, officer, employee, agent, consultant or representative of such party) to any other party to this Agreement, except that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in the event of termination under
                                         Section&nbsp;10.1 as a result of the Effective Time occurring, Section&nbsp;8.7 shall
                                         survive for a period of six (6) years following such termination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the event of termination under
                                         Section&nbsp;10.2, this Section&nbsp;10.4 and Article&nbsp;11 shall survive the termination
                                         of this Agreement, and provided further that no party shall be relieved of any liability
                                         for any wilful breach by it of this Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">nothing contained in this Agreement
                                         shall relieve or have the effect of relieving any party in any way from liability for
                                         damages incurred or suffered by a party if the Agreement is terminated in any circumstances
                                         other than pursuant to a Termination Payment Event; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">upon any termination of this Agreement
                                         under circumstances where the Acquiror is entitled to a Termination Payment and such
                                         Termination Payment is paid in full, the Acquiror and the Parent shall be precluded from
                                         any other remedy against the Corporation at Law or in equity or otherwise (including,
                                         without limitation, an order for specific performance), and shall not seek to obtain
                                         any recovery, judgment, or damages of any kind, including consequential, indirect, or
                                         punitive damages, against the Corporation or any of its subsidiaries or any of their
                                         respective directors, officers, employees, partners, managers, members, shareholders
                                         or Affiliates or their respective Representatives in connection with this Agreement or
                                         the transactions contemplated hereby, provided that the foregoing limitation shall not
                                         apply in the event of wilful breach by the Corporation of this Agreement.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.5</TD><TD STYLE="text-align: justify">Remedies</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to Section&nbsp;10.4, the parties
acknowledge and agree that an award of money damages would be inadequate for any breach of this Agreement by any party or its
Representatives and any such breach would cause the non-breaching party irreparable harm. Accordingly, the parties agree that,
in the event of any breach of this Agreement by one of the parties, the non-breaching party will also be entitled, without the
requirement of posting a bond or other security, to equitable relief, including injunctive relief and specific performance. Such
remedies will not be the exclusive remedies for any breach of this Agreement but will be in addition to all other remedies available
at law or equity to each of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;11<BR>
General Provisions</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.1</TD><TD STYLE="text-align: justify">Amendment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of the Interim
Order, the Plan of Arrangement and applicable Laws, this Agreement and the Plan of Arrangement may, at any time and from time
to time before or after the holding of the Meeting but not later than the Effective Date, be amended by mutual written agreement
of the parties, without further notice to or authorization on the part of the Securityholders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.2</TD><TD STYLE="text-align: justify">Waiver</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">At any time prior to the termination
                                         of this Agreement pursuant to Section&nbsp;10.2, either party may:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">extend the time for the performance
                                         of any of the obligations or other acts of the other party; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">waive compliance with any of the
                                         agreements of the other party or with any conditions to its own obligations, in each
                                         case only to the extent such obligations, agreements and conditions are intended for
                                         its benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">No waiver by any party shall be
                                         effective unless in writing and any waiver shall affect only the matter, and the occurrence
                                         thereof, specifically identified and shall not extend to any other matter or occurrence.
                                         No failure or delay in exercising any right, power or privilege under this Agreement
                                         will operate as a waiver thereof, nor will any single or partial exercise thereof preclude
                                         any other or further exercise thereof or the exercise of any right, power or privilege
                                         under this Agreement.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.3</TD><TD STYLE="text-align: justify">Expenses and Expense Reimbursement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as expressly provided in this Agreement,
all costs and expenses of the parties relating to the transactions contemplated herein, including legal fees, accounting fees,
financial advisory fees, regulatory filing fees, stock exchange fees, all disbursements of advisors and printing and mailing costs,
shall be paid by the party incurring such expenses, whether or not the Arrangement is consummated.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.4</TD><TD STYLE="text-align: justify">Notices</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any notice, consent, waiver, direction
or other communication required or permitted to be given under this Agreement by a party shall be in writing and may be given
by delivering same or sending same by facsimile transmission or by delivery addressed to the party to which the notice is to be
given at its address for service herein. Any notice, consent, waiver, direction or other communication aforesaid shall, if delivered,
be deemed to have been given and received on the date on which it was delivered to the address provided herein (if a Business
Day, if not, the next succeeding Business Day) and if sent by facsimile transmission be deemed to have been given and received
at the time of receipt (if a Business Day, if not the next succeeding Business Day) unless actually received after 4:30&nbsp;p.m.
(Eastern Daylight Time) at the point of delivery in which case it shall be deemed to have been given and received on the next
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The address for service for each of the
parties hereto shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if to the Corporation:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Cynapsus Therapeutics Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">828 Richmond Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Toronto, Ontario M6J 1C9</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Anthony Giovinazzo, President and <FONT STYLE="font-size: 10pt">Chief Executive
                                                                                    Officer</FONT></TD>
</TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Fax:</TD><TD STYLE="text-align: justify">(<FONT STYLE="font-size: 10pt">416) 703-8752</FONT></TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Email: </TD><TD STYLE="text-align: justify"><U>ajg@cynapsus.ca</U></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">with a copy to (which shall not
constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Borden Ladner Gervais LLP<BR>
Scotia Plaza, 40 King Street West<BR>
Toronto, Ontario<BR>
M5H 3Y4<BR>
<BR></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 1in; text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Alfred Page</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">(416) 367-6749</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>apage@blg.com</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Jason Saltzman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Fax:</TD>
    <TD STYLE="text-align: justify">(416) 367-6749</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>jsaltzman@blg.com</U></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">and to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Troutman Sanders LLP<BR>
401 9<SUP>th</SUP> Street, N.W., Suite 1000<BR>
Washington, D.C. 20004-2134<BR>
<BR></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 1in; text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Thomas Rose</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">757-687-1529</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>thomas.rose@troutmansanders.com</U></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if to the Acquiror or the Parent:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Sunovion Pharmaceuticals Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">84 Waterford Dr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Marlborough, MA 01752</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in">Attention:</TD><TD>Gregory M. Bokar, Senior Vice President, Legal Affairs and Corporate Secretary</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Facsimile:</TD><TD STYLE="text-align: justify">(508) 357-7511</TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Email: </TD><TD STYLE="text-align: justify"><U>gregory.bokar@sunovion.com</U></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">with a copy to (which shall not
constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Reed Smith LLP<BR>
Suite 250<BR>
136 Main Street<BR>
Princeton, New Jersey 08540<BR>
<BR></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 1in; text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Diane M. Frenier</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">(609) 951.0824</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>dfrenier@reedsmith.com</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Edward P. Bromley III</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">(609) 951.0824</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>ebromley@reedsmith.com</U></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">and to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Goodmans LLP<BR>
Bay Adelaide Centre<BR>
333 Bay Street, Suite 3400<BR>
Toronto, Ontario M5H 2S7<BR>
<BR></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 1in; text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Stephen H. Halperin</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">(416) 979.1234</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>shalperin@goodmans.ca</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Attention:</TD>
    <TD STYLE="text-align: justify">Sheldon N. Freeman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Facsimile:</TD>
    <TD STYLE="text-align: justify">(416) 979.1234</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Email:</TD>
    <TD STYLE="text-align: justify"><U>sfreeman@goodmans.ca</U></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.5</TD><TD STYLE="text-align: justify">Process Agent</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Parent hereby
irrevocably designates GODA Incorporators Inc. (in such capacity, the &ldquo;<B>Process Agent</B>&rdquo;), Attention: Ken
Crofoot, with an office at Goodmans LLP, Bay Adelaide Centre, 333 Bay Street, Suite 3400, Toronto, Ontario M5H 2S7 as its
designee, appointee and agent to receive, for and on its behalf and on behalf of the Acquiror service of process in such
jurisdiction in any legal action or proceedings with respect to this Agreement or the transactions contemplated hereby, and
such service shall be deemed complete upon delivery thereof to the Process Agent; provided that, in the case of any such
service upon the Process Agent, the party effecting such service shall also deliver a copy thereof to the Parent in the
manner provided in Section&nbsp;11.4. The Parent shall take all such action as may be necessary to continue said appointment
in full force and effect or to appoint another agent so that Parent will at all times have an agent for service of process
for the above purposes in the Province of Ontario. Nothing herein shall affect the right of any party to serve process in
any manner permitted by Law.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.6</TD><TD STYLE="text-align: justify">Severability</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any term, provision, covenant or restriction
of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected,
impaired or invalidated and the parties shall negotiate in good faith to modify the Agreement to preserve each party&rsquo;s anticipated
benefits under this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.7</TD><TD STYLE="text-align: justify">Entire Agreement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement and the Confidentiality
Agreement (together with all other documents and instruments referred to herein and therein) constitute the entire agreement and
supersede all other prior agreements and undertakings, both written and oral, among the parties with respect to the subject matter
hereof.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.8</TD><TD STYLE="text-align: justify">Assignment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall enure to the benefit
of and be binding upon the parties and their respective successors and permitted assigns. This Agreement may not otherwise be
assigned by either party without the prior written consent of the other parties (such consent not to be unreasonably withheld
by the Corporation if the Acquiror requests to be permitted to assign its rights and obligations under this Agreement to an Affiliate),
provided that if such assignment and/or assumption is consented to, the party making such assignment shall continue to be liable
joint and severally with the assignee of the Agreement for all of its obligations hereunder.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.9</TD><TD STYLE="text-align: justify">Governing Law</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall be governed in all
respects, including validity, interpretation and effect, by the Laws of the Province of Ontario and the federal Laws of Canada
applicable therein, without giving effect to any principles of conflict of Laws thereof which would result in the application
of the Laws of any other jurisdiction, and all actions and proceedings arising out of or relating to this Agreement shall be heard
and determined exclusively in the courts of the Province of Ontario.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.10</TD><TD STYLE="text-align: justify">Contra Proferentem</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The parties waive the application of any
rule of Law which otherwise would be applicable in connection with the construction of this Agreement that ambiguous or conflicting
terms or provisions should be construed against the party who (or whose counsel) prepared the executed agreement or any earlier
draft of the same.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.11</TD><TD STYLE="text-align: justify">No Third Party Beneficiaries</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as provided in Section&nbsp;8.7,
which without limiting its terms, is intended as stipulations for the benefit of the third persons mentioned in such provisions,
this Agreement shall not confer any rights or remedies upon any person other than the parties and their respective successors
and permitted assigns.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.12</TD><TD STYLE="text-align: justify">Time of Essence</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time shall be of the essence in this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.13</TD><TD STYLE="text-align: justify">No Liability</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No director or officer of the Acquiror
or the Parent shall have any personal liability whatsoever to the Corporation under this Agreement or any other document delivered
in connection with the transactions contemplated hereby on behalf of the Acquiror or the Parent. No director or officer of the
Corporation or any of its subsidiaries shall have any personal liability whatsoever to the Acquiror or the Parent under this Agreement
or any other document delivered in connection with the transactions contemplated hereby on behalf of the Corporation or any of
its subsidiaries.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.14</TD><TD STYLE="text-align: justify">Counterparts</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement may be executed in any
number of counterparts, each of which shall be deemed to be an original and all of which taken together shall be deemed to constitute
one and the same instrument, and it shall not be necessary in making proof of this Agreement to produce more than one counterpart.
The parties shall be entitled to rely upon delivery of an executed facsimile, PDF email transmission or similar executed electronic
copy of this Agreement, and such facsimile, PDF email transmission or similar executed electronic copy shall be legally effective
to create a valid and binding agreement among the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[THE REMAINDER OF THIS PAGE HAS BEEN
LEFT BLANK INTENTIONALLY]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&nbsp;-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, this Agreement
has been executed and delivered as of the date first above written, by the duly authorized representatives of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: Black"><B>CYNAPSUS
    THERAPEUTICS INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid">/s/ Anthony Giovinazzo<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Name:&#9; Anthony Giovinazzo</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Title: &nbsp;&nbsp; President
    and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SUNOVION CNS DEVELOPMENT
    CANADA ULC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">/s/ Gregory M. Bokar</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Name:&#9; Gregory M. Bokar</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Title:&nbsp;&nbsp;&#9; Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SUNOVION PHARMACEUTICALS
    INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">/s/ Nobuhiko Tamura</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Name:&#9; Nobuhiko Tamura</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Title:&nbsp;&nbsp;&#9; Chairman
    and Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Schedule&nbsp;A<BR>
Plan of Arrangement<BR>
Under Section 192 of the<BR>
<I>Canada Business Corporations Act</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;1<BR>
<BR>
INTERPRETATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">Definitions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this Plan of Arrangement, unless there
is something in the subject matter or context inconsistent therewith, the following terms shall have the respective meanings set
out below and grammatical variations of such terms shall have corresponding meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Act</B>&rdquo; means the <I>Canada
Business Corporations Act</I>, as amended, including the regulations promulgated thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Acquiror</B>&rdquo; means
Sunovion CNS Development Canada ULC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Arrangement
Agreement</B>&rdquo; means the arrangement agreement dated August 31, 2016 between the Acquiror, the Parent and the
Corporation, as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms
thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Arrangement</B>&rdquo; means
the arrangement under the provisions of section&nbsp;192 of the Act, on the terms and subject to the conditions set out in the
Arrangement Agreement and in this Plan of Arrangement, subject to any amendments or variations thereto made in accordance with
the Arrangement Agreement or the Plan of Arrangement or made at the direction of the Court in the Final Order with the consent
of the parties, each acting reasonably;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Arrangement Resolution</B>&rdquo;
means the special resolution of Securityholders approving the Arrangement to be considered at the Meeting, substantially in the
form attached as Schedule&nbsp;D to the Arrangement Agreement and any amendments or variations thereto made in accordance with
the provisions of the Arrangement Agreement or the Plan of Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Articles of Arrangement</B>&rdquo;
means the articles of arrangement in respect of the Arrangement to be filed with the Director after the Final Order is made;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Business Day</B>&rdquo; means
a day, other than a Saturday or a Sunday, on which the principal commercial banks located in Toronto, Ontario and New York, New
York are open for the conduct of non-automated business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Certificate of Arrangement</B>&rdquo;
means the certificate of arrangement giving effect to the Arrangement to be issued by the Director pursuant to subsection&nbsp;192(7)&nbsp;of
the Act in respect of the Articles of Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Circular</B>&rdquo; means the
notice of the Meeting and accompanying management information circular of the Corporation, including all schedules, appendices
and exhibits thereto, and all information incorporated by reference therein, to be prepared and sent to the Securityholders in
connection with the Meeting, as amended, supplemented or otherwise modified from time to time in accordance with the terms of
the Arrangement Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Common Share</B>&rdquo; means
a common share of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Consideration</B>&rdquo;
means $40.50 in cash per Common Share or, in the case of a Warrant or Option, the excess of $40.50 over the exercise price of such
Warrant or Option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Corporation</B>&rdquo;
means Cynapsus Therapeutics Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Corporation Sub</B>&rdquo; means
an unlimited liability company to be formed pursuant to the <I>Business Corporations Act</I> (British Columbia) as a direct, wholly-owned
subsidiary of the Corporation for the purposes of effectuating the Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Court</B>&rdquo; means the Ontario
Superior Court of Justice (Commercial List) or any appellate court, as the case may be;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Depositary</B>&rdquo; means
any trust company, bank or financial institution agreed to in writing by the Acquiror and the Corporation to act as depository
for the Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Director</B>&rdquo; means the
Director appointed pursuant to section&nbsp;260 under the Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Dissent Rights</B>&rdquo; means
the rights of dissent granted in favour of Securityholders in respect of the Arrangement as described in Article&nbsp;3 hereof
and the Interim Order;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Dissenting Shareholder</B>&rdquo;
means a Shareholder who properly dissents in respect of the Arrangement in strict compliance with the procedures for exercising
Dissent Rights and does not withdraw such dissent prior to the Effective Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Dissenting Securityholder</B>&rdquo;
means a Dissenting Shareholder or a Dissenting Warrantholder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Dissenting Warrantholder</B>&rdquo;
means a Warrantholder who properly dissents in respect of the Arrangement in strict compliance with the procedures for exercising
Dissent Rights and does not withdraw such dissent prior to the Effective Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Effective Date</B>&rdquo; means
the date shown on the Certificate of Arrangement giving effect to the Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Effective Time</B>&rdquo; means
11:59 p.m. (Eastern Daylight Time) on the Effective Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Final Order</B>&rdquo; means
the final order of the Court in a form and content satisfactory to the parties, each acting reasonably, approving the Arrangement,
as such order may be amended by the Court (with the consent of the parties, each acting reasonably) at any time prior to the Arrangement
becoming effective or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended (provided that
any such amendment is in a form and content satisfactory to the parties, each acting reasonably) on appeal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Interim Order</B>&rdquo; means
the interim order of the Court, in a form and content satisfactory to the parties, each acting reasonably, as the same may be
amended by the Court (with the consent of the parties, each acting reasonably), containing declarations and directions with respect
to the Arrangement and providing for, among other things, the holding of the Meeting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Letter of Transmittal</B>&rdquo;
means the letter of transmittal to be sent by the Corporation to the Securityholders with the Circular in connection with the
Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Meeting</B>&rdquo; means the
special meeting of Securityholders to be called and held for the purpose of considering the Arrangement Resolution and any adjournments
or postponements thereof in accordance with the terms of the Arrangement Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Option Plan</B>&rdquo; means
the stock option plan of the Corporation as amended and restated on May&nbsp;10, 2016;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Optionholder</B>&rdquo;<B> </B>means
a holder of an Option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Options</B>&rdquo; means the
outstanding options to purchase Common Shares issued pursuant to the Option Plan or any predecessor plan, as set out in the Disclosure
Letter (as such term is defined in the Arrangement Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Parent</B>&rdquo; means
Sunovion Pharmaceuticals Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>person</B>&rdquo; means an individual,
general partnership, limited partnership, corporation, company, limited liability company, unincorporated association, unincorporated
syndicate, unincorporated organization, trust, estate, trustee, executor, administrator or other legal representative, government
(including Governmental Authority) or other entity, whether or not having legal status;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Securityholder Encumbrance</B>&rdquo;
means any lien (statutory or otherwise), pledge, hypothecation, charge, restriction or adverse right or Claim (as defined in Arrangement
Agreement), mortgage, encroachments, option, right of first refusal or first offer, occupancy right, covenant, assignment, security
interest, adverse interest, defect of title, statutory or deemed trust, other third party interest or encumbrance of any kind,
in each case, whether contingent or absolute;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Securityholders</B>&rdquo; means,
collectively, the Shareholders and the Warrantholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Shareholders</B>&rdquo; means
holders of Common Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Tax Act</B>&rdquo; means the
<I>Income Tax Act</I> (Canada) and the regulations promulgated thereunder, as amended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Warrantholder</B>&rdquo; means
a holder of Warrants; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Warrants</B>&rdquo; means the
common share purchase warrants of the Corporation set out in the Disclosure Letter (as such term is defined in the Arrangement
Agreement).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">Construction</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this Plan of Arrangement, unless otherwise
expressly stated or the context otherwise requires:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">references to &ldquo;herein&rdquo;,
                                         &ldquo;hereby&rdquo;, &ldquo;hereunder&rdquo;, &ldquo;hereof&rdquo; and similar expressions
                                         are references to this Plan of Arrangement and not to any particular Section&nbsp;of
                                         this Plan of Arrangement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">references to a &ldquo;Section&rdquo;
                                         are references to a Section&nbsp;to this Plan of Arrangement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">words importing the singular shall
                                         include the plural and vice versa, and words importing gender shall include the masculine,
                                         feminine and neuter genders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the use of headings is for convenience
                                         of reference only and shall not affect the construction or interpretation hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">if the date on which any action
                                         is required to be taken hereunder by any of the parties is not a Business Day, such action
                                         shall be required to be taken on the next succeeding day that is a Business Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">a period of Business Days is to
                                         be computed as beginning on the day following the event that began the period and ending
                                         at 4:30 p.m. (Eastern Daylight Time) on the last day of the period if the period is a
                                         Business Day or at 4:30 p.m. on the next Business Day if the last day of the period does
                                         not fall on a Business Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">references to any legislation or
                                         to any provision of any legislation shall include any modification or re-enactment thereof,
                                         any legislation provision substituted therefor and all regulations, rules and interpretations
                                         issued thereunder or pursuant thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">references to any agreement or
                                         document shall be to such agreement or document (together with the schedules and exhibits
                                         attached thereto), as it may have been or may hereafter be amended, modified, supplemented,
                                         waived or restated from time to time; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">wherever the term &ldquo;includes&rdquo;
                                         or &ldquo;including&rdquo; is used, it shall be deemed to mean &ldquo;includes, without
                                         limitation&rdquo; or &ldquo;including, without limitation&rdquo;, respectively.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">Currency</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, all dollar
amounts referred to in this Agreement are expressed in United States dollars. Unless specifically provided for in this Plan of
Arrangement, all payments to be made in cash pursuant to this Plan of Arrangement shall be made in United States dollars. The
exercise price of the Options or Warrants or any other amount that is denominated in Canadian dollars shall be converted to United
States dollars at the Bank of Canada noon rate on the date that is two (2) Business Days prior to the Meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">Time</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time shall be of the essence in this Plan
of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;2<BR>
<BR>
ARRANGEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">Arrangement Agreement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Plan of Arrangement is made pursuant
to, is subject to the provisions of, and forms part of, the Arrangement Agreement, and constitutes an arrangement as referred
to in section&nbsp;192 of the Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">Binding Effect</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Plan of Arrangement and the Arrangement,
upon the filing of the Articles of Arrangement and the issuance of the Certificate of Arrangement, will become effective at and
be binding on and after the Effective Time, on: (a)&nbsp;the Corporation, (b)&nbsp;the Acquiror, (c)&nbsp;the Parent, (d)&nbsp;all
registered and beneficial Securityholders (including Dissenting Securityholders) and Optionholders, (e)&nbsp;the Depositary, and
(f)&nbsp;any registrar and transfer agent in respect of the Common Shares, Options or Warrants, in each case without any further
authorization, act or formality on the part of any person, except as expressly provided herein.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify">Arrangement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following transactions shall occur
and shall be deemed to occur, without any further authorization, act or formality, in the following order, provided that none
of the following will occur or will be deemed to occur unless all of the following occurs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Corporation shall transfer,
                                         assign and otherwise dispose of all of its property and assets to Corporation Sub. In
                                         consideration of this transfer, Corporation Sub shall assume all liabilities and other
                                         obligations of the Corporation, and shall issue one million (1,000,000) common shares
                                         of Corporation Sub&rsquo;s capital stock to the Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">at 12:01 a.m. on the day following
                                         the Effective Date, each Option outstanding immediately prior to the Effective Time shall
                                         be deemed to be surrendered by the holder in exchange for payment of the Consideration
                                         by the Corporation, and:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the holder thereof shall cease to
                                         be the holder of such Option and shall cease to have any rights as a holder in respect
                                         of such Option or under the Option Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such holder&rsquo;s name shall be
                                         removed from the register of Options, as of such time, and all option agreements, grant
                                         agreements and similar instruments relating thereto shall be cancelled; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">each Option and the Option Plan
                                         shall be cancelled as of such time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">at 12:03 a.m. on the day following
                                         the Effective Date, each Warrant outstanding immediately prior to the Effective Time
                                         (other than Warrants outstanding immediately prior to the Effective Time held by Dissenting
                                         Warrantholders, the Acquiror or Affiliates of the Acquiror) shall be deemed to be transferred
                                         (free and clear of any Securityholder Encumbrances) by the holder thereof to the Acquiror
                                         in exchange for the Consideration, and:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the holder thereof shall cease to
                                         be the holder of such Warrant and shall cease to have any rights as a holder in respect
                                         of such Warrant; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such holder&rsquo;s name shall be
                                         removed from the register of Warrants, as of such time, and all warrant agreements, indentures,
                                         grants and similar instruments relating thereto shall be cancelled</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">concurrently with Section&nbsp;2.3(c),
                                         each Warrant outstanding immediately prior to the Effective Time held by a Dissenting
                                         Warrantholder shall be deemed to have been transferred to the Acquiror (free and clear
                                         of any Securityholder Encumbrances); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">such Dissenting Warrantholder shall
                                         cease to have any rights as a holder in respect of such Warrants, other than the rights
                                         set out in Section&nbsp;3.1;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such Dissenting Warrantholder shall
                                         cease to be the holder of such Warrant and shall cease to have any rights as a holder
                                         in respect of such Warrant; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">such holder&rsquo;s name shall
                                         be removed from the register of Warrants, as of such time, and all warrant agreements,
                                         indentures, grants and similar instruments relating thereto shall be cancelled</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">at 12:05 a.m. on the day following
                                         the Effective Date, each Common Share outstanding immediately prior to the Effective
                                         Time (other than those held by Dissenting Shareholders, the Acquiror or Affiliates of
                                         the Acquiror) shall be transferred (free and clear of any Securityholder Encumbrances)
                                         to the Acquiror in exchange for the Consideration; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the holder thereof shall cease to
                                         be the holder of such Common Share and shall cease to have any rights as a holder in
                                         respect of such Common&nbsp;Share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such holder&rsquo;s name shall be
                                         removed from the register of holders of Common Shares of the Corporation, as of such
                                         time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the certificate representing such
                                         Common Share shall be deemed to have been cancelled as of such time; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Acquiror shall be entered as
                                         the sole holder of such Common Share on the register of holders of Common Shares of the
                                         Corporation as of such time, and shall be deemed to be the sole legal and beneficial
                                         owner of the such Common Share as of such time (free and clear of all Securityholder
                                         Encumbrances); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">concurrently with Section 2.3(e),
                                         each Common Share outstanding immediately prior to the Effective Time held by a Dissenting
                                         Shareholder shall be deemed to have been transferred to the Acquiror (free and clear
                                         of any Securityholder Encumbrances); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">such Dissenting Shareholder shall
                                         cease to have any rights as a holder in respect of such Common Share, other than the
                                         rights set out in Section&nbsp;3.1;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such Dissenting Shareholder shall
                                         cease to be the holder of such Common Share and shall cease to have any rights as a holder
                                         in respect of such Common Share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">such holder&rsquo;s name shall
                                         be removed from the register of holders of Common Shares of the Corporation, as of such
                                         time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the certificate representing such
                                         Common Share shall be deemed to have been cancelled as of such time; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the Acquiror shall be entered as
                                         the sole holder of such Common Share on the register of holders of Common Shares of the
                                         Corporation as of such time, and shall be deemed to be the sole legal and beneficial
                                         owner of such Common Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;3<BR>
<BR>
RIGHTS OF DISSENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">Rights of Dissent</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder of Common Shares or
Warrants immediately prior to the Effective Time may exercise Dissent Rights in accordance with the procedures set out in
section&nbsp;190 of the Act, as modified by this Article&nbsp;3, the Interim Order and the Final Order, with respect to such
Common Shares or Warrants in connection with the Arrangement, provided that notwithstanding section&nbsp;190(5)&nbsp;of the
Act, the written objection to the Arrangement Resolution contemplated by section&nbsp;190(5)&nbsp;of the Act must be received
by the Corporation by 5:00 pm (Eastern Daylight Time) two (2) Business&nbsp;Days prior to the date of the Meeting. Each
Dissenting Securityholder who is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">ultimately entitled to be paid
                                         fair value for such holder&rsquo;s Common Shares or Warrants, as applicable, which fair
                                         value, notwithstanding anything to the contrary contained in Part XV of the Act, shall
                                         be determined as of the close of business on the day before the Arrangement Resolution
                                         is adopted, shall be deemed to have transferred such holder&rsquo;s Common Shares or
                                         Warrants, as applicable to Acquiror as of the time set out in Section&nbsp;2.3(d) or
                                         2.3(f) hereof, as applicable, and will not be entitled to any other payment or consideration,
                                         including any payment that would be payable under the Arrangement had such Dissenting
                                         Securityholder not exercised Dissent Rights in respect of such Common Shares or Warrants;
                                         or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">ultimately not entitled, for any
                                         reason, to be paid such fair value for such Warrants or Common Shares, as applicable,
                                         shall be deemed to have participated in the Arrangement with respect to such Warrants
                                         or Common Shares, as applicable, as of the time set out in Section&nbsp;2.3(c) or 2.3(e)
                                         hereof, on the same basis as a Shareholder or a Warrantholder to which Section&nbsp;2.3(c)
                                         or 2.3(e) hereof applies, as applicable.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">Recognition of Dissenting Securityholders</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">In no circumstances shall the Corporation,
                                         the Parent, the Acquiror or any other person be required to recognize a Dissenting Securityholder
                                         as the holder of any Common Shares or Warrants at and after the Effective Time, and the
                                         names of such Dissenting Securityholders shall be removed from the register of Common&nbsp;Shares
                                         or Warrants, as applicable, maintained by or on behalf of Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">In addition to any other restrictions
                                         under section&nbsp;190 of the Act, Securityholders who voted (or have instructed a proxyholder
                                         to vote) in favour of the Arrangement Resolution, shall not be entitled to exercise Dissent
                                         Rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;4<BR>
<BR>
PAYMENT AND CERTIFICATES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">Payment of the Consideration</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Prior to the filing of the Articles
                                         of Arrangement, the Acquiror shall deposit, for the benefit of the holders of Common
                                         Shares (other than Dissenting&nbsp;Shareholders) and Warrants (other than Dissenting
                                         Warrantholders), as applicable, sufficient cash to pay (i)&nbsp;the aggregate Consideration
                                         payable to holders of Common Shares (other than Dissenting Shareholders) pursuant to
                                         Section&nbsp;2.3(e), and (ii)&nbsp;the aggregate Consideration payable to holders of
                                         Warrants (other than Dissenting Warrantholders) pursuant to Section&nbsp;2.3(c).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Upon surrender to the Depositary
                                         for cancellation of a certificate which immediately prior to the Effective Time represented
                                         outstanding Common Shares transferred pursuant to Section&nbsp;2.3(e), together with
                                         a duly completed and executed Letter of Transmittal and such additional documents and
                                         instruments as the Depositary may reasonably require, the holder thereof shall be entitled
                                         to receive in exchange therefor, and the Depositary shall deliver to such holder, the
                                         aggregate Consideration which such holder has the right to receive under Section&nbsp;2.3(e),
                                         less any amounts withheld pursuant to Section&nbsp;4.3, and any share certificate so
                                         surrendered shall forthwith be cancelled. Upon surrender to the Depositary for cancellation
                                         of a certificate which immediately prior to the Effective Time represented outstanding
                                         Warrants transferred pursuant to Section&nbsp;2.3(c), together with a duly completed
                                         and executed Letter of Transmittal and such additional documents and instruments as the
                                         Depositary may reasonably require, the holder thereof shall be entitled to receive in
                                         exchange therefor, and the Depositary shall deliver to such holder, the aggregate Consideration
                                         which such holder has the right to receive under Section&nbsp;2.3(c), less any amounts
                                         withheld pursuant to Section&nbsp;4.3, and any warrant certificate so surrendered shall
                                         forthwith be cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">On the day following the Effective
                                         Date, the Corporation shall pay the amounts to be paid to holders of Options either (i)
                                         pursuant to the normal payroll practices and procedures of the Corporation, or (ii) in
                                         the event that payment pursuant to the normal payroll practices and procedures of the
                                         Corporation is not practicable for any such holder, by cheque (delivered to such holder
                                         of Options as reflected on the register maintained by or on behalf of the Corporation
                                         in respect of the Options), less any amounts withheld pursuant to Section&nbsp;4.3. The
                                         Acquiror shall advance by way of a demand, non-interest bearing loan to the Corporation
                                         on the Effective Date by wire transfer in immediately available funds an amount, not
                                         exceeding the aggregate of the amounts to be so paid to the holders of Options and the
                                         amounts to be so withheld, as requested by the Corporation to the Acquiror by notice
                                         in writing given not less than three (3) Business Days prior to the Effective Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Pursuant to Section 2.3(e), each
                                         certificate that immediately prior to the Effective Time represented Common Shares shall
                                         be deemed as of and from the time specified in Section 2.3(e) to represent only the right
                                         to receive upon surrender of such certificate the Consideration, without interest, in
                                         lieu of such certificate as contemplated in this Section&nbsp;4.1, less any amounts withheld
                                         pursuant to Section&nbsp;4.3. Pursuant to Section 2.3(c), each certificate that immediately
                                         prior to the Effective Time represented Warrants shall be deemed as of and from the time
                                         specified in Section 2.3(c) to represent only the right to receive upon surrender of
                                         such certificate the Consideration under Section&nbsp;2.3(c), without interest, in lieu
                                         of such certificate as contemplated in this Section&nbsp;4.1, less any amounts withheld
                                         pursuant to Section&nbsp;4.3. Any such certificate formerly representing Common&nbsp;Shares
                                         or Warrants, as applicable, not duly surrendered on or before the sixth anniversary of
                                         the Effective Date shall cease to represent a claim by or interest of any former holder
                                         of Common Shares or Warrants, as applicable, of any kind or nature against the Corporation,
                                         the Acquiror or the Parent. On such date, all Consideration to which such former holder
                                         was entitled shall be deemed to have been surrendered to the Acquiror and all Consideration
                                         to which such former holder was entitled shall be returned to the Acquiror.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Any payment made by way of cheque
                                         by the Depositary or the Corporation pursuant to this Plan of Arrangement that has not
                                         been deposited or has been returned to the Depositary or the Corporation, as the case
                                         may be, or that otherwise remains unclaimed, in each case, on or before the sixth anniversary
                                         of the Effective Time, and any right or claim to payment hereunder that remains outstanding
                                         on the sixth anniversary of the Effective Time shall cease to represent a right or claim
                                         of any kind or nature and the right of the holder to receive the Consideration for Common
                                         Shares, Options or Warrants pursuant to this Plan of Arrangement shall terminate and
                                         be deemed to be surrendered and forfeited for no consideration, and all cash to which
                                         such holder was entitled shall be returned to the Acquiror or the Corporation, as applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">No holder of Common Shares, Options
                                         or Warrants shall be entitled to receive any consideration with respect to Common Shares,
                                         Options or Warrants other than as described in and in accordance with Section&nbsp;2.3
                                         and this Section&nbsp;4.1, and, for greater certainty, no such holder will be entitled
                                         to receive any interest (by reason of any delay in paying for such securities or otherwise),
                                         dividends, premium or other payment in connection therewith.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">Lost Certificates</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event any certificate which immediately
prior to the Effective Time represented one or more outstanding Common Shares or Warrants exchanged pursuant to Section&nbsp;2.3
shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming such certificate
to be lost, stolen or destroyed, the Depositary will pay and deliver in exchange for such lost, stolen or destroyed certificate,
the consideration which such holder is entitled to receive pursuant to Section&nbsp;2.3 (net of amounts required to be withheld
pursuant to Section&nbsp;4.3). When authorizing such payment and delivery in exchange for any lost, stolen or destroyed certificate,
the person to whom the payment is made shall, as a condition precedent to the delivery of such payment thereof, give a bond satisfactory
to the Corporation, the Parent, the Acquiror and the Depositary in such sum as the Parent, or the Acquiror may direct or otherwise
indemnify the Corporation, the Parent, the Acquiror and the Depositary in a manner satisfactory to the Corporation, the Parent
and the Acquiror against any claim that may be made against the Corporation, the Parent, the Acquiror or the Depositary with respect
to the certificate alleged to have been lost, stolen or destroyed.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">Withholding Rights</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation, the Acquiror and the
Depositary shall be entitled to deduct and withhold from any amount payable to any Optionholder or Securityholders (including
any payments to Dissenting Securityholders), such amounts as the Corporation, the Acquiror, or the Depositary may be entitled
or required to deduct and withhold with respect to such payment under the <I>Tax&nbsp;Act</I> or any provision of provincial,
state, local or foreign tax law, in each case, as amended or succeeded, and to remit such deducted and withheld amounts to the
appropriate taxing authority. To the extent that amounts are so properly deducted and withheld, such deducted and withheld amounts
shall be treated for all purposes as having been paid to the Optionholder or Securityholder in respect of which such deduction
and withholding was made, provided that such deducted and withheld amounts are actually remitted in accordance with applicable
law to the appropriate taxing authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;5<BR>
<BR>
AMENDMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">Amendments to Plan of Arrangement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation, the Parent and
                                         the Acquiror reserves the right to amend, modify and/or supplement this Plan of Arrangement
                                         at any time and from time to time prior to the Effective Time, provided that each such
                                         amendment, modification or supplement must be (i)&nbsp;set out in writing, (ii)&nbsp;approved
                                         by the parties, acting reasonably, (iii)&nbsp;filed with the Court and, if made following
                                         the Meeting, approved by the Court, and (iv)&nbsp;communicated to Securityholders if
                                         and as required by the Court.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Any amendment, modification or
                                         supplement to this Plan of Arrangement, if agreed to by the parties, made at any time
                                         prior to the Meeting with or without any other prior notice or communication, and if
                                         so proposed and approved by the persons voting at the Meeting (as may be required under
                                         the Interim Order), shall become part of this Plan of Arrangement for all purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Any amendment, modification or
                                         supplement to this Plan of Arrangement that is approved or directed by the Court following
                                         the Meeting shall be effective only if (i)&nbsp;it is consented to by each of the Corporation,
                                         the Parent and the Acquiror (in&nbsp;each case, acting reasonably), and (ii)&nbsp;if
                                         required by the Court, it is approved by the Securityholders voting in the manner directed
                                         by the Court.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Any amendment, modification or
                                         supplement to this Plan of Arrangement may be made unilaterally by the Acquiror, provided
                                         that it concerns a matter which, in the reasonable opinion of the Acquiror, is of an
                                         administrative nature required to better give effect to the implementation of this Plan
                                         of Arrangement, is not materially adverse to the financial or economic interests of any
                                         Securityholders or Optionholders, and is agreed to by the Corporation, acting reasonably.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">This Plan of Arrangement may be
                                         withdrawn prior to the Effective Time in accordance with the terms of the Arrangement
                                         Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;6<BR>
<BR>
FURTHER ASSURANCES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding that the transactions
and events set out herein shall occur and be deemed to occur in the order set out in this Plan of Arrangement and shall become
effective without any further act or formality, each of the Acquiror, the Parent and the Corporation shall make, do and execute,
or cause to be made, done and executed, all such further acts, deeds, agreements, transfers, assurances, instruments or documents
as may reasonably be required by any of them in order further to document or evidence any of the transactions or events set out
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article&nbsp;7<BR>
<BR>
PARAMOUNTCY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From and after the Effective Time (a)&nbsp;this
Plan of Arrangement shall take precedence and priority over any and all Common Shares, Options and Warrants issued and outstanding
prior to the Effective Time, (b)&nbsp;the rights and obligations of registered and beneficial Optionholders or Securityholders,
and the Corporation, the Acquiror, the Parent, the Depositary and any registrar and transfer agent for the Common Shares, Options
or Warrants in relation thereto, shall be solely as provided for in this Plan of Arrangement, and (c)&nbsp;all actions, causes
of action, claims or proceedings (actual or contingent and whether or not previously asserted) based on or in any way relating
to any Common Shares, Options or Warrants shall be deemed to have been settled, compromised, released and determined without liability
except as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Schedule&nbsp;B<BR>
Representations and Warranties of the Parent and Acquiror</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Organization and Qualification.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Parent is a corporation duly
                                         incorporated under the Laws of <B>Delaware</B>, is validly existing and has all necessary
                                         corporate power, authority and capacity to own, lease and operate its property and assets
                                         and to carry on its business as currently owned and conducted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Acquiror is an unlimited liability
                                         company duly incorporated under the Laws of British Columbia, is validly existing and
                                         has all necessary corporate power, authority and capacity to own, lease and operate its
                                         property and assets and to carry on its business as currently owned and conducted. The
                                         Parent owns, directly or indirectly, all of the issued and outstanding shares of the
                                         Acquiror.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">Authority Relative to this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of the Parent and the Acquiror has
the requisite power, authority and capacity to execute this Agreement and to perform its respective obligations hereunder. The
execution and delivery of this Agreement by the Acquiror and the Parent and the consummation by the Parent and the Acquiror of
the transactions contemplated by this Agreement (the &ldquo;<B>Contemplated Transactions</B>&rdquo;) have been duly authorized
by their respective boards of directors and no other corporate proceedings on the part of the Parent or the Acquiror (including
the approval of their shareholders), as the case may be, are necessary to authorize this Agreement or the Contemplated Transactions.
This Agreement has been duly executed and delivered by each of the Parent and the Acquiror and constitutes the legal, valid and
binding obligation of the Parent and the Acquiror, enforceable against each of them in accordance with its provisions, subject
to bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium and other Laws relating to limitations of actions or
affecting the availability of equitable remedies and the enforcement of creditors&rsquo; rights generally and general principles
of equity and public policy and to the qualification that equitable remedies such as specific performance and injunction may be
granted only in the discretion of a court of competent jurisdiction.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Consents and Approvals.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No consent, approval, order or Authorization
of, or declaration or filing with, any Governmental Authority is required to be obtained by the Acquiror or the Parent in connection
with the consummation of the transactions contemplated by this Agreement, except for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Interim Order and any approvals
                                         required by the Interim Order;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Final Order;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the HSR Approval;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">notification pursuant to the Investment
                                         Canada Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">filings with the Director under
                                         the Act; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 77; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">the Authorizations contemplated
                                         by this Agreement.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">Non Contravention.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The authorization of this Agreement, the
execution, delivery and performance by each of the Parent and the Acquiror of its obligations under this Agreement and the consummation
of the Contemplated Transactions (for greater certainty, if applicable, in compliance with the Interim Order and the Final Order),
do not and will not (i) contravene, conflict with, or result in any violation or breach of any provision of the constating documents
of the Parent or the Acquiror or any agreement with any shareholder of the Parent or the Acquiror, (ii) subject to obtaining applicable
regulatory approvals contemplated by this Agreement, contravene, conflict with or result in a violation or breach of any provision
of any applicable Laws, except to the extent that the violation or breach of, or default under, any applicable Laws, would not,
individually or in the aggregate, reasonably be expected to impede or delay the consummation of the Arrangement or materially
adversely affect the ability of the Parent or the Acquiror to perform its respective obligations under this Agreement, (iii) contravene,
conflict with, or result in any violation or breach of any note, bond, mortgage, indenture, contract, licence, permit or government
grant to which the Parent or the Acquiror is party or by which it is bound, except as would not, individually or in the aggregate,
reasonably be expected to impede or delay the consummation of the Arrangement or materially adversely affect the ability of the
Parent or the Acquiror to perform its respective obligations under this Agreement or any judgment, decree, order or award of any
Governmental Authority or arbitrator.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">Share Ownership.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the Parent nor the Acquiror beneficially
owns, or has control or direction over, directly or indirectly, any Common Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">Sufficiency of Funds.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Acquiror will make, or the Parent
will cause the Acquiror to make, prior to the Effective Time, adequate arrangements to ensure that the required funds are available
to effect payment in full of the Consideration in accordance with this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">Brokers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for any fee required to be paid
to Nomura Securities International, Inc., no agent, broker, person or firm acting on behalf of the Acquiror or any of its Affiliates
is, or will be, entitled to any commission or brokers&rsquo; or finders&rsquo; fees in connection with any of the Contemplated
Transactions.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><I>Investment Canada Act</I>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Acquiror is a WTO Investor within
the meaning of the <I>Investment Canada Act</I>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><I>Competition Act</I>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Acquiror and its affiliates do
not have assets in Canada that exceed, on a combined basis, C$200,000,000, or gross revenues from sales in, from or into
Canada that exceed, on a combined basis, C$390,000,000.00, all as determined in accordance with Part IX of the <I>Competition
Act</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Schedule&nbsp;C<BR>
Representations and Warranties of the Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Board Approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has unanimously determined,
after receiving financial and legal advice, that the Arrangement is fair, from a financial point of view, to Shareholders and
the Arrangement is in the best interest of the Corporation. The Board has unanimously approved the entering into of the Agreement
and the making of a recommendation that the Securityholders vote for the Arrangement Resolution.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">Corporate Existence and Power.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation and each of its
                                         subsidiaries is a corporation validly existing and in good standing under the laws of
                                         the jurisdiction of its formation and has all requisite corporate power, authority, and
                                         capacity to own, lease and operate its property and assets as now owned, and to carry
                                         on its business as currently owned and conducted and is in good standing with respect
                                         to the filing of all annual corporate reports.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Corporation and each of its
                                         subsidiaries is duly qualified, licensed or registered to carry on business and is in
                                         good standing in each jurisdiction in which the character of its assets and properties,
                                         owned, leased, licensed or otherwise held, or the nature of its activities make such
                                         qualification, licensing or registration necessary, except where the failure to be so
                                         qualified, registered or licensed has not had or would not reasonably be expected to
                                         have, individually or in the aggregate, a Material Adverse Effect on the Corporation
                                         and its subsidiaries, taken as a whole.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Corporate Authorization.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation and its subsidiaries have
the necessary corporate power, authority and capacity to enter into this Agreement and to perform its obligations hereunder. The
execution, delivery and performance of this Agreement by the Corporation and its subsidiaries and the consummation by the Corporation
and its subsidiaries of the Contemplated Transactions have been authorized by the Board and, except for the approval of the Arrangement
by Securityholders, no other corporate proceedings on the part of the Corporation (excluding the Interim Order and the Final Order)
or its subsidiaries are necessary to authorize the Corporation and its subsidiaries to enter into and to perform its obligations
under this Agreement or the Contemplated Transactions. This Agreement has been duly executed and delivered by the Corporation
and constitutes a valid and binding agreement of the Corporation, enforceable against the Corporation in accordance with its provisions,
subject to the qualification that such enforceability may be limited by bankruptcy, insolvency, reorganization, fraudulent transfer,
moratorium or other Laws relating to limitations of actions or affecting the availability of equitable remedies and the enforcement
of creditors&rsquo; rights generally and general principles of equity and public policy and to the qualification that equitable
remedies such as specific performance and injunction may be granted only in the discretion of a court of competent jurisdiction.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">Authority and No Violation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The authorization of this Agreement,
                                         the execution and delivery by the Corporation of this Agreement and the performance by
                                         the Corporation and its subsidiaries of their obligations under this Agreement, and the
                                         consummation of the Contemplated Transactions (for greater certainty, if applicable,
                                         in compliance with the Interim Order and the Final Order), will not result (with or without
                                         notice or the passage of time) in a violation or breach of or constitute a default under
                                         any provision of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the constating documents of the Corporation
                                         or its subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">subject to obtaining the applicable
                                         Authorizations contemplated by this Agreement, any applicable Laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">any note, bond, mortgage, indenture,
                                         contract, licence or permit to which the Corporation or any of its subsidiaries is party
                                         or by which it is bound; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">any judgment, decree, order or award
                                         of any Governmental Authority against the Corporation or its subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">except in the case of (ii), (iii)
or (iv) above, such violations, breaches or defaults as would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect on the Corporation or its subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Other than as set out in Section&nbsp;4(b)
                                         the Disclosure Letter or as would not reasonably be expected to have a Material Adverse
                                         Effect on the Corporation or its subsidiaries, taken as a whole, the authorization of
                                         this Agreement, the execution and delivery by the Corporation of this Agreement and the
                                         performance by the Corporation of its obligations under this Agreement, and the consummation
                                         of the Contemplated Transactions will not:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">allow any person to exercise any
                                         rights, require any consent or notice under or other action by any person, or constitute
                                         a default under, or cause or permit the termination, cancellation, acceleration or other
                                         change of any right or obligation or the loss of any benefit to which the Corporation
                                         or its subsidiaries are entitled (including by triggering any rights of first refusal
                                         or first offer, change in control provision or other restriction or limitation) under
                                         any Contract or any Authorization to which the Corporation or its subsidiaries are a
                                         party or by which the Corporation or its subsidiaries are bound; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 80; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">result in the imposition of any
                                         Encumbrance upon any assets of the Corporation or any of its subsidiaries, except for
                                         Encumbrances that are not material to the Corporation or any of its subsidiaries, taken
                                         as a whole.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">Consents and Approvals.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than as set out in Section&nbsp;5
of the Disclosure Letter, no consent, approval, order or other Authorization of, or declaration or filing with, any Governmental
Authority or any other third party is required to be obtained by the Corporation or its subsidiaries in connection with the consummation
of the Contemplated Transactions, except for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Interim Order and any approvals
                                         required by the Interim Order;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Final Order;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the filings required under the
                                         Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">compliance with the HSR Act, including the HSR Approval;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">the filings required by applicable
                                         Securities Laws or the Exchanges;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">the filings required by the Act
                                         and any other applicable corporate statutes; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the approval of the Arrangement
                                         Resolution by Securityholders; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">those that if not obtained would
                                         not, individually or in the aggregate, reasonably be expected to have a Material Adverse
                                         Effect on the Corporation and its subsidiaries, taken as a whole.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">Shareholders&rsquo; and Similar Agreements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed in Section&nbsp;6
of the Disclosure Letter, neither the Corporation nor its subsidiaries are subject to, or affected by, any unanimous shareholders
agreement and is not a party to any shareholder, pooling, voting, or other similar arrangement or agreement relating to the ownership
or voting of any of the securities of the Corporation or its subsidiaries or pursuant to which any person other than the Corporation
or its subsidiaries may have any right or claim in connection with any existing or past equity interest in the Corporation or
its subsidiaries.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">Capitalization.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The authorized share capital of the Corporation consists of an unlimited number of Common
                                                               Shares. As of the close of business on the date of this Agreement, there were 12,448,108 issued and outstanding Common
                                                               Shares. Section&nbsp;7(a) of the Disclosure Letter sets forth the number of Warrants and Options outstanding as of the close
                                                               of business on the date of this Agreement and the number of Common Shares issuable upon exercise thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Section&nbsp;7(b) of the Disclosure
                                         Letter contains a list of the Warrants, with the following details, in respect of each
                                         Warrant outstanding as of the close of business on the date of this Agreement: (i) the
                                         weighted average strike price, (ii) the date of grant; (iii) the date of expiry; (iv)
                                         the number of participants to whom such Warrants have been granted; and (v) the name
                                         of the registered holder. The issuance of Common Shares upon the exercise of all Warrants
                                         have been duly authorized by the Board in compliance with Laws, and have been recorded
                                         on the Corporation&rsquo;s financial statements in accordance with IFRS, and no such
                                         grants involved any &ldquo;back dating,&rdquo; &ldquo;forward dating,&rdquo; &ldquo;spring
                                         loading&rdquo; or similar practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Section&nbsp;7(c) of the Disclosure
                                         Letter contains a list of the Options, with the following details, in respect of each
                                         Option outstanding as of the close of business on the date of this Agreement: (i) the
                                         strike price, (ii) the date of grant; (iii) the date of expiry; (iv) the name of the
                                         participants to whom such Options have been granted; and (v) the name of the registered
                                         holder, identifying whether such holder is not an employee of the Corporation or its
                                         subsidiaries (and where not an employee, the basis for the grant). The Option Plan and
                                         the issuance of Common Shares under such plan (including all outstanding Options) have
                                         been duly authorized by the Board and/or any compensation committee or similar committee
                                         of the Board, as applicable, in compliance with Laws and the terms of the Option Plan,
                                         and have been recorded on the Corporation&rsquo;s financial statements in accordance
                                         with IFRS, and no such grants involved any &ldquo;back dating,&rdquo; &ldquo;forward
                                         dating,&rdquo; &ldquo;spring loading&rdquo; or similar practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Except with respect to the Warrants
                                         and the Options or as disclosed in Section&nbsp;7(d) of the Disclosure Letter, there
                                         are no outstanding options, warrants, conversion privileges or other Rights, agreements
                                         or commitments of any character whatsoever that would require the issuance, sale or transfer
                                         by the Corporation of any shares or other securities of the Corporation or of its subsidiaries
                                         or the issuance, sale or transfer of any securities convertible into, or exchangeable
                                         or exercisable for, or otherwise evidencing a right to acquire, any shares or other securities
                                         of the Corporation or of its subsidiaries. All outstanding Common Shares have been duly
                                         authorized and validly issued, are fully paid and non-assessable, and no such shares
                                         have been issued in violation of any pre-emptive rights. No Shareholder is entitled to
                                         any pre-emptive right granted by the Corporation or its subsidiaries. Other than as disclosed
                                         in Section&nbsp;7(d) of the Disclosure Letter, there are no outstanding contractual or
                                         other obligations of the Corporation or its subsidiaries to repurchase, redeem or otherwise
                                         acquire any of its securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">There are no notes, bonds, debentures
                                         or other evidences of indebtedness or any other agreements, arrangements, instruments
                                         or commitments of any kind that give any person, directly or indirectly, the right to
                                         vote with holders of Common Shares on any matter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">The Corporation has never declared or paid any dividends or, except as provided in the
                                                               Adagio Purchase Agreement and Section&nbsp;8.11 of the Agreement, made or obligated itself to make any other distributions
                                                               or                                                                payments to the holders of any securities of the
                                                               Corporation.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation is the registered
and beneficial owner of all of the outstanding shares of capital stock or other equity interests of its subsidiaries, free
and clear of any Encumbrances. All of such shares and other equity interests so owned by the Corporation are validly issued,
fully paid and non-assessable, and no such shares have been issued in violation of any pre-emptive or similar rights. Except
for the equity interests owned by the Corporation in its subsidiaries, neither the Corporation nor any of its subsidiaries
own, beneficially or of record, any equity interest of any kind in any other person. Except as set forth on Section&nbsp;8 of
the Disclosure Letter, Cynapsus Therapeutics (USA) Inc. does not conduct any business operations and has no material assets
or liabilities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">Securities Laws Matters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation is a &ldquo;reporting
issuer&rdquo; under the Securities Laws of the provinces of British Columbia, Alberta and Ontario and no other provinces or territories
and is not on the list of defaulting issuers (or the equivalent) under the Securities Laws of any province or territory. The Common
Shares are listed and posted for trading on each of the Exchanges. None of the Corporation&rsquo;s subsidiaries is subject to
any continuous or periodic, or other disclosure requirements under any Securities Laws in any jurisdiction. The Corporation is
not in default of any material requirements of any Securities Laws or the rules and regulations of the Exchanges. The Corporation
has not taken any action to cease to be a reporting issuer in any of the provinces or territories of Canada nor has the Corporation
received notification from any Securities Authority seeking to revoke the reporting issuer status of the Corporation. No delisting,
suspension of trading or cease trade or other order or restriction with respect to any securities of the Corporation is pending,
in effect, has been threatened, or is expected to be implemented or undertaken, and to the knowledge of the Corporation, the Corporation
is not subject to any formal or informal review, enquiry, investigation or other proceeding relating to any such order or restriction.
The Corporation has timely filed or furnished with any Governmental Authority all forms, reports, schedules, statements and other
documents required to be filed or furnished under Securities Laws or furnished by the Corporation with the appropriate Governmental
Authority since January 1, 2014. The documents comprising the Public Disclosure Record complied as filed or furnished in all material
respects with Securities Laws and did not, as of the date filed or furnished (or, if amended or superseded by a subsequent filing
or submission prior to the date of this Agreement, on the date of such filing or submission), contain any Misrepresentation. The
Corporation has not filed any confidential material change report (which at the date of this Agreement remains confidential) or
any other confidential filings (other than portions of filings which have been redacted) filed to or furnished with, as applicable,
any Securities Authority. There are no outstanding or unresolved comments from any Securities Authority with respect to any of
the Public Disclosure Record and to knowledge of the Corporation, neither the Corporation nor any of the Public Disclosure Record
is subject of an ongoing audit, review, comment or investigation by any Securities Authority or either of the Exchanges.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">U.S. Securities Law Matters</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Common Shares are registered
                                         pursuant to Section&nbsp;12(b) of the U.S. Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Other than the Common Shares, the
                                         Corporation does not have, nor is it required to have, any class of securities registered
                                         under the U.S. Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Other than with respect to the
                                         Common Shares, the Corporation is not subject to any reporting obligation (whether active
                                         or suspended), pursuant to section&nbsp;15(d) of the U.S. Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Corporation is not an investment
                                         company registered or required to be registered under the <I>United States Investment
                                         Company Act</I> of 1940, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">The Corporation is a &ldquo;foreign
                                         private issuer&rdquo; within the meaning of Rule 405 under the U.S. Securities Act and
                                         Rule 3b-4 under the U.S. Exchange Act.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">Financial Statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audited consolidated financial statements
of the Corporation for the fiscal year ended December 31, 2015, and the unaudited consolidated interim financial statements for
the three and six months ended June 30, 2016 (including, in each case, any notes and schedules thereto) that are part of the Corporation&rsquo;s
publicly filed documents complied as of their respective dates in all material respects with all applicable accounting requirements
and rules and regulations and presented fairly, in all material respects, in conformity with IFRS, the consolidated financial
position of the Corporation and the consolidated results of operations and cash flows as of the dates thereof and for the respective
periods then ended (subject to year-end adjustments and the absence of notes in the case of any unaudited interim financial statements).
The Corporation does not intend to correct or restate, nor, to the knowledge of the Corporation is there any basis for any correction
or restatement of, any aspect of any of the financial statements referred to in this Paragraph&nbsp;11. There are no, nor are
there any commitments to become a party to, any off-balance sheet transaction, arrangement, obligation (including contingent obligations)
or other relationships of the Corporation or its subsidiaries with unconsolidated entities or other persons.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">Disclosure Controls and Internal Control
                                         over Financial Reporting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation and its subsidiaries
                                         have established and maintain a system of disclosure controls and procedures that are
                                         designed to provide reasonable assurance that information required to be disclosed by
                                         the Corporation in its annual filings, interim filings or other reports filed or submitted
                                         by it under Securities Laws is recorded, processed, summarized and reported within the
                                         time periods specified in Securities Laws. Such disclosure controls and procedures include
                                         controls and procedures designed to ensure that information required to be disclosed
                                         by the Corporation in its annual filings, interim filings or other reports filed or submitted
                                         under Securities Laws are accumulated and communicated to the Corporation&rsquo;s management,
                                         including its chief executive officer and chief financial officer, as appropriate, to
                                         allow timely decisions regarding required disclosure.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Corporation has established
                                         and maintains a system of internal control over financial reporting that is designed
                                         to provide reasonable assurance regarding the reliability of financial reporting and
                                         the preparation of financial statements for external purposes in accordance with IFRS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">There is no material weakness (as
                                         such term is defined in National Instrument 52-109 &ndash; <I>Certification of Disclosure
                                         in Issuers&rsquo; annual and Interim Filings</I>) relating to the design, implementation
                                         or maintenance of its internal control over financial reporting, or fraud, whether or
                                         not material, that involves management or other employees who have a significant role
                                         in the internal control over financial reporting of the Corporation. None of the Corporation,
                                         the Corporation&rsquo;s subsidiaries or, to the knowledge of the Corporation, any director,
                                         officer, employee, auditor, accountant or representative of the Corporation or its subsidiaries
                                         have received or otherwise obtained knowledge of any complaint, allegation, assertion,
                                         or claim, whether written or oral, regarding accounting, internal accounting controls
                                         or auditing matters, including any complaint, allegation, assertion, or claim that the
                                         Corporation or its subsidiaries have engaged in questionable accounting or auditing practices,
                                         or any expression of concern from its employees regarding questionable accounting or
                                         auditing matters.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">Auditors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The auditors of the Corporation are independent
public accountants as required by applicable Laws and there is not now, and there has never been, any reportable event (as defined
in National Instrument 51-102 &ndash; <I>Continuous Disclosure Obligations</I>) with the present or any former auditors of the
Corporation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">No Undisclosed Liabilities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no liabilities or
obligations of the Corporation or its subsidiaries required by IFRS to be reflected on a balance sheet or in the notes
thereto, other than: (i) liabilities or obligations to the extent reflected in the financial statements of the Corporation
that are included in the publicly filed documents of the Corporation, (ii) liabilities or obligations incurred by the
Corporation since June 30, 2016 in the ordinary course consistent with past practices or that are otherwise described in
Section&nbsp;14 of the Disclosure Letter, (iii) immaterial liabilities and obligations, and (iv) liabilities or obligations
incurred in connection with the transactions contemplated hereby as set out in Section&nbsp;14 of the Disclosure Letter and
pursuant to the amendment on the date hereof of the Adagio Purchase Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">No Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since December 31, 2015, other
than the transactions contemplated in this Agreement and the amendment on the date hereof of the Adagio Purchase Agreement, the
business of the Corporation and its subsidiaries has been conducted in the Ordinary Course and there has not occurred a
Material Adverse Effect.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">Ordinary Course.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed in
Section&nbsp;16 of the Disclosure Letter and except for the amendment on the date hereof of the Adagio Purchase Agreement
since December 31, 2015:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Corporation and each of its
                                         subsidiaries has conducted their respective business only in the Ordinary Course;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">no liability or obligation of any
                                         nature (whether absolute, accrued, contingent or otherwise) which has had, or is reasonably
                                         likely to have, a Material Adverse Effect has been incurred;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">there has not been any material
                                         change in the accounting practices used by the Corporation and its subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">except for Ordinary Course adjustments
                                         to employees (other than directors or officers), there has not been any increase in the
                                         salary, bonus, or other remuneration payable to any non-executive employees of any of
                                         Corporation or its subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">there has not been a material change
                                         in the level of accounts receivable or payable, inventories or employees, other than
                                         those changes in the Ordinary Course;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">there has not been any increase
                                         in the salary, bonus, retainer or other remuneration payable to any director or officer
                                         of any of Corporation or its subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">there has not been any redemption,
                                         repurchase or other acquisition of Common Shares by the Corporation, or any declaration,
                                         setting aside or payment of any dividend or other distribution (whether in cash or otherwise)
                                         with respect to the Common Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">there has not been any entering
                                         into, or an amendment of, any Material Contract other than in the Ordinary Course;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">there has not been any satisfaction
                                         or settlement of any material claims or material liabilities that were not reflected
                                         in the Corporation&rsquo;s audited financial statements, other than the settlement of
                                         claims or liabilities incurred in the Ordinary Course; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">except for Ordinary Course adjustments,
                                         there has not been any increase in the salary, bonus, or other remuneration payable to
                                         any officers of the Corporation or its subsidiaries or any amendment or modification
                                         to the vesting or exercisability schedule or criteria, including any acceleration, right
                                         to accelerate or acceleration event or other entitlement under any stock option, restricted
                                         stock, deferred compensation or other compensation award of any officer of the Corporation
                                         or any of its subsidiaries.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">No Brokers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for the fees to be paid to Merrill
Lynch, Pierce, Fenner &amp; Smith Incorporated and Stifel, Nicolaus &amp; Company, Incorporated and as set out in Section&nbsp;17
of the Disclosure Letter, no Securityholder of the Corporation, director, officer, employee, consultant, broker, &ldquo;finder&rdquo;,
investment banker or other person is entitled to any brokerage, &ldquo;finder&rsquo;s&rdquo; or other fee or commission or similar
form of compensation, or to the reimbursement of any of its expenses, in connection with this Agreement or the Contemplated Transactions.
True and complete copies (subject only to redaction of confidential information identifying potential alternative acquirors) of
the engagement letters between the Corporation and its financial advisors and between the Corporation and the financial advisors
to the Special Committee have been provided to the Acquiror and the Corporation has made true and complete disclosure to the Acquiror
of all fees, commissions or other payments that may be incurred pursuant to such engagements or that may otherwise be payable
to the Corporation&rsquo;s financial advisors.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify">Long Term and Derivative Transactions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the Corporation nor its subsidiaries
have any material obligations or liabilities, direct or indirect, vested or contingent in respect of any rate swap transactions,
basis swaps, forward rate transactions, commodity swaps, commodity options, equity or equity index swaps, equity or equity index
options, bond options, interest rate options, foreign exchange transactions, cap transactions, floor transactions, collar transactions,
currency swap transactions, cross currency rate swap transactions or currency options having terms greater than 90 days (including
any option with respect to any of such transactions) or any combination of such transactions, except in the Ordinary Course.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.</TD><TD STYLE="text-align: justify">Compliance with Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation and its subsidiaries are,
and have been since January 1, 2014, in compliance in all material respects with, and to the knowledge of the Corporation are
not under investigation with respect to and have not been threatened in writing to be charged with or given written notice of
any material violation of, any material applicable Laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.</TD><TD STYLE="text-align: justify">Regulatory Compliance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Section&nbsp;20(a) of the Disclosure
                                         Letter sets forth a true and complete list, (i) identifying all material Authorizations
                                         granted by any Governmental Authority, and (ii) outlining the status of all pending Authorizations
                                         by any Governmental Authority, in each case relating to the Product. The Corporation
                                         has made available to the Acquiror all such Authorizations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Corporation and its subsidiaries
                                         own, possess or have obtained all Authorizations that are required by Law in connection
                                         with the operation of the business of the Corporation and its subsidiaries as presently
                                         or previously conducted. The Corporation has made available to the Acquiror all such
                                         Authorizations. The Corporation or its subsidiaries, as applicable, lawfully hold, own
                                         or use, and have complied with, all such Authorizations, except as would not, individually
                                         or in the aggregate, have a Material Adverse Effect on the Corporation and its subsidiaries,
                                         taken as a whole. Each Authorization is valid and in full force and effect, and is renewable
                                         by its terms or in the Ordinary Course, except as would not, individually or in the aggregate,
                                         have a Material Adverse Effect on the Corporation and its subsidiaries, taken as a whole.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Corporation or its subsidiaries
                                         have filed with the applicable Governmental Authority (including the FDA, Health Canada
                                         or any other Governmental Authority performing functions similar to those performed by
                                         the FDA) all required filings, approvals, authorizations, clearances, Claims, declarations,
                                         listings, notices, registrations, reports or submissions, including but not limited to
                                         the investigational new drug application (&ldquo;<B>IND</B>&rdquo;) relating to the Product,
                                         the protocols relating to each clinical trial of the Corporation, and all Serious Adverse
                                         Events deemed reportable to the applicable Governmental Authority. The Corporation has
                                         made available to the Acquiror true and complete copies of all such documents, where
                                         available, or provided current true and complete current information with respect to
                                         such matters where no documentation is available. All such documents were when filed
                                         or submitted, and continue to be, in material compliance with applicable Laws, including
                                         guidance documents, good laboratory practices, and good clinical practices requirements
                                         (all such Laws in this Section being &ldquo;<B>Approval Requirements</B>&rdquo;), of
                                         the applicable Governmental Authority and no material deficiencies have been asserted
                                         by any applicable Governmental Authority with respect to any such filings, approvals,
                                         authorizations, clearances, Claims, declarations, listings, notices, registrations, reports
                                         or submissions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Except as set forth on Section&nbsp;20(d)
                                         of the Disclosure Letter, the Corporation has not amended the protocol relating to clinical
                                         trials CTH-300 and CTH-301, modified or taken any action that deviated from the current
                                         clinical trial study designs, timelines for clinical trials CTH-300 and CTH-301, including
                                         without limitation, taken any action that has or would reasonably be expected to impact
                                         the study cycle time line, patient and study site recruitment and enrollment status,
                                         patient standards of care, study objectives or strategy, protocol complexity, or the
                                         statistical analyses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries have initiated, conducted, or issued any recall, withdrawal, safety alert,
                                         warning, investigator notice, or other notice relating to an alleged lack of safety or
                                         efficacy of the Product. Neither the Corporation nor its subsidiaries are currently contemplating
                                         such actions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Except as described in Section&nbsp;20(f)
                                         of the Disclosure Letter, all business operations, including preclinical and clinical
                                         investigations sponsored by the Corporation or its subsidiaries, and those in which any
                                         or all obligations under the FDCA or Approval Requirements administered by any other
                                         Governmental Authority have been transferred to a third party, have been in compliance
                                         in all material respects with, and have not been threatened in writing to be charged
                                         with or given written notice of and, to the knowledge of the Corporation, are not under
                                         investigation with respect to any violation of, any applicable Laws, including (i) the
                                         FDCA, as amended, 21 U.S.C. &sect; 301 et seq., (ii) the federal False Claims Act, 31
                                         U.S.C. &sect; 3729 3733, as amended, (iii) the Physician Payments Sunshine Act, 42 U.S.C.
                                         &sect; 1320a 7h, (iv) the Patient Protection and Affordable Care Act, P.L. 111 148, (v)
                                         the United States federal Medicare and Medicaid statutes and related state or local statutes
                                         or regulations, (vi) the federal Anti-Kickback Statute, 42 U.S.C. &sect; 1320a 7b, the
                                         federal Physician Self-Referral (Stark) Law, 42 U.S.C. &sect; 1395nn, and the Federal
                                         Civil Monetary Penalties Law, 42 U.S.C. &sect; 1320a 7a, (vii) 42 U.S.C. &sect;&sect;
                                         1320d through 1320d 8 and 42 C.F.R. &sect;&sect; 160, 162 and 164, which are commonly
                                         referred to as the &ldquo;Health Insurance Portability and Accountability Act of 1996&rdquo;
                                         or &ldquo;HIPAA&rdquo;, (viii) the following binding rules and regulations: Good Clinical
                                         Practices, Good Laboratory Practices, and Good Manufacturing Practices as promulgated
                                         by the FDA under and in accordance with the U.S. Federal Food, Drug and Cosmetic Act,
                                         Title 21, Parts 50, 54, 56, 58, 210, 211, and 312 of the C.F.R, (ix) the applicable European
                                         regulation and UK regulation, including the European Directive 2001/83/EC on the Community
                                         code relating to medicinal products for human use, the European Clinical Trial Directive
                                         2001/20/EC, the European Clinical Trial Guidelines, the applicable transparency and anti-gift
                                         Laws, and the European Data Protection Directive 95/46/EC, in each case except as would
                                         not, individually or in the aggregate, have a Material Adverse Effect on the Corporation
                                         and its subsidiaries, taken as a whole. The Corporation has made available to Acquiror
                                         all such written threats or written notices of non-compliance with applicable Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">Except as described in Section&nbsp;20(g)
                                         of the Disclosure Letter, neither the Corporation nor its subsidiaries have received
                                         any warning letters, untitled letters, regulatory letters, notices of inspectional observations
                                         (Form FDA 483s), correspondence regarding the termination or suspension or delay or modification
                                         of any ongoing clinical or pre-clinical studies or tests, establishment inspection reports
                                         or other correspondence or notices from the FDA, Health Canada or any other applicable
                                         Governmental Authority relating to deficiencies in the Development, investigation, and
                                         manufacture of the Product, in each case except as would not, individually or in the
                                         aggregate, have a Material Adverse Effect on the Corporation and its subsidiaries, taken
                                         as a whole. All such documents described in Section&nbsp;20(g) of the Disclosure Letter
                                         have been made available to the Acquiror.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">Except as described in Section&nbsp;20(h)
                                         of the Disclosure Letter, neither the Corporation nor its subsidiaries have received
                                         written notice of any threatened or pending investigation, hearing, finding of deficiency
                                         or noncompliance, adverse inspection report, penalty, fine, sanction, request for recall,
                                         relabeling or other remedial action, audit or other regulatory action (other than non-material
                                         routine or periodic inspections or reviews) by any Governmental Authority against (i)
                                         the Corporation or its subsidiaries or, (ii) any person that manufactures, packages,
                                         labels, imports/exports, stores, distributes or sells pursuant to a manufacturing, supply
                                         or other arrangement with the Corporation or its subsidiaries, in each case except as
                                         would not, individually or in the aggregate, have a Material Adverse Effect on the Corporation
                                         and its subsidiaries, taken as a whole. All such documents described in Section&nbsp;20(h)
                                         of the Disclosure Letter have been made available to the Acquiror.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries, nor, to the knowledge of the Corporation, any officer or employee, of the
                                         Corporation or its subsidiaries, have made an untrue statement of fact or a fraudulent
                                         statement, including, but not limited to certification to the FDA, Health Canada or any
                                         other Governmental Authority or agent thereof, failed to disclose a fact required to
                                         be disclosed to the FDA, Health Canada or any other Governmental Authority or agent thereof,
                                         or committed an act, made a statement or failed to make a statement that, at the time
                                         such disclosure was made, would reasonably be expected to provide a basis for the FDA,
                                         Health Canada or any other Governmental Authority or agent thereof to invoke its policy
                                         respecting &ldquo;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&rdquo;
                                         set forth in 56 Fed. Reg. 46191 (September 10, 1991) or for the FDA. Neither the Corporation
                                         nor its subsidiaries, nor any officer or employee of the Corporation or its subsidiaries,
                                         have been debarred or convicted of any crime or engaged in any conduct that would reasonably
                                         be expected to result in debarment under 21 U.S.C. Section 335a or any similar Laws or
                                         exclusion under 42 U.S.C. Section 1320a 7 or any similar Laws. Neither the Corporation
                                         nor its subsidiaries nor any officer or employee of the Corporation or its subsidiaries
                                         are subject to an investigation or proceeding by any Governmental Authority that would
                                         reasonably be expected to result in such suspension, exclusion or debarment and to the
                                         knowledge of the Corporation, there are no facts that would reasonably be expected to
                                         give rise to such suspension, exclusion or debarment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries are currently developing, nor has it developed or sought approval for, any
                                         product other than the Product.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.</TD><TD STYLE="text-align: justify">Clinical Studies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All clinical studies undertaken by the
Corporation or its subsidiaries have been conducted in all material respects in accordance with all applicable Law, including
good clinical practices.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.</TD><TD STYLE="text-align: justify">Litigation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed in Section&nbsp;22
of the Disclosure Letter and any inquiry, investigation or proceeding solely related to satisfying or obtaining the Authorizations,
there are no claims, actions, suits, arbitrations, inquiries, investigations or proceedings pending, or, to the knowledge of the
Corporation threatened, against the Corporation or its subsidiaries by or affecting any of their respective current or former
properties or assets by or before any Governmental Authority that, if determined adverse to the interests of the Corporation or
its subsidiaries, could potentially result in criminal sanctions, or would have, individually or in the aggregate, a Material
Adverse Effect or would or would be reasonably expected to prevent or delay the consummation of the Arrangement or the transactions
contemplated hereby or would or would be reasonably expected to materially affect the Acquiror&rsquo;s ability to own or operate
the business of the Corporation or its subsidiaries,, nor, to the knowledge of the Corporation, are there any events or circumstances
which could reasonably be expected to give rise to any such claim, action, suit, arbitration, inquiry, investigation or proceeding.
There is no bankruptcy, liquidation, winding up or other similar proceeding pending or in progress, or, to the knowledge of the
Corporation, threatened against or relating to the Corporation or its subsidiaries before any Governmental Authority. Neither
the Corporation nor its subsidiaries nor any of their respective properties or assets are subject to any outstanding judgment,
order, writ, injunction or decree that would have or would be reasonably expected to have, individually or in the aggregate, a
Material Adverse Effect or that would or would be reasonably expected to prevent or delay the consummation of the Arrangement
or the transactions contemplated hereby.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify">Taxes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed in Section&nbsp;23
of the Disclosure Letter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Each of the Corporation and its
                                         subsidiaries have duly and timely filed all material Tax Returns required to be filed
                                         by them prior to the date hereof (taking into account any extended due dates therefor)
                                         and all such material Tax Returns are complete and correct in all material respects and
                                         no such material Tax Return has been amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Each of the Corporation and its
                                         subsidiaries have paid all assessments and reassessments of Taxes, and all other material
                                         Taxes required to be paid on or before the date hereof, other than those which are being
                                         or have been contested in good faith and in respect of which reserves have been provided
                                         in the most recently published consolidated financial statements of the Corporation.
                                         The Corporation has provided adequate accruals in accordance with IFRS in the most recently
                                         published consolidated financial statements of the Corporation for any Taxes of the Corporation
                                         and its subsidiaries for the period covered by such financial statements that have not
                                         been paid whether or not shown as being due on any Tax Returns. Since such publication
                                         date, no material liability in respect of Taxes not reflected in such statements or otherwise
                                         provided for has been assessed, proposed to be assessed, incurred or accrued, other than
                                         in the Ordinary Course. Neither the Corporation nor its subsidiaries have received a
                                         refund to which it was not entitled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">No material deficiencies, litigation,
                                         proposed adjustments or matters in controversy exist or have been asserted with respect
                                         to Taxes of the Corporation or its subsidiaries, and neither the Corporation nor its
                                         subsidiaries are a party to any action or proceeding for assessment or collection of
                                         Taxes and no such event has been asserted or, to the knowledge of the Corporation, threatened
                                         against the Corporation or any of its subsidiaries or any of their respective assets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Each of the Corporation and its
                                         subsidiaries have withheld or collected all material amounts required to be withheld
                                         or collected by it on account of Taxes and has remitted all Taxes required to be remitted
                                         to the appropriate Governmental Authority when required by Law to do so.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">No claim has been made by any Governmental
                                         Authority in a jurisdiction where the Corporation or its subsidiaries do not file Tax
                                         Returns that the Corporation or its subsidiaries are subject to material Tax by that
                                         jurisdiction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 91; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">There are no Encumbrances with
                                         respect to Taxes upon any of the assets of the Corporation or its subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">There are no outstanding agreements
                                         extending or waiving the statutory period of limitations applicable to any claim for,
                                         or the period for the collection or assessment or reassessment of Taxes due from the
                                         Corporation or its subsidiaries for any taxable period and no request for any such waiver
                                         or extension are currently pending.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">The Corporation and its subsidiaries
                                         have made available to the Acquiror true, correct and complete copies of all material
                                         Tax Returns, examination reports and statements of deficiencies for taxable periods,
                                         or transactions consummated, for which the applicable statutory periods of limitations
                                         have not expired.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries have ever directly or indirectly transferred any property to or supplied
                                         any services to or acquired any property or services from a person with whom it was not
                                         dealing at arm&rsquo;s length (for the purposes of the <I>Tax Act</I>) for consideration
                                         other than consideration equal to the fair market value of the property or services at
                                         the time of the transfer, supply or acquisition of the property or services.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">There are no circumstances existing
                                         which could result in the application of Section&nbsp;78 or Sections 80 to 80.04 of the
                                         <I>Tax Act</I>, or any equivalent provision under provincial Law, to the Corporation
                                         or its subsidiaries. Other than in the Ordinary Course, the Corporation and its subsidiaries
                                         have not claimed nor will they claim any reserve under any provision of the <I>Tax Act
                                         </I>or any equivalent provincial provision, if any amount could be included in the income
                                         of the Corporation or its subsidiaries for any period ending after the Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">The Corporation is a taxable Canadian
                                         corporation within the meaning of the <I>Tax Act</I>.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify">Employee Matters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">For the purposes hereof, &ldquo;<B>Employee
                                         Plans</B>&rdquo; means all health, medical, dental, welfare, supplemental unemployment
                                         benefit, bonus, profit sharing, stock option, insurance, incentive, incentive compensation,
                                         deferred compensation, share purchase, share based compensation, disability, pension,
                                         retirement or supplemental retirement plans and all other material compensation or benefit
                                         plans or agreements for the benefit of employees or former employees or directors or
                                         former directors of the Corporation and/or its subsidiaries, or their dependents or beneficiaries,
                                         which are maintained by, contributed to, or binding upon the Corporation or its subsidiaries
                                         or in respect of which the Corporation or its subsidiaries have any material liability
                                         (contingent or otherwise), with the exception of (i) any statutory plans or agreements
                                         which the Corporation or its subsidiaries are required to participate in or comply with
                                         under applicable Laws, including the Canada Pension Plan, and (ii) any other plans or
                                         agreements established or administered under applicable health, workplace safety and
                                         insurance and employment insurance legislation. True and complete copies of each written
                                         Employee Plan, as amended to the date hereof, and summaries of any unwritten Employee
                                         Plans, have been delivered or made available to the Acquiror.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 92; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">All of the Employee Plans have
                                         been, as applicable, established, registered (including registration with the relevant
                                         authorities where such registration is required to qualify for Tax exemption or other
                                         beneficial Tax status), and administered, in accordance with all applicable Laws, and
                                         in accordance in all material respects with their terms, except in either such case where
                                         any such failure would not reasonably be expected to have, individually or in the aggregate,
                                         a Material Adverse Effect on the Corporation and its subsidiaries, taken as a whole.
                                         All contributions and premiums required to be made or remitted by the Corporation or
                                         its subsidiaries, as applicable, under the terms of each Employee Plan or by applicable
                                         Laws in respect of the Employee Plans have been made or remitted in accordance with applicable
                                         Laws and the terms of the applicable Employee Plan when due, except where any such failure
                                         would not reasonably be expected to have, individually or in the aggregate, a Material
                                         Adverse Effect on the Corporation and its subsidiaries, taken as a whole. Except as disclosed
                                         in Section&nbsp;24(b) of the Disclosure Letter, no currently outstanding notice of underfunding,
                                         noncompliance, or failure to be in good standing has been received by the Corporation
                                         or its subsidiaries thereof from any applicable Governmental Authority in respect of
                                         any Employee Plan. The Corporation and its subsidiaries have made no legally binding
                                         promise or commitment to create any additional Employee Plan or to improve or change
                                         the benefits provided under any Employee Plan. Except as disclosed in Section&nbsp;24(b)
                                         of the Disclosure Letter, none of the Employee Plans provide benefits beyond retirement
                                         or other termination of service to employees or former employees or to the dependents
                                         or beneficiaries of such employees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Section&nbsp;24(c) of the Disclosure
                                         Letter contains a complete and correct list of all employees, dependent contractors and
                                         independent contractors who are employed by or work in connection with the business of
                                         the Corporation which sets forth the following information with respect to each: (i)
                                         name; (ii) title or position; (iii) in the case of employees, age; (iv) date of hire;
                                         (v) entity or entities by which such individual is employed or engaged; (vi) current
                                         wage or salary rate and last bonus; (vii) in the case of employees, accrued but unused
                                         vacation or paid time off; (viii) in the case of employees, active or inactive status
                                         and, if applicable, the reason for the inactive status and anticipated return to work
                                         date; (ix) in the case of employees, full time or part time status; and (x) employment
                                         location.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 93; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Except as disclosed in Section&nbsp;24(d)
                                         of the Disclosure Letter, the amount of salaries, bonuses, commissions and other material
                                         remuneration of any nature, including vacation pay and overtime pay as well as any termination
                                         pay, severance pay and compensation in lieu of notice of termination to employees, consultants,
                                         officers and/or directors of the Corporation or its subsidiaries that are earned and
                                         due have been paid in full or accrued (except for amounts due as normal salaries and
                                         bonuses and in reimbursement of ordinary expenses) in all material respects in accordance
                                         with all applicable accounting requirements and rules and regulations, and neither the
                                         Corporation or its subsidiaries have received any notice of any outstanding overdue assessment,
                                         order, lien or judgment under applicable Laws relating to such matters. All other liabilities
                                         to or arising in connection with all employees of the Corporation or its subsidiaries
                                         (including Taxes and all payments, contributions or premiums required to be remitted
                                         or paid in respect of each of the Employee Plans, employment insurance, Canada Pension
                                         Plan, employer health tax, workers&rsquo; compensation any other employment related legislation)
                                         have been paid in a timely fashion when due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries are a party to or negotiating, and none of their employees are covered by,
                                         any collective bargaining agreement or union agreement or employee association agreement.
                                         Neither the Corporation nor its subsidiaries are aware of any current attempts to organize
                                         or establish any trade union, employee association or other similar entity affecting
                                         its employees and no collective bargaining agreement is currently being negotiated. There
                                         is no labour strike, dispute, slowdown, stoppage or other labour difficulty pending,
                                         involving, affecting or, to the knowledge of the Corporation, threatened against the
                                         Corporation or any of its subsidiaries, and there have been none of the foregoing during
                                         the three (3) years preceding the date of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">The Corporation and each of its
                                         subsidiaries has complied in all material respects with all applicable Laws pertaining
                                         to the employment or termination of employment of their respective employees, including
                                         all Laws relating to employment standards and practices (including wages and hours or
                                         work and overtime), labour relations, employment equity, pay equity, human rights, privacy,
                                         occupational health and safety, workers' compensation, employment insurance and employer
                                         health tax. Neither the Corporation nor any of its subsidiaries are aware of any pending
                                         or threatened proceedings before any Governmental Authority with respect to any of the
                                         foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">Each of the Corporation and its
                                         subsidiaries has properly characterized retained individuals as either employees or independent
                                         contractors for the purposes of Tax Laws and none of the Corporation or any of its subsidiaries
                                         has received any written notice from any Governmental Authority disputing such classification.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">There are no outstanding assessments,
                                         penalties, fines, liens, charges, surcharges or other amounts due or owing pursuant to
                                         any workplace safety and insurance legislation or pay equity legislation and the Corporation
                                         has not been reassessed in any material respect under such legislation during the past
                                         three (3) years and no audit of the Corporation is currently being performed pursuant to
                                         any applicable workplace safety and insurance legislation or pay equity legislation and
                                         neither the Corporation nor any of its subsidiaries are aware of any potential inspection
                                         orders, violations, investigations or prosecutions against the Corporation under any
                                         applicable workplace safety and insurance legislation or pay equity legislation. There
                                         are no claims or potential claims which may materially adversely affect the Corporation&rsquo;s
                                         accident cost experience.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify">Change of Control Payments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for the amendment on the
date hereof of the Adagio Purchase Agreement, Section&nbsp;25 of the Disclosure Letter discloses all material payments the
Corporation or its subsidiaries are required to make to employees, officers and/or directors as a result of the
Contemplated Transactions, including any change of control, severance, retention, bonus, termination or other amounts
(collectively, the &ldquo;<B>Change of Control Payments</B>&rdquo;), including Change of Control Payments that are
conditional on consummation of the Contemplated Transactions and an additional event such as the termination of any
employee&rsquo;s employment.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify">Related Party Transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than as disclosed in Section&nbsp;26
of the Disclosure Letter, the Corporation and its subsidiaries are not indebted to any director, officer, employee or Securityholder
of the Corporation (except for amounts due as normal salaries and bonuses and in reimbursement of ordinary expenses). Other than
as disclosed in Section&nbsp;26 of the Disclosure Letter, no director, officer, employee or Securityholder of the Corporation
or its subsidiaries are a party to any loan, contract, arrangement or understanding or other transactions with the Corporation
or its subsidiaries.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify">No &ldquo;Collateral Benefit&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed in Section&nbsp;27
of the Disclosure Letter, to the knowledge of the Corporation, no related party of the Corporation or its subsidiaries, together
with its associated entities, beneficially owns or exercises control or direction over 1% or more of the outstanding Common Shares,
except for related parties who will not receive a &ldquo;collateral benefit&rdquo; (within the meaning of MI 61-101) as a consequence of the transactions contemplated by this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.</TD><TD STYLE="text-align: justify">Shareholder Rights Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation and its subsidiaries do
not have a shareholder rights plan and is not a party to any pooling, voting trust or other similar agreement relating to the
voting of the securities of the Corporation or its subsidiaries, or pursuant to which any person other than the Corporation or
its subsidiaries may have any right or claim in connection with any existing or past equity interest in the Corporation or its
subsidiaries, other than in respect of Options disclosed in Section&nbsp;7(c) of the Disclosure Letter, Warrants disclosed in
Section&nbsp;7(b) of the Disclosure Letter and the rights of the parties under the Adagio<B> </B>Purchase Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.</TD><TD STYLE="text-align: justify">Investment Canada Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The enterprise value of the assets of
the Corporation, calculated in the manner prescribed under the <I>Investment Canada Act</I>, is less than C$600,000,000. The
Corporation is not engaged in a &ldquo;cultural business&rdquo; as defined in section 14.1 of the <I>Investment Canada
Act</I>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30.</TD><TD STYLE="text-align: justify">Competition Act</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation and its affiliates do
not have assets in Canada that exceed, on a combined basis, C$200,000,000 or gross revenue from sales in, from or into Canada
that exceed, on a combined basis, C$10,000,000, all as determined in accordance with Part IX of the Competition Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.</TD><TD STYLE="text-align: justify">Personal Property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation and its subsidiaries have
good title to all material personal property of any kind or nature which the Corporation and its subsidiaries purport to own free
and clear of all Encumbrances, except (i) such as set out in Section&nbsp;31 of the Disclosure Letter or (ii) where the failure
to hold any such title free and clear of any Encumbrances, singly or in the aggregate, would not reasonably be expected to result
in a Material Adverse Effect on the Corporation. The Corporation and its subsidiaries, as lessee, have the right under valid and
subsisting leases to use, possess and control all personal property leased by and material to the Corporation as now used, possessed
and controlled by the Corporation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.</TD><TD STYLE="text-align: justify">Environmental Matters.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as would not, individually or in
the aggregate, result in a Material Adverse Effect on the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">no written notice, Claim, order,
                                         complaint or penalty has been received by the Corporation alleging that the Corporation
                                         or its subsidiaries are in violation of, or have any liability or any potential material
                                         Environmental Liability which either has been received in the past twelve (12) months
                                         or is outstanding or unresolved, and, there are no judicial, administrative or other
                                         actions, suits, proceedings, orders, decrees or judgments unresolved, pending or threatened
                                         which allege a violation by the Corporation of any Environmental Laws or relating to
                                         the environment or the presence of contaminant, pollutant, waste or other material or
                                         substance in the environment that could reasonably give rise to material Environmental
                                         Liability; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Corporation has all permits
                                         necessary for its operations to comply in all material respects with all Environmental
                                         Laws and the operations of the Corporation and its subsidiaries are and have been in
                                         compliance in all material respects with such permits.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.</TD><TD STYLE="text-align: justify">Immoveable Property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither the Corporation nor its subsidiaries
own any real or immoveable property. Section&nbsp;33 of the Disclosure Letter sets out a list of all real property (the &ldquo;<B>Corporation
Leased Property</B>&rdquo;) leased by the Corporation. The Corporation is the tenant of the Corporation Leased Property subject
to the terms and conditions of leases appertaining thereto. The Corporation has, to its knowledge, the right to possess, use and
occupy the Corporation Leased Property for the purposes of conducting its business as currently conducted. Except as disclosed
in Section&nbsp;33 of the Disclosure Letter or where the failure to hold any such title free and clear of any Encumbrances, individually
or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect on the Corporation, all interests
of the Corporation in the Corporation Leased Property as lessee under the leases are free and clear of all Encumbrances.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">34.</TD><TD STYLE="text-align: justify">Intellectual Property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Section&nbsp;34(a)(ai) of the Disclosure
Letter sets forth a true and complete list of all Company Owned Registered IP. Section&nbsp;34(a)(aii) of the Disclosure Letter
sets forth a true and complete list of all Company Licensed Registered IP. Section&nbsp;34(a)(ai) of the Disclosure Letter identifies
the following for each patent of the Company Owned Registered IP therein: (i) the name of applicant/registrant, (ii) the current
title owner, (iii) the jurisdiction of application/registration, and (iv) the application number and registration number, if applicable.
Section&nbsp;34(a)(ai) of the Disclosure Letter identifies the following for each trademark of Company Owned Registered IP therein:
(i) the brand, (ii) the status, (iii) the origin, (iv) the holder, (v) the number, (vi) the application date, and (vii) Nice cl.
Section&nbsp;34(a)(ai) of the Disclosure Letter identifies the following for each domain name of Company Owned Registered IP therein:
(i) the domain name, (ii) the creation date, (iii) the expiration date, and (iv) the registrar. Section&nbsp;34(a)(aii) of the
Disclosure Letter identifies the following for each Company Licensed Registered IP therein: (i) the jurisdiction of the application/registration,
(ii) the application number, and (iii) the registration number, if applicable. The Company Owned Registered IP listed in Section
34(a)(ai) of the Disclosure Letter (A) is subsisting, and, to the knowledge of the Corporation, enforceable and valid, (B) to
the knowledge of the Corporation, has not been misused, withdrawn, cancelled or abandoned, and (C) to the knowledge of the Corporation,
all applications, registrations, issuances, renewals and maintenance fees due for such Company Owned Registered IP listed in Section&nbsp;34(a)(ai)
of the Disclosure Letter having a final due date on or before the date hereof have been paid in full and are current. Except as
disclosed in the Disclosure Letter, to the knowledge of the Corporation, there is no pending or threatened litigation, interference,
opposition, cancellation, reissue, re-examination, post-grant proceeding or other Legal Proceeding of any nature (other than communications
arising from the prosecution of Registered Company IP with Governmental Authorities) in which the scope, validity, registrability,
enforceability, use or ownership of any Company Owned Registered IP in Section 34(a)(ai) of the Disclosure Letter is being or
has been contested or challenged. Neither the Corporation nor its subsidiaries have failed to: diligently prosecute or cause to
be prosecuted, maintained or cause to be maintained, any application or registration, or to comply with any agreement or order
of any court, board or other Governmental Authority which would prevent the Corporation from owning, using, commercializing, exploiting
or enforcing any Company Owned Registered IP with claims of the same scope as listed in Section&nbsp;34(a)(ai) of the Disclosure
Letter. The Company Licensed Registered IP listed in Section 34(a)(aii) of the Disclosure Letter (I) to the knowledge of the Corporation
is subsisting, (II) to the knowledge of the Corporation, none of such Company Licensed Registered IP has been misused, withdrawn,
cancelled or abandoned, and (III) to the knowledge of the Corporation, all applications, registrations, issuances, renewals and
maintenance fees due for such Company Licensed Registered IP listed in Section&nbsp;34(a)(aii) of the Disclosure Letter having
a final due date on or before the date hereof have been paid in full and are current. Neither the Corporation nor its subsidiaries
have failed to comply with any agreement or order of any court which would prevent the Corporation from owning, using, commercializing,
exploiting or enforcing any Company Licensed Registered IP with claims of the same scope as listed in Section&nbsp;34(a)(aii)
of the Disclosure Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 97; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Section&nbsp;34(b) of the Disclosure
                                         Letter sets forth (i) all known previous owners or assignees of the Company Owned Registered
                                         IP listed in Section&nbsp;34(a)(ai) of the Disclosure Letter, (ii) all assignments with
                                         any other Governmental Authority of the Company Owned Registered IP listed in Section&nbsp;34(a)(ai)
                                         of the Disclosure Letter from all previous owners, whether or not a Corporation Associate,
                                         (iii) all recordals of Company Owned Registered IP in writing, listed in Section&nbsp;34(a)(ai)
                                         of the Disclosure Letter, and (iv) all receipts for recordals of such assignments, to
                                         the extent available.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Section&nbsp;34(c) of the Disclosure
                                         Letter sets forth a true and complete list, identifying each license agreement or other
                                         contract pursuant to which the Corporation and/or its subsidiaries have acquired or has
                                         the right to acquire rights, title and/or interest in present or future Company Licensed
                                         Registered IP or any other Intellectual Property Rights as a licensee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Except as described in Section&nbsp;34(d)
                                         the Disclosure Letter and without giving effect to 35 U.S.C. &sect;271(e)(i) or any other
                                         Law of similar effect in any jurisdiction, to the knowledge of the Corporation, (i) the
                                         Corporation or its subsidiaries own exclusively and possesses all right, title and interest
                                         in and to, or has the exclusive right to exploit fully, enforce and use, including by
                                         sublicensing, pursuant to a valid and enforceable agreement, all Company Owned Registered
                                         IP listed in Section&nbsp;34(a)(ai) of the Disclosure Letter, free and clear of all Encumbrances
                                         and neither the Corporation nor its subsidiaries have granted any rights into, and to
                                         the knowledge of the Corporation, no third parties have rights to, such Company Owned
                                         Registered IP listed in Section&nbsp;34(a)(ai) of the Disclosure Letter; and (ii) the
                                         Corporation or its subsidiaries has the exclusive right to use in the Licensed Field,
                                         including by sublicensing, pursuant to a valid and enforceable agreement, all Company
                                         Licensed Registered IP listed in Section&nbsp;34(a)(aii) of the Disclosure Letter, free
                                         and clear of all Encumbrances and neither the Corporation nor its subsidiaries have granted
                                         any rights into, and to the knowledge of the Corporation, no third parties have rights
                                         in the Licensed Field to, such Company Licensed Registered IP listed in Section&nbsp;34(a)(aii)
                                         of the Disclosure Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Except as provided in Section&nbsp;34(e)
                                         of the Disclosure Letter, neither the Corporation nor its subsidiaries owe or will owe
                                         any royalties or other payments to any third party as a result of the use or exploitation
                                         of any of the Registered Company IP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 98; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Other than as set out in Section&nbsp;34(f)
                                         of the Disclosure Letter, no Corporation Associate owns or has any Claim, right (whether
                                         or not currently exercisable), interest to, or interest in any Company IP, including
                                         without limitation any Company Owned Registered IP in Section&nbsp;34(a)(ai) of the Disclosure
                                         Letter and each Corporation Associate who is or, to the knowledge of the Corporation,
                                         was or is involved in the conception and reduction to practice of any Intellectual Property
                                         Rights for the Corporation or its subsidiaries have signed a valid, enforceable agreement
                                         containing an assignment to the Corporation of a grant of exclusive ownership of all
                                         such Intellectual Property Rights (without further payment being owed to any such Corporation
                                         Associate and without any restrictions or obligations on the Corporation&rsquo;s ownership
                                         and use thereof), or where such an assignment is not permitted under applicable Laws,
                                         a waiver of moral rights, and contains confidentiality provisions, non-disclosure provisions
                                         or the like protecting such Company Owned Registered IP listed in Section 34(a)(ai) of the
                                         Disclosure Letter, which has not been materially breached by such Corporation Associate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">To the knowledge of the Corporation
                                         and without giving effect to 35 U.S.C. &sect;271(e)(1) or any other Law of similar effect
                                         in any jurisdiction no person is infringing, misappropriating or otherwise violating
                                         any Company Owned Registered IP. The Corporation has not threatened, asserted, initiated
                                         or served any Legal Proceeding claiming actual, alleged, or suspected, infringement,
                                         misappropriation, or other violation of any Company IP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">To the knowledge of the Corporation
                                         the operation of the business of the Corporation and its subsidiaries as currently conducted
                                         does not infringe, misappropriate or otherwise violate any Intellectual Property Rights
                                         owned, in whole or in part, by any other person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Neither the Corporation nor its
                                         subsidiaries have received any written notice or other written communication of any claim,
                                         demand, threat, assertion or complaint relating to any actual, alleged or suspected infringement,
                                         misappropriation or other violation of any Intellectual Property Right of another person
                                         by the Corporation or its subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">Excluding communications arising
                                         from the prosecution of Registered Company IP with Governmental Authorities and except
                                         as provided in Section&nbsp;22 of the Disclosure Letter, none of the Corporation or its
                                         subsidiaries have received any written notice or other written communication of any claim,
                                         notice, threat or assertion challenging the validity or scope of any Registered Company
                                         IP listed in Section&nbsp;34(a)(ai) or Section&nbsp;34(a)(aii) of the Disclosure Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">None of the Company Owned Registered
                                         IP in Section&nbsp;34(a)(ai) of the Disclosure Letter is subject to any pending or outstanding
                                         injunction, directive, order, decree, award, settlement, judgment encumbrance or other
                                         disposition of dispute that would adversely restrict the use, enforcement, transfer,
                                         registration or licensing of any such Registered Company IP listed in Section&nbsp;34(a)(ai)
                                         of the Disclosure Letter by the Corporation or its subsidiaries, or would adversely restrict
                                         the Company from enforcing the Registered Company IP to exclude others from making, using,
                                         offering for sale, selling, manufacturing or importing the Product, or would adversely
                                         affect the validity, scope, use, registrability, or enforceability of any Registered
                                         Company IP. To the knowledge of the Corporation without reasonable inquiry, there has
                                         been no breach of the representations, warranties and covenants made by the licensor
                                         in the license agreement conveying rights to the Company Licensed Registered IP in Section&nbsp;34(a)(aii)
                                         of the Disclosure Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 99; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">To the knowledge of the Corporation,
there is no prior art that may render any patent or patent application included in the Company Owned Registered IP unpatentable
or unenforceable that has not been disclosed to, or was required to be disclosed to, the applicable patent office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">No registered trademark, registered
                                         trade name, trademark application or trade name application included in the Company Owned
                                         IP has been licensed to a party other than the Corporation or its subsidiaries. Section&nbsp;34(m)
                                         of the Disclosure Letter sets forth a true and complete list, identifying the trademarks,
                                         service marks and trade names in which the Corporation and/or its subsidiaries claim
                                         common law rights, as well as a true and complete list, identifying all renewal and other
                                         fee due dates and deadlines for all trademark applications or registrations included
                                         in the Registered Company IP.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.</TD><TD STYLE="text-align: justify">Material Contracts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&nbsp;35 of the Disclosure Letter
lists every Material Contract that is currently in force. Except as made available via SEDAR or EDGAR since January 1, 2015, true
and complete copies of the Material Contracts which are in writing have been made available to the Acquiror and where such Material
Contracts are oral, they are with employees and are accurately summarized in Section&nbsp;35 of the Disclosure Letter or as cross-referenced
therein. Except as disclosed in Section&nbsp;35 of the Disclosure Letter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">each Material Contract is legal,
                                         valid, binding and in full force and effect and is enforceable by the Corporation and
                                         its subsidiaries, as applicable, in accordance with its terms (subject to bankruptcy,
                                         insolvency and other Laws affecting creditors&rsquo; rights generally, and to general
                                         principles of equity);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Corporation and its subsidiaries
                                         have performed in all material respects all respective obligations required to be performed
                                         by them to date under the Corporation and neither the Corporation nor any of its subsidiary
                                         is in material breach or default under any Material Contract, nor does the Corporation
                                         have knowledge of any condition that with the passage of time or the giving of notice
                                         or both would result in such a material breach or default;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Corporation and its subsidiaries
                                         do not know of, and have not received any notice (whether written or oral) of, any material
                                         breach or default under, nor to the knowledge of the Corporation, does there exist any
                                         condition which with the passage of time or the giving of notice or both would result
                                         in such a material breach or default under, any such Material Contract by any other party
                                         to a Material Contract; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 100; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">neither the Corporation nor any
                                         of its subsidiaries has received any notice (whether written or oral), that any party
                                         to a Material Contract intends to cancel, terminate or otherwise modify or not renew
                                         its relationship with the Corporation or its subsidiaries, and no such action has been
                                         threatened.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.</TD><TD STYLE="text-align: justify">Indebtedness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than as disclosed in Section&nbsp;36
of the Disclosure Letter, the Corporation and its subsidiaries have no outstanding material indebtedness for borrowed money, capital
leases, obligations under hedging arrangements, letters of credit and similar obligations of, or outstanding guarantees of indebtedness
for borrowed money, capital leases, letters of credit and similar obligations of any person, except as reflected in the financial
statements of the Corporation that are included in the Public Disclosure Record.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.</TD><TD STYLE="text-align: justify">Insurance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of the Corporation and its subsidiaries
are insured by insurers that the Corporation believes to be reputable. There are no outstanding or pending material Claims under
insurance policies of the Corporation. The insurance policies of the Corporation and its subsidiaries are in full force and effect
in accordance with their terms and the Corporation and its subsidiaries are not in material default under the terms of any such
policy. Section&nbsp;37 of the Disclosure Letter sets forth a list of all current policies of insurance of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 101; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Schedule&nbsp;D<BR>
Arrangement Resolution</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BE IT RESOLVED THAT:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>The arrangement (the &ldquo;Arrangement&rdquo;) under section 192 of the Canada Business Corporations Act (the &ldquo;CBCA&rdquo;)
involving, among others, Cynapsus Therapeutics Inc. (&ldquo;Cynapsus&rdquo;), its securityholders, and Sunovion CNS Development
Canada ULC (&ldquo;AcquireCo&rdquo;), as more particularly described and set forth in the management information circular (the
&ldquo;Circular&rdquo;) of &#9632; dated &#9632;, 2016, as the Arrangement may be modified or amended, and all transactions contemplated
thereby are hereby authorized and approved.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>The plan of arrangement, as it may be or have been amended (the &ldquo;Plan of Arrangement&rdquo;) involving, Cynapsus , its
securityholders and AcquireCo, the full text of which is set out in Schedule A to the Circular, is hereby authorized and approved.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>The Arrangement Agreement dated August 31, 2016, between AcquireCo, Sunovion Pharmaceuticals Inc. and Cynapsus (the &ldquo;Arrangement
Agreement&rdquo;), the actions of the directors of Cynapsus in approving the Arrangement and the actions of the officers of Cynapsus
in executing and delivering the Arrangement Agreement and any amendments thereto are hereby ratified and approved.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>Notwithstanding that this resolution has been passed (and the Arrangement adopted) by the securityholders of Cynapsus or that
the Arrangement has been approved by the Superior Court of Justice of Ontario (Commercial List), the directors of Cynapsus are
hereby authorized and empowered (i) to amend the Arrangement Agreement or the Plan of Arrangement to the extent permitted by the
Arrangement Agreement, and (ii) subject to the terms of the Arrangement Agreement, not to proceed with the Arrangement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>Any officer or director of Cynapsus is hereby authorized and directed for and on behalf of Cynapsus to execute, under the corporate
seal of the Corporation or otherwise, and deliver articles of arrangement and such other documents as are necessary or desirable
to the Director under the CBCA in accordance with the Arrangement Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD>Any officer or director of Cynapsus is hereby authorized and directed for and on behalf of Cynapsus to execute or cause to
be executed and to deliver or cause to be delivered, all such other documents, agreements and instruments and to perform or cause
to be performed all such other acts and things as in such person&rsquo;s opinion may be necessary or desirable to give full effect
to the foregoing resolution and the matters authorized thereby, such determination to be conclusively evidenced by the execution
and delivery of such document, agreement or instrument or the doing of any such act or thing.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 102; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
